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ABSTRACT 
As a branch of healthcare, medical diagnosis can be defined as finding the disease based on the signs 
and symptoms of the patient. To this end, the required information is gathered from different sources 
like physical examination, medical history and general information of the patient. Development of 
smart classification models for medical diagnosis is of great interest amongst the researchers. This 
is mainly owing to the fact that the machine learning and data mining algorithms are capable of 
detecting the hidden trends between features of a database. Hence, classifying the medical datasets 
using smart techniques paves the way to design more efficient medical diagnostic decision support 
systems.  
Several databases have been provided in the literature to investigate different aspects of diseases. 
As an alternative to the available diagnosis tools/methods, this research involves machine learning 
algorithms called Classification and Regression Tree (CART), Random Forest (RF) and Extremely 
Randomized Trees or Extra Trees (ET) for the development of classification models that can be 
implemented in computer-aided diagnosis systems. As a decision tree (DT), CART is fast to create, 
and it applies to both the quantitative and qualitative data. For classification problems, RF and ET 
employ a number of weak learners like CART to develop models for classification tasks. 
We employed Wisconsin Breast Cancer Database (WBCD), Z-Alizadeh Sani dataset for coronary 
artery disease (CAD) and the databanks gathered in Ghaem Hospital’s dermatology clinic for the 
response of patients having common and/or plantar warts to the cryotherapy and/or immunotherapy 
methods. To classify the breast cancer type based on the WBCD, the RF and ET methods were 
employed. It was found that the developed RF and ET models forecast the WBCD type with 100% 
accuracy in all cases. To choose the proper treatment approach for warts as well as the CAD 
diagnosis, the CART methodology was employed. The findings of the error analysis revealed that 
the proposed CART models for the applications of interest attain the highest precision and no 
literature model can rival it. 
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The outcome of this study supports the idea that methods like CART, RF and ET not only improve 
the diagnosis precision, but also reduce the time and expense needed to reach a diagnosis. However, 
since these strategies are highly sensitive to the quality and quantity of the introduced data, more 
extensive databases with a greater number of independent parameters might be required for further 
practical implications of the developed models. 
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1 INTRODUCTION  
The last decades witnessed the utilization of machine learning and data mining approaches for 
investigating a large number of topics/problems in the realm of different sciences and engineering 
disciplines. This rapidly developing branch of artificial intelligence encompasses a wide variety of 
algorithms by which the method learns to perform tasks like regression and classification when 
exposed to data. Each of these methods has its advantages and disadvantages. In the medical domain, 
these methods have achieved success for supervised learning tasks. Indeed, many researchers have 
conducted smart techniques over medical data to uncover hidden knowledge and use them to learn 
regressors or classifiers for clinical decision making.  
Although smart techniques have shown promising performance for medical diagnosis, the success 
of such algorithms in real-world applications largely depends on the employed data for training and 
testing the model. Generally, machine learning-based methodologies require massive training 
datasets to generate an accurate yet reliable model for a correct diagnosis of the unseen cases. As 
modern hospitals and research institutes are well equipped with different data gathering tools, it is 
expected that having extensive medical datasets is achievable in the near future.  
In addition to the quantity of available data, the quality of the data plays a substantial rule in the 
development of a reliable model. For imbalanced datasets, the performance of the developed model 
is towards the class with higher instances. In the case of an imbalanced dataset for a classification 
task, accuracy is not a good criterion for the performance of presented models. Further to the 
accuracy, other parameters like sensitivity and specificity are helpful to ensure the classification 
performance of the models.  
Fig. 1.1 illustrates a typical medical diagnostic decision support system (MDDSS). As can be seen, 
by introducing medical data the MDDSS provides suggestion for healthcare professionals and they 
can make a decision based on their expertise and the system’s output.  
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Fig. 1.1: A typical medical diagnostic decision support system 
 
Utilization of machine learning approaches and others statistical pattern recognition models can 
improve the performance of MDDSSs. This research aims at designing and developing decision 
tree-based models that can be implemented in MDDSSs. To this end, CART, RF and ET algorithms 
were employed, and several classifiers were developed for: 
- Classification of breast cancer into benign and malignant; 
- Diagnosis of coronary artery disease; and  
- Selecting a proper approach for wart treatment. 
This dissertation consists of a review paper, and three original research works as follows: 
- Chapter 2: A review paper on breast cancer classification (submitted for publication) 
In the past few years, researchers developed several predictive models capable of classifying 
breast cancer types. Amongst all publicly available databases for breast cancer, the WBCD 
is the most widely used dataset to develop BC classification models. Chapter 1 of this thesis 
aims at identifying the published studies related to the implementation of machine learning 
and data mining algorithms for WBCD classification. Herein, the developed classifiers based 
on such algorithms as the artificial neural network (ANN), support vector machine (SVM), 
fuzzy logic (FL), DT and K-nearest neighbour (KNN), from 1995 to 2020, are reviewed and 
 3 
 
analyzed employing statistical parameters namely classification accuracy, sensitivity and 
specificity. 
 
- Chapter 3: A research work on the classification of breast cancer (submitted for 
publication) 
The first chapter of this thesis presented a review of published classification models for the 
WBCD. The main goal of this chapter is to evaluate the performance of two ensemble 
methods, namely RF and ET, in the classification of WBCD. To the best of the authors’ 
knowledge, this is the first work that presents simple visualized models based on the ET 
methodology in conjunction with the CART method to classify the WBCD. The RF and ET 
approaches include four main stages; namely input identification, determination of optimal 
number of trees, voting analysis, and final decision. The models implemented in this research 
consider important factors such as uniformity of cell size, bland chromatin, mitoses, and 
clump thickness as the input parameters. 
- Chapter 4: A research work on selecting a proper approach for wart treatment 
(published in Computers in Biology and Medicine 108, 400-409) 
In this work, the CART algorithm is employed to develop accurate predictive models capable 
of analyzing the response of patients having common and/or plantar warts to the cryotherapy 
and/or immunotherapy methods. To develop a CART classifier for the cryotherapy method, 
independent parameters including the age and gender of patient, number of warts, type of 
wart, surface area of warts and the time elapsed before treatment are used. In the case of 
immunotherapy, in addition to the above-mentioned variables, the induration diameter of the 
initial test is also considered. To the best of our knowledge, there no research studies in the 
literature that use CART-based methods for selection of the best approach for wart removal. 
The primary objective of the present work is to introduce simple-to-employ and accurate 
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DT-based models that can be used by physicians to select the best treatment method for 
common and/or plantar warts. 
 
- Chapter 5: A research work on the diagnosis of coronary artery disease (published in 
Computer Methods and Programs in Biomedicine 192, 105400) 
This paper involves a DT learning algorithm, namely CART, for a simple and reliable 
diagnosis of coronary artery disease, also called ischemic heart disease. Several CART 
models are developed based on the recently coronary artery disease dataset published in the 
literature. To the best of our knowledge, this is the first work on the application of CART to 
study the Z-Alizadeh Sani CAD dataset for diagnosis/classification purposes. 
The last section of this dissertation provides the readers with a summary, conclusions, and 
recommendations for future work. 
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ABSTRACT 
Breast cancer (BC) is one of the most frequently diagnosed cancers among women around the globe. 
Over the past few decades, several studies have attempted to develop classification models to 
identify BC by applying machine learning and data mining (MLDM) approaches to both private and 
public BC datasets. These classifiers can be used for the development of computer-aided diagnosis/ 
detection (CAD) systems to investigate BC. Up until now, several databases have been provided in 
the literature to investigate different aspects of BC. Amongst all available BC databanks, the 
Wisconsin Breast Cancer Database (WBCD) is the most widely used dataset to develop BC 
classification models. This research aims at identifying the published studies related to the 
implementation of MLDM algorithms for WBCD classification. Herein, the developed classifiers 
based on such algorithms as the artificial neural network (ANN), support vector machine (SVM), 
fuzzy logic (FL), decision tree (DT) and K-nearest neighbour (KNN), from 1995 to 2020, are 
reviewed and analyzed employing statistical parameters namely classification accuracy, sensitivity 
and specificity. It was found that some of these techniques are capable of providing excellent results 
for breast cancer diagnosis. However, to implement these systems on large scales, further analyses 
should be performed on different breast cancer datasets.  
 
KEYWORDS: Breast cancer; WBCD; classification; machine learning; data mining; computer 
aided diagnosis; review 
 
 
2.1 INTRODUCTION 
2.1.1 BC Overview  
BC occurs in both women and men. However, as opposed to other cancers like lung, prostate, 
colorectal and stomach, BC is rare cancer amongst men. Nevertheless, this heterogeneous disease is 
one of the most common cancers amongst females worldwide. The abnormal breast cells are the 
starting points for BC development. Commonly, BC appears in the ducts, lobules, milk-producing 
glands and the milk-carrying tubes. The simplified anatomy of the woman adult breast is depicted 
in Fig. 2.1.  
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(a) 
 
(b) 
Fig. 2.1: Anatomy of the woman breast; (a) front view; (b) cross section view (Adapted from Ref. 
[376])  
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BCs can be split into two main categories: the sarcomas and the carcinomas. Sarcomas, that account 
for less than 1% of primary BCs [1], are cancers originating in connective tissues of the breast like 
blood vessel cells and myofibroblasts. As the most common BCs, carcinomas start in epithelial 
tissues of the breast, i.e. the components that line the terminal ducts and the lobules. In situ and 
invasive carcinomas are significant types of carcinomas. As pre-invasive carcinoma, in situ 
carcinoma grows inside of the normal ducts and/or lobules (stages 0 and I). Invasive carcinomas 
(stages II to IV) are the cancers that have infiltrated the outside of the normal breast ducts/lobules. 
Invasive cancers may spread to other parts of the body in the way of metastases.  
A worldwide estimation of the age-standardized rates (ASR) of incidence and mortality of common 
cancers in 2018, for both genders and all ages, is depicted in Fig. 2.2. As can be observed from Fig. 
2.2(a), BC is the most prevalent cancer in the world. Moreover, Fig. 2.2(b) shows that this 
multifaceted and complex disease is the primary cause of cancer death for women.  
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Breast Prostate Lung Colorectum Cervix uteri
A
S
R
 p
e
r 
1
0
0
,0
0
0
0
10
20
30
40
50
Incidence
Mortality
 
(a) 
 9 
 
Cancer
Breast Colorectum Lung Cervix uteri Thyroid
A
S
R
 p
e
r 
1
0
0
,0
0
0
0
10
20
30
40
50
Incidence
Mortality
 
(b) 
Fig. 2.2: Estimated ASR of incidence and mortality of most common cancers in 2018 (a) 
worldwide, all ages, both genders; (b) worldwide, all ages, women (Based on the data from 
GLOBOCAN 2018 [2]) 
 
The occurrence of BC for women of all ages in different regions, in terms of incidence and mortality 
rates, is illustrated in Fig. 2.3. Fig. 2.3 shows that the incidence and mortality rates vary across 
different regions, ranging between 34.4-86.7 and 11.3-17.2, respectively [2]. Generally, more 
developed areas, i.e. Oceania, Europe and North America, experience much higher BC incidence 
rates than other regions, including Africa, Asia, Latin America and the Caribbean. As can be seen 
from Fig. 2.3, the lowest BC incidence rate is found in Africa, but here has the highest BC mortality 
rate as well.    
Studies showed that the incidence of BC has increased over the last decades. However, a research 
study showed that the survival rate from BC in the previous four decades has risen from 40% to 80% 
[3]. Another work showed that the five-year survival rate for patients with BC had been increased 
 10 
 
from 75% in 1976 to more than 90% in 2017 [4]. Another study indicated that the ASR of BC 
mortality fell from 33 per 100,000 per year in 1990 to 21.3 per 100,000 per year in 2010, which 
shows a 36% decline in mortality rate [5]. The improvements in survival rates from BC are 
commonly attributed to two main lines of thought [5]. A group of researchers believe that 
mammographic screening yields positive results [6-8]. On the other hand, it is claimed that the 
decline in deaths from BC is due to the adjuvant systemic therapies [9, 10].   
ASR per 100,000
0 20 40 60 80 100
Africa
Latin America & Caribbean
North America
Asia
Europe
Oceania
Incidence
Mortality
 
Fig. 2.3: Estimated ASR of incidence and mortality of BC in women in different regions. (Based 
on the data from GLOBOCAN 2018 [2])  
 
2.1.2 Classification Studies 
The last decades witnessed the utilization of MLDM approaches and/or CAD systems for 
investigating a large number of topics/problems in the realm of different sciences and engineering 
disciplines. In the case of BC, there are a large number of publications employing methods like 
ANN, FL, SVM, DT and KNN for developing the classification models and/or CAD systems. There 
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are publicly available databases for BC. For example, the Mammographic Image Analysis Society 
(MIAS) digital mammogram database [11], Image Retrieval in Medical Applications (IRMA) 
databank [12], Digital Database for Screening Mammography (DDSM) [13], WBCD [14] and 
Wisconsin Diagnostic Breast Cancer Database (WDBC) [15-17].  
In addition to the publicly accessible databases, there are various private databanks in the literature. 
Utilizing these private databases, researchers employed MLDM methods to study breast cancer. For 
example, researchers employed fuzzy C-means (FCM) to detect suspicious breast tissue regions 
[18]. The used database included 40 malignant and 21 benign samples. These samples were biopsy-
confirmed lesions in 34 female cases. It was revealed that fuzzy-based detection of breast masses, 
benign or malignant, using appropriate feature sets could provide 100% accuracy. The FCM method 
was also employed in another study to analyze a private database for breast cancer [19]. The 
achieved accuracies were around 95%. Schaefer [20] applied the ACO-based classification method 
to study the breast thermograms (117 benign and 29 malignant samples). The proposed model 
provided 79.5% accuracy for the test data. In another work [21], the ultrasound images of patients 
at the University of Chicago Medical Center were analysed using linear discriminant analysis (LDA) 
algorithm to classify the nodes that were negative for metastasis (114 cases) and nodes that were 
positive for metastasis (109 cases). Applying multiple discriminant analysis (MDA) on private 363 
ultrasound images, the obtained accuracies for invasive carcinomas, non-invasive carcinomas, 
fibroadenomas and cysts were 88.4%, 80.6%, 86.0% and 84.1%, respectively [22].     
Using the KNN algorithm, a study was performed on a database, including 97 ultrasonographic 
images of the breast at Mie University Hospital [23]. This database has 49 malignant samples and 
48 benign cases. In the observer investigation, three breast surgeons (expert) and seven clinicians 
(general) were employed. It was found that utilization of KNN model as a CAD scheme improved 
the capability of viewing the probability of the histological classifications of non-mass lesions that 
appear as the hypoechoic zone in a mammary gland for both the general and expert cases. In another 
work [24], the KNN technique was applied on a databank of 200 women patients’ magnetic 
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resonance images in order to classify the non-invasive lesion subtype. From the group of 200 women 
patients, it was identified that 148 lesions were suitable for investigation. For all histological 
subtypes, including lobular, ductal and DCIS, the accuracy of the KNN classification was about 
75%. Studying 234 female patients (149 malignant and 85 benign lesions) by magnetic resonance 
imaging (MRI) at the Sun Yat-sen University Cancer Center, researchers defined 28 features for 
each lesion [25]. Then, KNN, SVM and random forest (RF) methods were used to test their 
classification performance. Using different feature subsets, the average accuracy of the SVM and 
KNN models was around 80%, and the RF provided an accuracy of about 70%. Both KNN and ANN 
methods were used to classify a database of mammograms into biopsy-proven malignant mass (80 
samples) and masses without cancer (120 samples) [26]. In a research study [27], the ANN model 
was developed to classify the density of breast tissue using mammograms collected at EL FARABI 
radiologic center.  
For lesion classification, employment of SVM method with different kernels including linear, 
polynomial, radial basis function (RBF) and sigmoid on a database containing 84 MRI images (23 
benign and 61 malignant lesions) was evaluated in the literature [28]. A group of researchers 
presented a phase-based texture descriptor for discriminating the malignant and benign cases in 
breast ultrasound images [29]. To this end, the authors employed the SVM approach with the RBF 
kernel function. The used databank contains 138 images (69 benign samples and 69 malignant 
samples) that were obtained from Huashan Hospital. Although the proposed model, with around 
85% accuracy, provided satisfactory results, this CAD system is not fully automatic. In another work 
[30], the combined performance of morphological and textural features for detecting the breast 
masses in 120 ultrasound images was assessed. The used database consists of 50 malignant cases 
and 70 benign samples. For the classification purpose, a particle swarm optimization (PSO)-based 
SVM method with RBF kernel was employed that provided an accuracy of higher than 95%. To 
classify the ultrasound breast tumour images of 90 malignant cases and 120 benign cases, Wu, Lin 
and Moon [31] employed immune system-based SVM strategy. The proposed classification model 
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achieved accuracy of 96.7%. Other related works in this regard can be found in the literature [32-
135].  
 
2.1.3 Study Objectives  
Based on recent research, a large number of deaths happens because of cancers like BC. The most 
important reason is the detection of cancer at an advanced stage. Hence, early-stage detection of BC 
is crucial to adopt a proper treatment. As an alternative to traditional approaches for BC 
investigations, MLDM algorithms have been used in the literature for BC studies. The primary 
objective of the present study is to review the published works on the implementation of MLDM 
algorithms and CAD systems for investigation of the BC; in particular, the classification models 
developed using WBCD.  
To this end, the rest of the work is organized as follows: In Section 2.2, the theoretical aspects related 
to the BC, like factors causing BC, prevention of BC, BC diagnosis methods, imaging modalities 
for BC and different therapy approaches of BC is presented. Section 2.3 briefly presents a general 
development procedure of the CAD system for BC. In Section 2.4, the classification models 
developed based on the WBCD are reviewed. Using some statistical parameters, the performance of 
the developed classifiers for WBCD is assessed in Section 2.5. The study is concluded in Section 
2.6. Finally, Section 2.7 presents the recommendations for future studies. 
 
2.2 THEORETICAL ASPECTS 
2.2.1 Factors that Affect BC 
The risk factor is defined as anything that increases the chances of developing a specific disease. 
Generally, the more risk factors an individual has, the higher the chance that he/she gets the disease. 
However, the presence of a risk factor, and even several risk factors, doesn't necessarily mean that 
developing a particular condition is inevitable. In other words, the risk factors do not directly cause 
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disease. Furthermore, risk factors can be categorized as unchangeable and changeable factors. 
Factors like gender and age are fixed risk factors and cannot be modified, while variable risk factors 
like smoking and blood pressure can be modified with changing the lifestyle or treatment.  
Different risk factors are associated with different diseases like cancers [136]. Leading contributing 
factors in BC development are known to be as follow: 
- Gender: the most substantial risk factor for BC is gender (being a woman) [136]. Indeed, 
around 99 percent of BC cases occur in women [137]. However, BC incidence amongst 
males has risen 60 percent since 1990 [138]. With an estimated 41000 deaths in 2018, BC 
has the second-highest mortality rate amongst females [139]. Studies showed that the 
lifetime risk for women in the UK and the USA of being detected with BC was one in every 
eight cases [140, 141]. 
- Age: ageing is another considerable risk factor for the development of BC. Getting older 
increases the likelihood of developing BC. For example, if the current age of a woman is 20, 
the probability of developing BC in the next ten years is 0.05%. On the other hand, the 
probability value for a woman of age 70 is 4.14% [142]. Due to the fact that the probability 
of a female developing BC is dependent on her age, it is suggested to consider the risk 
estimation at certain ages instead of considering the lifetime risk estimation [138]. 
- Family history/genetics: although more than 85% of women diagnosed with BC do not have 
a family history of BC, it is believed that women with a family history of BC have an 
increased likelihood of BC development [143, 144]. In the period from 1950 to 1979, family 
history was identified as a risk factor for BC [145]. Three main variables are at play in 
examining the role of family history: the degree of relationship between relatives with BC 
and the patient (first degree, second degree or beyond), the age of BC diagnosis in the 
relatives and the history of other genetic factors/cancers that are related to BC [138]. The 
lifetime risk of BC increases by 40-85% as a result of high penetrance gene mutations called 
BRCA1 and BRCA2 [146, 147]. In addition to family history, the personal history of BC or 
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other types of cancers is also known to be a risk factor. Indeed, women who are BC survivors 
or women with a history of specific cancers have an increased risk of BC development [148]. 
- Ethnicity/race: as can be observed from Fig. 2.3, ASRs of incidence and mortality of BC in 
women vary from region to region. The reasons behind these differences are not well 
addressed in the literature yet. However, the roles of factors like access to health care, 
lifestyle and genetics are considered to be important in this regard. For example, it was found 
that the risk profile of daughters of Asian women who are born in North America are similar 
to white American women [138].  
- Lifestyle: studies relate some behavioural factors to the risk of developing BC. For example, 
the risk of developing BC increases by 30-60% by being overweight [149]. Doing regular 
exercise is a factor that reduces the risk of BC [150]. The association of tall stature with 
increased BC risk is also documented in the literature [151]. Alcohol consumption is known 
as a factor that increases BC risk [152]. Diet is another risk factor that is modifiable [153-
155]. Exposure to radiation ranging between 1 and 3 Gy for treatment o some diseases like 
scoliosis increases the risk of BC in women aged less than 40 years [156]. 
-  Reproductive and menstrual factors: high levels of estradiol circulation in the bloodstream 
increases the risk of BC amongst postmenopausal females [157]. This study also showed that 
girls who began menses after age 15 have a decreased risk compared with girls who started 
before age 12 [157]. There is a slight increase in BC risk for the first ten years after the 
delivery of the baby. However, eventually, BC risk decreases to below that of a female 
without children. Furthermore, breastfeeding leads to a reduction in BC risk [138]. The 
protection from BC is even better if women breastfeed for more than 25 months [158]. 
Studies also revealed a relationship between the use of hormone replacement therapy and 
BC risk [159]. Females with high bone density are considered at higher risks for BC [160]. 
More considerable amounts of connective and milk duct tissues in the breast, i.e. higher 
breast density, is found to increase the risk of BC [159]. 
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Identification of BC risk factors and, consequently, underlying the impact of each of them on 
developing BC is a crucial task. The widely available way to reduce the risk of BC is the 
implementation of proper lifestyle modifications according to the impacts of modifiable risk factors. 
In addition to the lifestyle modifications, chemoprevention and genetic counselling are other 
strategies for BC risk reduction. Furthermore, one of the most critical actions that should be taken 
is following the early detection approaches and guidelines. Although early detection of BC does not 
prevent the disease, it increases the chances of successful treatment. 
 
2.2.2 Methods for BC Diagnosis 
Early detection of BC improves the likelihood of survival and increases the possible options for 
treatment as well. Furthermore, early BC detection reduces treatment expenses [161]. Currently, 
average treatment costs for stages 0, I, II, III and IV are $60637, $82121, $82121, $129387 and 
$182655, respectively [162]. Several screening approaches are proposed in the literature for the 
detection of BC. According to the Canadian Cancer Society [163], screening is defined as checking 
for a particular disease in a group of individuals who have no symptoms of the disease. The manual 
self-examination is the most straightforward and widely available technique for BC screening. In 
this method, every breast is palpated for abnormal lumps and distortions [161]. As the self-
examination can detect up to 50% of asymptomatic BCs [164], monthly self-exam is recommended 
by the American Medical Association. However, studies have shown that this method might lead to 
a high rate of false positives. As a result, women who practice self-exams may experience depression 
and anxiety [161].  
Several image modalities can be utilized for examination of the breast for probable cancer. In 
general, these imaging modalities are helpful for precise analysis of certain facets of breast tissue 
organs. The most common choice in clinical practice is the mammography that employs low-dose 
x-rays. Since mammography might be less accurate for women with dense breasts [165], ultrasound 
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imaging can be considered as a proper modality [166]. To form pictures of the whole breast volume, 
the magnetic resonance imaging (MRI) technique can be utilized. Other conventional image 
modalities are infrared thermography and microscopic imaging. The rest of this section gives a brief 
introduction to the mammography, ultrasound and MRI modalities for BC screening. 
A typical mammographic picture of a woman’s breast is shown in Fig. 2.4. Although mammography 
is a low-cost proper screening method for BC, mass detection in mammograms could be challenging. 
This is owing to the fact that masses available in different sizes, shapes and margins [167]. 
Moreover, masses are often indistinguishable from their surrounding tissues [168, 169]. Over the 
past years, more efficient mammography systems were introduced. The replacement of x-ray films 
by electronics is the most significant improvement in this regard. This technique, called digital 
mammography or full-field digital mammography (FFDM), needs a lower radiation dose and 
provides better pictures [170]. For women aged under 50 years, FFDM found to be more accurate 
[165]. Some studies indicated that BC detection rate with FFDM is more than 4.2 per thousand 
mammograms [171, 172]. 
 
Fig. 2.4: A mammographic picture of a woman’s breast (adapted from Ref. [377]) 
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For women with dense breasts, breast ultrasound is suggested as a proper alternative for 
mammography. As an advantage over the mammography, the ultrasound modality is a radiation-
free approach and patients well tolerate it [45]. However, according to a report by the American 
College of Radiology Imaging Network [173], the combination of mammography and ultrasound 
methods improves the BC detection. To perform high-quality breast ultrasound, the American 
College of Radiology (ACR) standards established professional guidelines that cover technical 
parameters, equipment, personnel and image annotation [174]. Based on the ACR standards, Baker 
and Soo [175] assessed the imaging appearance and technical quality of breast sonograms. In Fig. 
2.5, a sample of the ultrasound images is depicted.  
 
 
Fig. 2.5: A picture of a woman’s breast captured using ultrasound modality (adapted from Ref. 
[378]) 
 
Another valuable tool for assessment of the BC is MRI. Fig. 2.6 shows an image of a woman's breast 
generated using the MRI.  
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Fig. 2.6: A picture of a woman’s breasts obtained via MRI (adapted from Ref. [177]) 
 
This imaging modality that entails injecting the contrast medium in the patient's body is often 
utilized in high-risk cases. Furthermore, this technique is a good tool to evaluate the newly detected 
BC before operation [176]. Indeed, MRI enables us to get more information on probable deep 
involvement, and it is capable of revealing signs of chest structure and underlying muscles' 
inflammation [177]. The sensitivity of the MRI modality in BC ranges between 85 and 100%. As a 
result, this technique is efficient in excluding the BC recurrence in cases without any access to image 
the primary tumor region on mammography [178]. On the other hand, since the specificity of this 
imaging modality may be moderate (ranged from 60 to 90%), it can be impossible to define the 
tumor’s origin, i.e. malignant or benign [178-180]. For breast MRI with final evaluations that are 
connected to suggestions for care, a lexicon is provided by the American College of Radiology 
Breast Imaging Reporting and Data System (BI-RADS) [181]. 
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Further to the above, positron emission tomography (PET) is another tool that visualizes the areas 
of higher metabolism in the region of interest. In this method, the body receives a slightly radioactive 
sugar; consequently, more tracer substance is absorbed by the tissues having a higher metabolism. 
Compared to other tissues, tissues with higher metabolic rates show brighter [161]. Utilization of 
the PET technique in combination with the computed tomography plays a progressively significant 
role in all facets of BC like staging, curative treatment as well as follow-ups [182, 183]. PET-CT 
method has high sensitivity in the detection of primary breast tissue. Furthermore, this technique has 
revealed high specificity as well as a high positive predictive value [184]. Surgical options are also 
available for the diagnosis of BC [185].  
 
2.2.3 Therapy/Treatment Methods of BC 
A range of treatments and therapies are available to deal with BC. However, decision making 
regarding the BC treatment approach for each patient is a multidisciplinary task, and all the cons 
and pros of the possible options must be discussed before finalization of the plan [186]. Due to the 
discussions of tumor board about the patient status, the mortality from BC has been reduced [187]. 
Biometric data of the patient like age, height and weight is an essential factor that must be taken into 
account to design a BC treatment plan. The tumour size and biological characteristics, cancer type, 
involvement of axillary nodes as well as nearby regions like the breast skin, estrogen receptor, 
metastases and also the financial status of the patient are some other important factors in this regard 
[188]. The main approaches for BC treatment are surgery, radiotherapy, chemotherapy, hormonal 
therapy and targeted therapy. In some cases, a combination of these treatments may be utilized.  
Nowadays, the surgical approach is the central aspect of BC therapy and treatment, as it was before. 
The primary treatment modality for the majority of females diagnosed with early BC is the surgical 
option [3]. Generally, mastectomy and breast-conserving surgery are the two fundamental types of 
this treatment approach. The form of surgery is substantially associated with the size of the tumor 
[188]. In cases that the tumour is too large, the surgery is in the form of mastectomy. However, 
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breast-conserving surgery can be utilized if the neoadjuvant chemotherapy could shrink the tumour 
to small enough size [136]. For early-stage invasive carcinomas, breast-conserving surgery is the 
most fundamental part of the patient's treatment [189-191]. After the mastectomy, the next essential 
step of the procedure might be the breast reconstruction that has emotional and psychological 
benefits to the patients [192, 193].  
Generally, BC treatment consists of surgery with or without systemic therapy like hormonal therapy 
and chemotherapy and with or without radiation. Systemic therapy might be applied before surgery 
(known as neoadjuvant) or after surgery. If the systemic therapy must be administered after the 
surgery, it might be employed after radiation, concurrent with radiation or before radiation [138]. 
For the systemic chemotherapy, there are several regimens that typically contains a taxane and an 
anthracycline [194-196]. Patients with HER2-positive BC are treated utilizing chemotherapy in 
combination with targeted therapy [197]. For patients with stage I HER2-positive BC, employing 
the paclitaxel with trastuzumab is a common regimen [198]. For stage II and II HER2-positive BC, 
the standard is the administration of dual-HER2 agents [199]. Commonly, endocrine therapy is 
recommended for patients with HR-positive BC [200]. 
Cancer treatments might have physical and psychosocial side effects. Fatigue, pain, nausea, changes 
in skin and nail, appetite changes, loss of sex drive, fertility issues in females, memory and sleeping 
problems, nerve problems and changing body image are some common side effects on the physical 
status of the patients [201]. Psychosocial side effects of BC are related to the psychological, lifestyle 
and social aspects of the patient [188]. Complementary therapies can be helpful in the effective 
management of the BC treatment side effects and the recovery process. This type of therapy (like 
music and energy therapy, hypnotherapy, acupressure, meditation, etc.) is not part of/alternatives to 
the medical treatments [188]. Since the recurrence of BC after the treatment procedures is probable, 
surveillance of BC survivors is a crucial part of their care. American Society of Clinical Oncology 
(ASCO) developed the guidelines for post-treatment surveillance in BC [202]. 
 22 
 
2.3 CAD SYSTEMS FOR BC STUDIES 
2.3.1 Development Procedure 
The development of CAD systems for investigation of the BC is considered as a practical approach 
to detect masses and classifying them as well. Indeed, CAD systems are beneficial, helping experts 
to interpret the breast images (mammogram, ultrasound, MRI, microscopic, or infrared 
thermography). Research showed that CAD-based approaches are being more accurate as the 
MLDM methods and related areas are developing [203, 204]. Since the majority of the published 
studies utilized mammograms to detect BC via CADs, this section overviews the CAD development 
procedure for mammograms. It is worthwhile to mention that CAD in mammograms was approved 
by FDA in 1998 [205]. 
Considering the mammograms, the CAD systems can be employed to classify the mammographic 
lesions into malignant or benign mass. There are several main steps in the development of a typical 
CAD system for breast mass detection and classification. Fig. 2.7 schematically demonstrates a 
typical CAD, which includes four main stages, for the application of interest. CAD also can be 
divided into two parts, namely computer-aided detection (CADe) and computer-aided diagnosis 
(CADx). Utilizing CADe, such abnormalities in breast lesion as clustered masses and micro-
calcifications can be detected. Then, the CADx is used to classify the detected anomalies. Finally, 
the computer flags the regions of concern on the image [206].  
As can be observed from Fig. 2.7, the first step is the digitization of the mammograms and pre-
processing the images. As shown in Fig. 2.8, and having the anatomy of the breast (Fig. 2.1) into 
consideration, it is demonstrated that the dense tissues, like glandular, are represented by bright 
areas, and the less tense tissues, like fatty, are less bright. Generally, the brighter areas have higher 
noise levels. In other words, different brightness levels in different sections of the image produce 
some noise. Hence, the pre-processing step should be performed for decreasing/ equalizing the noise 
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level in mammograms and improving the image's contrast. Proper pre-processing substantially 
increases the success probability in the next steps of CAD design for breast cancer study. 
 
 
Fig. 2.7: Schematic of a typical mammogram-based CAD system for breast mass classification   
 
Since most mammograms are high resolution and large size images, applying a size reduction 
technique is usually done during the pre-processing step. The detailed information regarding the 
mammogram pre-processing can be found in the literature [207-214].  
 
 
(a) 
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(b) 
Fig. 2.8: (a) A typical ROI showing a mass in the mammogram; (b) mass segmentation from the 
tissue of the background (adapted from Ref. [379]) 
 
The segmentation phase can be defined as the separation of the main sections from the other parts 
of the image. Indeed, the contours of the suspected lesion, or region of interest (ROI), are identified 
and separated to define meaningful regions for speeding up the next steps of CAD system 
development. Fig. 2.8 demonstrates a sample of mass segmentation from the tissue of the 
background in a mammogram. However, due to the problems like homogeneity between breast and 
pectoral tissues, imperfections in the process of mammograms scanning, tags and light leakages, this 
step is a challenging task [215, 216]. There are many methods and techniques in the literature 
proposed for the segmentation of mammograms [217-233].  
The segmented regions, then, are employed to extract out the features. These features that are 
quantitative measures are the primary representative of the mammograms of the breast. A variety of 
feature extraction methods have been used and evaluated in the literature [77, 234-243]. As opposed 
to feature extraction methods that build a new set of attributes via combining the existing features, 
a value of importance is assigned to each feature in the feature selection algorithms [244]. Indeed, 
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the feature selection methodologies eliminate the redundant and irrelevant features from the original 
set [245]. As a result, the informative features are selected for the classification phase.    
The next primary step in the development of a CAD system for BC is the classification. In this phase, 
corresponding to a malignancy/benignancy and/or the lesion type, the vector of features is labelled 
as a specific class. The previous steps directly affect the accuracy of the classification process. 
ANNs, SVMs, FL, adaptive neuro-fuzzy inference system (ANFIS), KNN, DTs and Naïve Bayesian 
(NB) are good examples of classifiers that can be used to perform the classification task. The 
constructed model can be utilized for the prediction of future samples. The final step in the CAD 
system development can be defined as the assessment stage. The purpose of this step is to evaluate 
the accuracy and robustness of the developed CAD system for the investigation of BC.    
 
2.3.2 Software and Computational Tools for BC Classification 
Several data mining tools and software are available that can be utilized for BC investigations. 
Waikato Environment for Knowledge Analysis, also known as Weka, is free software that has an 
assortment of modeling and visualization techniques. Data mining and modeling tasks like data pre-
processing, data visualization, feature selection, regression, classification and clustering can be 
performed using Weka. Orange is another toolkit for MLDM and data visualization. This open-
source component-based visual programming software can be used as a Python library for widget 
alteration and data manipulation. KNIME provides an easy to implement tool for fast data 
exploration. As a new platform for data analytics, KNIME has a wide variety of machine learning 
algorithms, from decision trees to deep learning networks, for predictive modeling. Another free 
suite of MLDM approaches for researchers is Tangara. This tool consists of techniques and 
algorithms for instance selection, feature selection and construction, descriptive statistics, data 
visualization, classification, clustering, regression and association rule learning.  
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2.3.3 Current Status and Future Prospects of BC Classification 
The last decade witnessed an increase in applying different MLDM techniques like ANNs, SVMs, 
fuzzy logic and evolutionary algorithms for BC investigations. As a result, the diagnosis of BC, 
especially at the early stages, has boosted up. However, there is still a need for better models in 
terms of accuracy, precision and speed.  
Amongst the available MLDM methods, deep learning showed a good potential for solving 
regression, classification and pattern recognition problems. The deep learning approach provided 
satisfactory results, especially in tasks related to image processing. This is owing to the fact that this 
approach enables the user to capture even the smallest changes in images. This feature is very vital 
in tasks like BC detection/classification. Besides all the advantages that deep learning has to offer 
for BC studies, some considerable drawbacks are associated with this approach. Indeed, a large 
amount of data is required to develop predictive models based on deep learning. Furthermore, due 
to its complex data models, training a system using deep learning can be expensive.    
 
2.4 WBCD CLASSIFICATION STUDIES 
2.4.1 WBCD: An Overview 
This section briefly introduces the WBCD. The WBCD, originally reported by Dr. William H. 
Wolberg at the University of Wisconsin Hospitals in Madison [14], presents some measurements 
related to BC. This databank is provided in accordance with the FNAB data [246]. Each dataset of 
this database comprised of nine cytological characteristics of benign or malignant breast fine-needle 
aspirates. The WBCD has a total number of 699 records where 458 (65.5%) datasets are defined as 
"benign," and 241 (34.5%) datasets are classified as "malignant." 
Excluding the ID number, each dataset of the WBCD has ten attributes, nine of which are 
independent parameters and the breast cancer type, i.e. benign or malignant, is the dependent 
 27 
 
parameters. Each independent characteristic is graded with a value that ranges between 1 and 10. In 
respective order, 1 and 10 indicate the typical benign and typical malignant. There are 16 datasets 
in the WBCD with missing values. The remaining datasets contain 444 benign and 239 malignant 
cases. Further information about the WBCD independent attributes is given in Table 2.1. 
 
Table 2.1: Information about the refined WBCD 
Feature  Range Average 
Uniformity of Cell Size 1-10 4.442 
Uniformity of Cell Shape 1-10 3.151 
Bare Nuclei 1-10 3.215 
Single Epithelial Cell Size 1-10 2.830 
Bland Chromatin 1-10 3.234 
Normal Nucleoli 1-10 3.545 
Clump Thickness 1-10 3.445 
Marginal Adhesion 1-10 2.870 
Mitoses 1-10 1.603 
  
From the early nineties, a great number of modeling attempts have been made by implementing 
different MLDM algorithms to analyze the WBCD. In this section, the published works on the 
classification of breast cancer based on the WBCD using various MLDM techniques such as ANNs, 
FL and SVMs, from 1995 to 2020, are reviewed. It should be noted that although ANNs and SVMs, 
as the most employed approaches in BC classification, can be used for performing nonlinear 
modeling, they mainly have a "black box" nature. Indeed, ANNs and SVMs do not provide detailed 
insights into the mathematical formulation/structure of the function. Moreover, these techniques, in 
general, suffer from overfitting problems. Being stuck in multiple local minima is another serious 
drawback for a majority of connectionist tools. To improve the accuracy of the modeling, the 
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methods might be implemented in conjunction with various algorithms such as genetic algorithm 
(GA) and PSO. Besides, the models appear to be complicated. 
 
2.4.2 ANN-Based Models 
ANN frameworks are able to learn to do assignments by pondering models, generally without being 
programmed by task-explicit guidelines. ANNs are trainable even with deficient information. 
However, ANNs give a superior exhibition when there is an extensive dataset for training. These 
algorithms have the ability to break the main problem into simpler ones. On the other hand, ANNs 
function as a black box. Furthermore, there is no universal method for deciding the structure of an 
ANN. 
Using a neural network (NN) pruning algorithm, Setiono [247] presented three-layer feed-forward 
(FF) ANN models having a different number of neurons in the hidden layer. Then, some rules were 
extracted from the developed NN models for the diagnosis of breast cancer. Setiono and Liu [248] 
used a standard FF-ANN to obtain the most useful attributes of the WBCD for defining the breast 
cancer classes. For this database, 30 ANNs with 12 hidden neurons were created. Results suggested 
that the performance of the network can be increased using about one-third of the total input features. 
Unfortunately, the selected input features are not reported in this study. In another study, Setiono 
and Liu [249] compared the DT and three-layer FF-ANN rules for the WBCD. Amongst the 
available DT methods, the authors employed the C4.5 model [250]. Although the FF-ANN slightly 
provided better results than the DT, the neuron-based model has more rules than the DT. The number 
of extracted rules from the ANN and DT models were seven and four, respectively. Moreover, using 
the DT produces interpretable rules. However, the ANN models are commonly known as "black-
box" models that are hard to interpret. As a continuation of the published series on the application 
of FF-ANN method for WBCD classification, Setiono [251] investigated the influence of the data 
pre-processing on the accuracies of both the networks and the associated rules (the rules extracted 
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from the developed networks). First, the datasets with missing values were discarded from the 
databank. Second, the most relevant independent parameters of the WBCD were selected for 
classification. It was found that data pre-processing improves the performance of the networks and 
the extracted rules for the problem of WBCD classification.  
Further to the above, Taha and Ghosh [252] introduced an extracted rule-based system using the 
ANN strategy. Then, they integrated the trained ANN model and the rule-based system to improve 
classification accuracy. Indeed, the authors employed three methods to extract rules from trained 
FF-ANNs, including the binarized input-output rule extraction (BIO-RE), partial-RE and full-RE. 
The use of four different NN architectures, including the multi-layer perceptron (MLP), RBF, a 
mixture of experts (MOE) and general regression (GR) network for the breast cancer classification, 
was evaluated by West and West [253]. Results showed that all these methods approximately 
provide the same accuracies. The MLP-ANN method, in combination with a learning algorithm that 
applies linear least square, is also used in a different study as the classifier for the database of WBC 
[254]. The authors compared the proposed linear algorithm with four well-known learning 
algorithms: gradient descent (GD), gradient descent with adaptive momentum and step sizes (GDX), 
Levenberg-Marquardt (LM) and scaled conjugated gradient (SCG). The best results in terms of 
accuracy, as well as the processing speed obtained from the GDX methodology. However, the speed 
of the proposed linear algorithm found to be better than GD, LM and SCG techniques. In summary, 
this linear method offers an acceptable combination of simplicity, accuracy and speed. Utilizing 
three models, including RBF, MLP and probabilistic NNs,  Azar and El-Said [255] classified the 
WBCD into two categories. Amongst the presented models, probabilistic ANN provided the best 
outputs.  
Using a particular type of MLPs, namely artificial metaplasticity (AM) MLP algorithm, a 
classification model/approach was developed by researchers to deal with the information of WBCD 
[256]. The developed AM-MLP, then, was compared to the classical back-propagation (BP) ANN. 
According to the outcomes, the AM-MLP is superior to the BP-ANN training in all samples. 
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Application of several BP algorithms including the batch gradient descent (BGD), Quasi-Newton 
(QN), batch gradient descent with momentum (BGDM), resilient back-propagation (RBP), LM and 
conjugate gradient (CG) in WBCD classification was also evaluated in some other literature studies 
[257, 258]. In addition to the BP-ANN, Šter and Dobnikar [259] tested a special type of ANNs 
known as learning vector quantization (LVQ) for the WBCD case. Classification and regression tree 
(CART), LDA, quadratic discriminant analysis (QDA), KNN, look ahead feature construction 
(LFC), assistant-I (ASI), assistant-R (ASR), NB and semi-Naïve Bayesian (SNB) are other 
employed methods in this study. Based on the error analysis, the QDA model provided the lowest 
accuracy. Other developed models have approximately equal performance. Janghel, Shukla, Tiwari 
and Kala [260] implemented several ANN algorithms, including BP-ANN, LVQ, recurrent ANN 
(R-ANN), RBF-ANN, probabilistic ANN (P-ANN) and competitive learning (CL) ANN for the 
breast cancer classification. LVQ, big LVQ, and artificial immune recognition system (AIRS) were 
applied to the WBC database by Goodman, Boggess and Watkins [261]. 
Three classification models using BP-ANN, real coded GA, and binary-coded GA were presented 
by Örkcü and Bal [262]. Results showed a better performance of the real code GA over other 
investigated algorithms. Implementing the GA and adaptive resonance theory (ART) ANN, Punitha 
and Santhanam [263] studied the classification of the breast cancer datasets. In their proposed model, 
the dimension is reduced by GA and the ART implemented with the reduced parameters. In another 
study [264], a wavelet ANN (W-ANN), that combines NN and wavelet transform, was trained with 
the GA for WBCD classification. Indeed, the excitation function of NN is the wavelet and 
optimization of the weights was done using the GA algorithm. For the breast cancer prediction, 
Ahmad, Mat Isa, Hussain and Sulaiman [265] used a combination of a multi-objective GA-based 
Pareto-optima and ANN (GA-MOO-ANN). Senapati and Dash [266] developed local linear wavelet 
ANN (LLW-ANN) and RBF-ANN models for breast cancer data's classification. The parameters of 
the LLW-ANN model was optimized using a recursive least square (RLS) method. The Kalman 
filter and RLS were employed to find the BP-ANN parameters. Beside the ANN, Liou and Chang 
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[267] utilized GA, LR, and C4.5 to forecast the breast cancer. Ahmad, Mat Isa, Hussain, Osman and 
Sulaiman [268] implemented the GA linked to the ANNs trained with BP, LM, and GD algorithms 
on the WBCD. 
For the case of WBC classification, Huang, Hung and Chen [269] used a PSO optimization 
algorithm to train the ANN system. Moreover, the authors presented two case-based reasoning 
(CBR) classifiers as well as an ANFIS model. To assign the attribute weights for CBR models, C4.5 
and logistic regression (LR) were employed. Malmir, Farokhi and Sabbaghi-Nadooshan [270] 
developed MLP-ANN models using the PSO method and imperialist competitive algorithm (ICA). 
They also presented traditional genetic classification (TGC) and classification rules mining model 
with GA in cloud computing (CGCRMM) models. Leema, Nehemiah and Kannan [271] optimized 
the ANN classifier using differential evolution PSO and GD-based BP. Senapati, Panda and Dash 
[272] employed the RBF-ANN classification model. They used KPSO and extended Kalman filter 
(EKF) to initialize the centers and variances of the network. For updating these parameters, the BP 
algorithm was utilized. 
For the BC classification, Abbass [273] utilized the memetic pareto  (MP) ANN, which is a category 
of evolutionary neural network models. Verma and Hassan [274] proposed two categories of a 
hybrid combination, including parallel neural-based strong clusters fusion (PNSCF) and parallel 
neural-based clusters fusion (PNCF) for classification of the breast cancer databank. Moreover, the 
MLP, k-means and self-organizing map (SOM) models were also investigated. 
Employing the rotation forest (RF) ANN, Koyuncu and Ceylan [275] proposed an ensemble 
classifier. In this model, the principal component analysis (PCA) is used as the feature selector. 
Furthermore, they presented another PSO-based classifier for breast cancer detection Uzer, Inan and 
Yılmaz [276] studied the WBCD for classification, through implementing ANN and two hybrid 
feature selection methods namely sequential forward selection (SFS) and sequential backward 
selection (SBS). In another work [277], both the generally optimized (GO) ANN and BP-ANN 
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methodologies were utilized. Nahato, Harichandran and Arputharaj [278] investigated the WBCD 
using rough set theory (RST) combined with BP-ANN. Implementation of the artificial meta-
plasticity (AM) in MLP at the artificial neuron learning level for the diagnosis of breast cancer data 
is investigated in a research study [279]. In addition to an ANN model, Tsai, Lu, Wu and Lee [280] 
developed three different ANN-based hybrid classification systems for breast cancer cases: 
association rule-based ANN, GA-based ANN and correlation-based ANN. A stimulus-sampling 
technique for boosting the BP-ANN was introduced by Gorunescu and Belciug [281]. The presented 
model, denoted as BPSS-BP-ANN, is a hybrid model combining the MLP and stimulus-sampling 
algorithm. This model, then, was compared to the SVM, NB and KNN models.  Abdel-Zaher and 
Eldeib [282] suggested a breast cancer classifier employing a deep belief network (DBN) 
unsupervised path or randomly initialized weight (RIW) network followed by an LM or CG 
algorithm. A hybrid model of BP-ANN and NSGA-II algorithm was also developed by Ibrahim, 
Shamsuddin and Saleh [283] for classification of breast cancer. 
In 2020, Korani and Mouhoub [284] implemented a deep feed-forward neural network (DFNN), 
mother tree optimization (MTO), MTO algorithm with climate change (MTOCL) and PSO for 
classifying the WBCD. Using a two-step feature selection algorithm in conjunction with ANN, 
Rahman and Muniyandi [285] developed a classification model. 
 
2.4.3 SVM-Based Models 
In the SVM method, which is a supervised learning algorithm, the principal thought is to discover 
the isolating hyperplane that can amplify the edge of the training dataset ideally. The objective is to 
increase the space between the closest points to each class and the hyperplane that prompts an ideal 
breaking hyperplane. It works effectively on datasets with smaller training data as well as linearly 
and nonlinearly splittable datasets. However, SVMs are not the best choice for working on large 
datasets because of the high training time and exhaustive computations. 
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Bennett and Blue [286] made an effort to generalize the SVMs to DTs. The proposed method is 
something between a univariate DT and a single SVM. Indeed, for each DT in the tree, a SVM was 
employed. The developed method was then applied to several databanks like WBCD. Based on the 
results for WBCD classification, however, the SVM model provided the best outcomes as compared 
to C4.5 and OC1 as DTs and global tree optimization (GTO) and GTO-SVM. Polat and Güneş [287] 
used the least-squares version of SVM (LS-SVM) for the classification of breast cancer. They 
employed RBF kernel functions. Subashini, Ramalingam and Palanivel [288] developed SVM and 
RBF-ANN models for the same goal, i.e. WBCD classification, where a polynomial kernel function 
was employed. Using the WBCD, Akay [289] presented a SVM-based classifier model with the 
feature selection utilizing F-score. The used kernel function was a RBF kernel. Similarly, employing 
FS feature selection method and SVM algorithm, WBCD is classified in another work [290]. 
Furthermore, the authors also presented a SVM-based model using kernel FS. 
Using the Gaussian kernel function, Chen, Yang, Liu and Liu [291] developed a SVM classifier 
coupled with a rough set reduction algorithm for removing the redundant features/points of the 
database. Stoean and Stoean [292] utilized the SVMs and evolutionary algorithms (EAs). The 
authors presented four different models for WBCD classification: SVM, cooperative coevolution 
(CC), pedagogical CC-SVM and decompositional CC-SVM. In another study [293], The SVM-
based model was developed for breast cancer classification through using polynomial and RBF 
kernel functions with varying arguments (poly order, BoxConstraint and RBF-sigma). In different 
research studies, automated diagnostic systems, including various types of ANNs as well as  SVMs, 
were implemented by Übeyli [294] and Shahare and Giri [295] for detection of BC type using the 
WBCD.  
For simultaneously solving the feature selection and model selection in SVM, a literature study 
suggested the PSO optimization algorithm [296]. To control the global and local search in PSO, the 
authors employed the inertia weight and time-varying acceleration coefficients. Ibrikci, Ustun and 
Kaya [297] presented the SVM classifier using the exponential-Gaussian combined kernel functions 
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for breast cancer. Employing a sigmoid kernel function, Zheng, Yoon and Lam [298] developed a 
hybrid model of SVM and K-means for the WBCD problem (denoted as K-SVM). 
In a comparative study conducted by Vig [299], the effectiveness of SVMs, ANN, RF, and NB in 
classifying breast cancer was evaluated. In addition to the SVM technique, Bashir, Qamar and Khan 
[300] presented several classification models, including NB, Gini index-DT, DT using information 
gain (IG), and memory-based learner (MBL). SVM, MLP-ANN, RBF-ANN, C4.5, RF, and the 
rotational forest were employed in a systematic study by Aličković and Subasi [301] for dealing 
with the BC databanks.  
Based on employing kernels with feature spaces composed by logical propositions, Polato and  
Aiolli [302] presented an approach, namely BK-SVM, to extract explanation rules from SVM. Mao 
et al. [303] proposed the transformed ensemble learning (TrEnL) technique for breast cancer 
classification. They also compared seven ensemble methods, including bagging, AdaBoost, 
weighted majority vote (WMV), NB, evolutionary ensemble classifiers (EVEN), combining 
classifiers by using correspondence analysis (SCANN) and MDM. The authors used SVM and 
CART as base learners in their experiments. Abdar and Makarenkov [304] presented several 
classifiers based on SVM and ANN algorithms.  
 
2.4.4 Rule/Fuzzy-Based Models 
Among real-world problems, there are several cases in various fields with a level of uncertainty and 
vagueness. The rule/fuzzy-based modes can be implemented for this type of problems. Generally, 
in a fuzzy rule-based system, the fuzzy sets are used in a way that demonstrate various forms of 
knowledge about the problem. The simple reasoning process in these algorithms enables them to 
save computing power. However, lots of data and expertise are required to develop a fuzzy system 
model.  
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Several works in the literature proposed rule/fuzzy-based methods in engineering, science, and 
medicine disciplines for screening, diagnosis, prediction, and classification. Hamilton, Shan and 
Cercone [305] applied a rule induction algorithm based on the approximate classification (RIAC) 
method to induce the rules from the database. The accuracy of the RIAC model was then compared 
to that of the C4.5 method. Peña-Reyes and Sipper [306] presented fuzzy systems in combination 
with the GA algorithm for WBCD classification. The applied GA defined four main parameters, 
including input membership function (MF) values, antecedents, relevant variables and consequents 
of rules. The reasoning mechanism of the proposed models (we denote the models by GA-FLs) was 
based on Takagi-Sugeno-Kang fuzzy system. In another study [307], the employed fuzzy systems 
were combined with evolutionary algorithms for breast cancer diagnosis. The authors used a 
singleton-type fuzzy system for the models. Mallinson and Bentley [308] used a hybrid fuzzy-
genetic programming (GP) methodology to discover patterns in the WBCD. In a research 
investigation carried out by Nauck and Kruse [309], a neuro-fuzzy system, namely NEFCLASS, 
was developed to obtain classification rules from the WBCD.  
A fuzzy classifier based on a fuzzy entropy measure, known as a fuzzy entropy-based fuzzy classifier 
(FEBFC), was proposed by Lee, Chen, Chen and Jou [310] for the BC pattern classification. In a 
literature study [311], a methodology was described for extracting the crisp and fuzzy logical rules 
from WBCD. This method was obtained by changing the MLP network into a logical network (LN) 
that called MLP2LN. C-MLP2LN method starts from a single neuron and builds the LN employing 
training data points directly. Authors also proposed two more methods, namely separability split 
value (SSV) and feature space mapping (FSM).  
A fuzzy classifier structure was developed by Abonyi and Szeifert [312] on the basis of the 
unsupervised Gath-Geva clustering technique. The proposed approach can be considered as an 
extension of the quadratic Bayes classifier. Based on fuzzy subsethood measurements, Rasmani and 
Shen [313] conducted quantifier-based fuzzy modeling to classify the breast cancer database. They 
compared the accuracy of the proposed approach, denoted by FuzzyQSBA, to that of weighted 
 36 
 
subsethood-based algorithm. As an adaptive fuzzy pattern classification method, an influential rule 
search scheme (IRSS) was applied to the breast cancer classification problem by Chatterjee and 
Rakshit [314].  
An ANFIS classification strategy was proposed in the literature [315] as a diagnosis system on the 
WBCD. In addition to the ANFIS models, the authors also developed several AdaBoost models for 
comparison. In this study, three different methods were used as a dominant input selector: GA 
algorithm, DT learning and correlation coefficient computation. Wang and Cheng [316] suggested 
a fuzzy clustering based on the aggregate attribute method (AAM) for breast cancer detection. To 
achieve the decision rules from the breast cancer database, Chen and Hsu [317] used the GA-based 
approach. Şahan, Polat, Kodaz and Güneş [318] hybridized a fuzzy-artificial immune system (FAIS) 
with the algorithm of KNN. Based on the KNN, neural fuzzy and quadratic classifier (QC) 
algorithms, researchers developed WBCD classifier models [319]. Furthermore, NF ensemble 
(NFE), QC ensemble (QCE) and KNN ensemble (KNNE)-based models were also presented. 
Lekkas and Mikhailov [320] recommended architecture for evolvable fuzzy rule-based classifiers to 
be implemented for breast cancer detection. On the basis of association rules (ARs) and neural 
network, Karabatak and Ince [321] proposed an expert system to classify the breast cancer types. 
Fuzzy robust principal component analysis (FRPCA) algorithms were used by Luukka [322] for data 
pre-processing. Then, the classification was made by the similarity classifier (SC). A hybrid hidden 
Markov model (HMM) fuzzy approach was also proposed for WBCD classification [323]. Based on 
fuzzy entropy measures (FEMs), Luukka [324] presented a feature selection method in combination 
with the SC for the application of interest.  
Ramathilagam and Huang [325] developed an extended Gaussian version of FCM for the 
classification task. Vannucci and Colla [326] proposed a model, called LASCUS, based on the FIS 
and SOM. Fuzzy neural networks, namely fuzzy Gaussian potential neural network (FGPNN) and 
hierarchical fuzzy neural network (HFNN), were investigated to categorize the database of breast 
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cancer [327]. The used training procedures were GD and EKF. Jaganathan and Kuppuchamy [328] 
presented a feature selection method based on a threshold fuzzy entropy (FE). For feature selection, 
three different criteria were employed: mean selection strategy (MSS), half selection strategy (HSS) 
and neural network for threshold selection (NNTS). Further to the hyper-rectangular composite 
neural network (HRCNN) model, a PSO-based fuzzy HRCNN model was also developed in another 
study [329] for the WBCD problem. Though using the theoretical concept of a fuzzy-rough nearest 
neighbor (FRNN) algorithm, a classification model was developed by Onan [330]. 
Fuzzy-based models namely linguistic hedges neuro-fuzzy classifier with selected features 
(LHNFCSF), conjugate gradient neuro-fuzzy classifier (CGNFC), an adaptive neuro-fuzzy classifier 
with the linguistic hedges (ANFCLH) and speeding up scaled conjugate gradient neuro-fuzzy 
classifier (SSCGNFC) were utilized by Azar and El-Said [331] to develop breast cancer classifiers. 
A hybrid classification system consisting of the CART, RF and/or fuzzy min-max (FMM) neural 
network was proposed by Seera and Lim [332]. In a BC classification study by Panda and Abraham 
[333], the ant colony optimization (ACO), PSO, SVM, RF, fuzzy rough KNN (FRKNN) and 
synthetic minority over-sampling technique (SMOTE) approaches were used. For WBCD 
classification, there several classification models in a published work on the basis of fuzzy 
ARTMAP (FARTMAP), fuzzy SAM (FSAM), GA-FSAM, ANFIS, P-ANN and SVM [334]. In 
another work, researchers employed the wavelet transformation and interval type-2 fuzzy logic 
system (T2FLS) for data classification [335]. Authors also used Karnik–Mendel iterative procedure 
(KMIP) and Greenfield–Chiclana Collapsing Defuzzifier (GCCD) algorithm. Hassani and Jafarian 
[336] evaluated the ability of hybrid methods such as harmony search fuzzy-ART, GA fuzzy-ART, 
and PSO fuzzy-ART in classifying the datasets of breast cancer. Satishkumar, Sita Mahalakshmi 
and Katneni [337] proposed a rule discovery algorithm on the basis of swarm intelligence for the 
breast cancer classification.  
Recently, Pota, Esposito and De Pietro [338] presented several rule-based fuzzy systems for 
classifying the medical databases like WBCD. Recently, another research paper was published on 
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the use of fuzzy SVM-RWTS AIRS (FSRAIRS) and AIRS techniques for the classification of 
WBCD [339]. In a study done by Pourpanah et l. [340], brain storm optimization (BSO) is used for 
the classification of the WBCD. Furthermore, a hybrid model was built by combining BSO with 
FARTMAP. Hancer [341] presented a fuzzy kernel filter criterion by combining the fuzzy and kernel 
mutual information estimators for the application of interest.  
 
2.4.5 Other Models  
Quinlan [342] used a divide-and-conquer approach of the C4.5 decision tree classifier for WBCD 
classification. He presented two classification models based on C4.5 and modified C4.5 in a research 
study [343], a learning technique that combines the classical perceptron algorithm (PA) with the 
logarithmic simulated annealing (LSA) is implemented to categorize the breast cancer database. In 
addition to the C4.5 decision tree, Smith and Bull [344] employed the genetic algorithm and 
programming (GAP) for analysis of the WBCD. Bagui, Bagui, Pal and Pal [345] compared the 
results of the k-rank nearest neighbour (KRNN) with the conventional KNN. Using a Bayesian 
feature selection (BFS) method, a classification model was proposed for classifying the breast cancer 
data [346]. In another study [347], the Bayesian networks were utilized for imputation in the breast 
cancer classification.  
The kernel principal component analysis (KPCA) on the BC database was performed by Hoffmann 
[348]. The KPCA was then compared with PCA, SVM and Parzen density. The FS-AIRS 
methodology is another approach that was proposed in the literature for WBCD classification [349].  
Using the ordered weighted averaging (OWA) operator, Cheng, Wang and Wu [350] introduced a 
classifier for this database. Mohammed, Naugler and Far [351] applied OWA-based methods 
employing KNN, Laplace and logistic regression (LLR) and SVM to the problem of breast cancer 
detection. The variable predictive model based class discrimination (VPMCD) and discriminating 
partial correlation coefficient metric (DPCCM) machine learning approaches were used in the 
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literature [352] for the classification of BC. Furthermore, LDA, CART and TreeNet methods were 
used as a basis for comparison.  
Several classification models were developed by Lavanya and Rani [353] for breast cancer 
classification. The best model was obtained using the principal components attribute evaluation 
(PCAE) FS method. Other FS methods were CFS subset evaluation (CFSSE), Chi-squared attribute 
evaluation (CSAE), classifier subset evaluation (CSE), consistency subset evaluation (COSE), 
filtered attribute evaluation (FAE), filtered subset evaluation (FSE), gain ratio attribute evaluation 
(GRAE), information gain attribute evaluation (IGAE), relief attribute evaluation (RAE), SVM 
attribute evaluation (SVMAE), symmetric uncertainty attribute evaluation (SUAE) and symmetric 
uncertainty attribute set evaluation (SUASE). Malar and Nadarajan [354] developed different 
classification models based on the DT, SVM, isotonic separation (IS), and evolutionary IS (EIS) 
methods. The EIS method used GA for the training phase. Using the cluster analysis methods with 
feature selection, a hybrid model was suggested by Chen [355] to analyze the WBCD database. 
Combining the RST and KNN classifier, El-Baz [356] investigated the breast cancer database in 
terms of screening and categorization. To achieve a reliable method for the breast cancer detection, 
Onan [357] developed ensembles of bagging, AdaBoost, dagging, multi boost, random sunspace, 
and decorate in conjunction with the SVM, MLP, LMT, RF, Bayes Net, KNNs, FURIA, C4.5, KR, 
kernel logistic regression (KLR), RIPPER, KStar, NB, and simple CART. Karabatak [358] 
introduced another NB and weighted NB (W-NN) classifiers to detect the BC type. In another 
published research [359], the BC classification ability of SMO, C4.5, decorate, NB, bagging, and 
IBK algorithms was examined and compared. 
Rashmi, Lekha and Bawane [360] implemented the KNN algorithm for the classification of the BC 
datasets. Modi and Ghanchi [361] investigated several classification and feature selection methods 
and machine learning algorithms, including NB, C4.5, RF, Bayes net (BN) and KNN to classify the 
breast cancer datasets. Sheikhpour, Sarram and Sheikhpour [362] developed several kernel density 
estimation (KDE)-based classifiers for various breast cancer cases. They used the PSO and GA 
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algorithms for the feature selection and bandwidth determination of the classifiers. For the problem 
of breast cancer classification, Azar, Inbarani and Renuga Devi [363] developed several classifiers 
using several methods such as Zero R, decision table, C4.5, random tree (RT), RF, MLP-ANN, IBk, 
KStar, LWL, NB, KNN, classical RST and improved dominance-based rough set (IDRSA). Sayed, 
Darwish, Hassanien and Pan [364] compared the breast cancer classification ability of whale 
optimization algorithm (WOA) to that of GA, PCA, statistical dependency, mutual information 
(MI), random subset feature selection (RSFS), sequential forward selection (SFS), and sequential 
floating forward selection (SFFS). Dora, Agrawal, Panda and Abraham [365] implemented the 
Gauss-Newton representation-based algorithm (GNRBA) on the cancer databases. The GNRBA 
model then was compared to other models like BP-ANN, Koza’s model (KM) and GO-ANN.  
Lu et al. [366] developed a genetic algorithm-based online gradient boosting (GAOGB) classifier. 
They also implemented other methods like online gradient boosting with the adaptive linear 
regressor (OLRGB), online adaptive boosting with the adaptive linear regressor (OLRAB), online 
sequential extreme learning machine (OSELM) and online linear regressor (OLR). With the aim of 
efficient dimensionality reduction, Hu et al. [367] applied ELM-SOM+ technique to the WBCD. 
Mohamed et al. [368] compared the classification performance of the Parasitism-Predation 
algorithm (PPA) to that of Cuckoo search (CS), cat swarm optimization (CSO) and crow search 
algorithm (CSA). Alroobaea et al. [369] developed several Bayesian-based models, including 
Gaussian distribution (GDis), Generalized Gaussian distribution (GGDis), Bounded Gaussian 
distribution and Bounded generalized Gaussian distribution (BGGDis) in conjunction with Bayesian 
inference (B) or maximum likelihood (ML). Mushtaq [370] presented several KNN-based models 
for breast cancer classification. 
In 2020, Devarria et al. [371] proposed two frameworks, namely D score and F2 score in 
combination with the GP algorithm and to classify between malignant and benign cases. In another 
study, Hancer [372] employed the WBCD for multi-objective clustering. Nayak et al. [373] 
implemented a Filter Approach using Elitism based Multi-objective Differential Evolution for 
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feature selection (FAEMODE) and compared the results to the outputs of methods based on SFS 
and SBS. Employing several datasets, including the WBCD, Aydemir [374] applied the Polygon 
Area Metric method to evaluate the performance of classifiers. In another study, Habib et al. [375] 
employed multi-objective particle swarm optimization (MOPSO), multi-objective evolutionary 
algorithm based on decomposition (MOEA/D) and non-dominated sorting genetic algorithm 
(NSGA-II).  
 
2.5 ANALYSIS OF THE LITERATURE MODELS  
2.5.1 Assessment Parameters  
To evaluate the performance of the created models for classification purposes, the following 
parameters are commonly determined: classification accuracy, sensitivity and specificity. Eqs (2.1) 
to (2.3) mathematically represent these parameters in a respective order.  
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where tn, tp, fp, and fn denote the true negative, true positive, false positive, and false negative, 
respectively.   
 
2.5.2 Evaluation of the WBCD Models  
Table 2.2 gives the error analysis results of the presented neural-based models in the literature for 
WBCD classification. Fig. 2.9 demonstrates the histogram of the literature ANN-based models’ 
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accuracy for WBCD classification. As can be observed from this figure, most of the published ANN-
based models provide accuracies more than 95%. However, some developed models have very low 
accuracy. According to Table 2.2, these models were presented by Janghel et al. [260]. Other models 
with accuracies less than 90% are BGD-ANN [257], BGDM-ANN [257], SOM [274] and MLP-
ANN [274]. 
 
Table 2.2: Performance of the available neural-based WBCD classification models in the literature 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
FF-ANN (all features) [248]  1997 96.8 * * 
FF-ANN (selected features) [248]   1997 98.6 * * 
FF-ANN [249] 1996 96.5 * * 
PFF-ANN (rule#1) [247] 1996 95.4 * * 
PFF-ANN (rule#2) [247] 1996 94.7 * * 
PFF-ANN (rule#3) [247] 1996 97.1 * * 
PFF-ANN (rule#1, pre-processed data) [251] 2000 97.4 * * 
PFF-ANN (rule#2, pre-processed data) [251] 2000 98.1 * * 
PFF-ANN (rule#3, pre-processed data) [251] 2000 98.2 * * 
Binarized ANN [252] 1997 95.2 * * 
Normalized ANN [252] 1997 95.8 * * 
Continuous ANN [252] 1997 97.4 * * 
MLP-ANN [253] 2000 95.7 91.3 98.1 
MOE-ANN [253] 2000 96.3 93.7 97.7 
RBF-ANN [253] 2000 97.0 97.0 97.1 
GR-ANN [253] 2000 96.8 94.6 98.0 
GDX-ANN [254] 2007 97.7 * * 
Linear-ANN [254] 2007 96.0 * * 
AM-MLP [256] 2013 99.3 100 97.9 
BP-ANN [256] 2013 94.5 87.4 98.3 
BGD-ANN [257] 2011 83.3 * * 
QN-ANN [257] 2011 98.4 * * 
BGDM-ANN [257] 2011 84.4 * * 
RBP-ANN [257] 2011 98.6 * * 
LM-ANN [257] 2011 99.3 * * 
CG-AMM [257] 2011 99.0 * * 
BP-ANN [258] 2017 98.0 * * 
BP-ANN [259] 1996 96.7 * * 
LVQ [259] 1996 96.6 * * 
LVQ [261] 2002 96.7 * * 
BLVQ [261] 2002 96.8 * * 
BP-ANN [260] 2010 51.9 17.4 79.5 
RBF-ANN [260] 2010 49.8 19.6 74.2 
*indicates that the value of the parameter in not reported in the original work 
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Table 2.2: Continued. 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
LVQ [260] 2010 95.8 95.8 95.8 
P-ANN [260] 2010 49.8 19.6 74.2 
R-ANN [260] 2010 52.7 21.0 75.5 
CL-ANN [260] 2010 74.5 25.0 77.1 
GA-ART-ANN [263] 2007 97.6 * * 
BP-ANN [264] 2010 98.2 * * 
GA-W-ANN [264] 2010 98.6 * * 
GA-MOO-ANN [264] 2012 98.9 98.5 99.1 
RLS-LLW-ANN [20] 2011 97.3 * * 
KF-RBF-ANN [20] 2011 96.4 * * 
RLS-RBF-ANN [20]  2011 97.1 * * 
ANN [21] 2015 95.0 96.3 92.7 
GA-RP-ANN [22] 2014 99.4 99.5 97.6 
GA-LM-ANN [22] 2014 98.9 97.8 98.0 
GA-GD-ANN [22] 2014 99.4 98.5 97.1 
ICA-MLP-ANN [270] 2013 97.8 * * 
PSO-MLP-ANN [270] 2013 97.6 * * 
BP-ANN [271] 2016 91.2 88.9 93.8 
DE-BP- ANN [271] 2016 92.6 91.4 93.9 
PSO-BP- ANN [271] 2016 95.6 94.3 97.0 
KPS-RBF-ANN [272] 2012 97.9 * * 
EKF-RBF-ANN [272] 2012 96.4 * * 
MP-ANN [273] 2002 98.1 * * 
SOM [274] 2011 86.5 81.3 89.4 
MLP-ANN [274] 2011 87.5 91.75 95.0 
PNCF [274] 2011 96.0 99.0 90.0 
PNSCF [274] 2011 97.9 98.5 94.3 
RF-PCA-ANN [275] 2013 98.0 * * 
PSO-ANN [275] 2013 97.4 * * 
SBSP-ANN [276] 2013 98.6 * * 
BP-ANN (average) [277] 2015 91.2 95.3 82.8 
GO-ANN (average) [277] 2015 98.8 99.1 98.4 
RST-BP-ANN [278]  2015 98.6 98.8 98.6 
AM-MLP-ANN [279] 2015 97.9 98.9 96.9 
ANN [280] 2015 95.3 97.6 97.2 
AR-ANN [280] 2015 94.1 93.7 96.1 
C-ANN [280] 2015 95.9 98.5 97.5 
GA-ANN [280] 2015 94.7 97.1 96.1 
BPSS-BP-ANN [281] 2016 95.3 * * 
CG-RIW-BP-ANN [282] 2016 98.9 100 98.2 
LM-RIW-BP-ANN [282] 2016 99.0 99.1 99.0 
CG-DBN-BP-ANN [282] 2016 99.6 100 99.4 
LM-DBN-BP-ANN [282] 2016 99.7 100 99.5 
NSGA-II-BP-ANN [283] 2018 97.7 97.6 97.1 
RBF-ANN [288] 2009 96.6 97.3 96.5 
FF-ANN [295] 2015 96.2 * * 
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Table 2.2: Continued. 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
MLP-ANN [294] 2007 91.9 91.2 92.3 
R-ANN [294] 2007 98.6 98.1 98.9 
C-ANN [294] 2007 97.5 96.9 97.8 
P-ANN [294] 2007 98.2 98.1 98.9 
ANN [299] 2014 92.4 93.0 92.0 
MLP-ANN [301] 2017 96.7 * * 
RBF-ANN [301] 2017 95.8 * * 
GA-MLP-ANN [301] 2017 98.5 * * 
GA-RBF-ANN [301] 2017 98.4 * * 
MLP-ANN [309] 1999 94.8 * * 
MLP-ANN [321] 2009 95.2 * * 
P-ANN [334]  2015 93.9 * * 
PCA-P-ANN [334] 2015 94.9 * * 
Wavelets-P-ANN [334] 2015 93.8 * * 
MLP-ANN [363] 2017 95.1 * * 
BP-ANN [363] 2017 95.1 * * 
BP-ANN (average) [365] 2017 91.2 * * 
GO-ANN (average) [365] 2017 98.8 * * 
MLP [304] 2019 96.7 97.1 96.4 
RBF [304] 2019 95.4 93.4 96.5 
MLP-boosting [304] 2019 98.1 97.8 99.8 
RBF-boosting [304] 2019 96.4 94.4 97.5 
DFNN-PSO [284] 2020 * 97.9 * 
DFNN-MTO [284] 2020 * 100 * 
DFNN-MTOCL [284] 2020 * 97.9 * 
ANN [285] 2020 99.4 99.9 98.4 
 
Statistical parameters values of the studied SVM-based classifiers for the WBCD problem are given 
in Table 2.3. In accordance with Table 2.3, more than 70% of the investigated SVM-based models 
for the application of interest provided accuracies more than 95%. On the other hand, three models, 
including the SVM (quadratic) [299], SVM (linear) [299] and SVM [281] showed accuracies less 
than 90%.  
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Fig. 2.9: Histogram of the accuracies obtained from the developed ANN-based models in the 
literature 
 
Table 2.3: Performance of the available SVM-based WBCD classification models in the literature 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
SVM [281] 2016 83.0 *. * 
SVM [286] 1998 97.2 *. * 
GTO-SVM [286]  1998 96.6 *. * 
LS-SVM (average) [287] 2007 96.5 95.8 97.3 
SVM [288] 2009 92.1 86.7 95.9 
FS-SVM [289] 2009 99.51 99.6 97.7 
FS-SVM [290] 2013 95.6 97.0 95.0 
KFS-SVM [290] 2013 97.0 97.0 96.0 
RS-SVM (average) [291] 2011 96.7 99.9 100 
SVM [292] 2013 96.5 * * 
CC-SVM (pedagogical) [292] 2013 97.1 * * 
CC-SVM (decompositional) [292] 2013 95.9 * * 
SVM [293] 2014 97.1 * * 
SVM (RBF) [294] 2007 99.5 99.4 99.6 
SVM (linear) [295] 2015 97.9 * * 
SVM (quadratic) [295] 2015 97.3 * * 
SVM (polynomil) [295] 2015 97.5 * * 
*indicates that the value of the parameter in not reported in the original work 
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Table 2.3: Continued. 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
SVM (RBF) [295] 2015 98.0 * * 
SVM (MLP) [295] 2015 96.7 * * 
FS-SVM [296] 2012 97.0 95.2 97.8 
PSO-SVM [296] 2012 99.3 99.5 99.1 
SVM (exponential-Gaussian) [297] 2012 98.3 99.4 94.4 
K-SVM [298] 2014 97.4 * * 
SVM (RBF) [299] 2014 93.6 94.0 92.0 
SVM (linear) [299] 2014 78.5 72.0 81.0 
SVM (quadratic) [299] 2014 72.9 68.0 75.0 
SVM [300] 2014 93.7 99.2 86.5 
SVM [301] 2017 96.8 * * 
GA-SVM [301] 2017 99.0 * * 
SMOTE-SVM (average) [333] 2014 96.4 * * 
FRSE-PSO-SVM (average) [333] 2014 96.4 * * 
SVM [334] 2015 93.9 * * 
PCA-SVM [334] 2015 94.9 * * 
Wavelets-SVM [334] 2015 93.8 * * 
OWA-SVM [351] 2016 96.3 * * 
SVMAE[353] 2011 94.6 * * 
SVM [354] 2013 96.6 96.5 96.8 
BK-SVM [302] 2019 97.5 * * 
Bagging (SVM/CART) [302] 2019 98.5 * * 
AdaBoost (SVM/CART) [302]  2019 98.1 * * 
WMV (SVM/CART) [302] 2019 98.5 * * 
NB (SVM/CART) [302] 2019 98.3 * * 
EVEN (SVM/CART) [302] 2019 98.5 * * 
MDM (SVM/CART) [302] 2019 98.5 * * 
SCANN (SVM/CART) [302] 2019 98.5 * * 
TrEnL (SVM/CART) [302] 2019 98.2 * * 
SVM [304] 2019 97.1 95.5 98.0 
polynomial-SVM [304] 2019 98.4 98.7 98.3 
CPG-SVM (average) [304] 2019 99.7 99.5 99.4 
CWV-BANN-SVM [304] 2019 100 100 100 
SVM [374] 2020 98.0 100 95.0 
 
Histogram of the accuracy of the SVM-based models presented for WBCD is depicted in Fig. 2.10. 
With accuracy, sensitivity and specificity of 100%, the CWV-BANN-SVM model [304] is the best 
literature model for the classification of the WBCD. Looking at other effective SVM-based models 
for BC classification, it can be observed that hybrid of SVM with other techniques is a great way to 
improve the classification performance of the final model for the WBCD. 
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Fig. 2.10: Histogram of the accuracies obtained from the developed SVM-based models in the 
literature 
 
For the literature rule/fuzzy-based models, the error analysis results are tabulated in Table 2.4. the 
majority of these classifiers provide satisfactory outcomes. However, nine models out of 82 studied 
rule/fuzzy-based literature models have accuracies below 95%. Histogram of the rule/fuzzy-based 
models’ accuracy is demonstrated in Fig. 2.11. As given in Table 2.4, a fuzzy-based model, namely 
FSRAIRS [339], provided the best achievable accuracy, i.e. 100%. However, since there is no 
information regarding the sensitivity and specificity values of this model and some other models as 
well, it is not possible to conclude that this model presents the best results for the WBCD problem. 
Similar to SVM-based models, hybrid of fuzzy models with some algorithms provided satisfactory 
results.    
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Table 2.4: Performance of the rule/fuzzy-based WBCD classification models in the literature 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
RIAC [305] 1996 95.0 * * 
GA-FL (two-rule) [306] 1998 96.7 *. * 
GA-FL (single-rule) [306] 1998 96.4 * * 
GA-FL (single-rule) [307] 1999 97.1 * * 
GA-FL (two-rule) [307] 1999 97.4 * * 
GA-FL (three-rule) [307] 1999 97.8 * * 
GA-FL (four-rule) [307] 1999 97.8 * * 
GA-FL (five-rule) [307] 1999 97.5 * * 
GP-FL [308] 1999 95.0 * * 
NEFCLASS [309] 1999 95.1 * * 
FEBFC [310] 2001 94.7 * * 
FEBFC (with feature selection) [310]  2001 95.1 * * 
SSV (3 crisp rules) [311] 2001 96.5 * * 
FSM (12 fuzzy rules) [311] 2001 96.3 * * 
C-MLP2LN (average) [311] 2001 97.2 * * 
GG-FL (average) [312] 2003 94.1 * * 
FuzzyQSBA [313] 2004 92.2 * * 
WSBA [313] 2004 92.8 * * 
IRSS [314] 2004 95.9 * * 
ANFIS [315] 2005 95.9 * * 
GA-ANFIS [315] 2005 97.7 * * 
DT-ANFIS [315] 2005 98.0 * * 
CC-ANFIS [315] 2005 97.4 * * 
AAM-FL [316]  2006 98.2 * * 
GA-Rule [317] 2006 96.6 * * 
FAIS-KNN [318] 2007 99.1 * * 
NF [319] 2012 94.3 * * 
NFE [319]  2012 96.6 * * 
NF-KNN-QC [319] 2012 97.1 * * 
eClass [320] 2009 99.5 * * 
FS-eClass [320] 2009 99.5 * * 
AR1-ANN [321] 2009 97.4 * * 
AR2-ANN [321] 2009 95.6 * * 
FRPCA1 [322] 2009 98.2 * * 
FRPCA2 [322]  2009 98.1 * * 
FRPCA3 [322] 2009 98.2 * * 
SC-FEM1 [324] 2011 97.1 * * 
SC-FEM2 [324] 2011 97.2 * * 
LASCUS [326] 2011 98.0 * * 
GD-FGPNN [327] 2012 98.1 98.0 98.1 
EKF-FGPNN [327] 2012 98.2 98.3 98.1 
GD-HFNN [327]  2012 98.1 98.0 98.1 
EKF-HFNN [327]  2012 98.2 98.3 98.1 
GD-FNN [327] 2012 98.2 98.3 97.8 
EKF-FNN [327] 2012 97.8 97.2 98.3 
*indicates that the value of the parameter in not reported in the original work 
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Table 2.4: Continued. 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
NNTS-FE [328] 2013 97.3 94.0 99.0 
MSS-FE [328] 2013 96.0 93.0 97.0 
HSS-FE [328] 2013 96.7 94.0 98.0 
HRCNN [329] 2014 95.0 * * 
PSO-HRCNN [329] 2014 97.8 * * 
FRNN [330] 2015 99.7 * * 
LHNFCSF [331] 2013 98.9 * * 
ANFCLH [331] 2013 97.5 * * 
SSCGNFC [331] 2013 97.5 * * 
SCGNFC [331] 2013 97.8 * * 
FMM (average) [332] 2014 95.2 * * 
CART-FMM (average) [332] 2014 94.6 * * 
CART-RF-FMM (average) [332] 2014 97.9 * * 
FRSE-ACO-FRKNN (average) [333]  2014 95.6 * * 
FRSE-PSO-FRNN (average) [333]  2014 95.6 * * 
SMOTE-FRNN (average) [333] 2014 98.0 * * 
FARTMAP [334] 2015 94.9 * * 
PCA-FARTMAP [334] 2015 96.3 * * 
Wavelets-FARTMAP [334] 2015 95.6 * * 
ANFIS [334]  2015 93.1 * * 
PCA-ANFIS [334] 2015 95.5 * * 
Wavelets-ANFIS [334] 2015 95.7 * * 
FSAM [334] 2015 94.9 * * 
PCA-FSAM [334] 2015 95.3 * * 
Wavelets-FSAM [334] 2015 96.2 * * 
GA-FSAM [334] 2015 95.6 * * 
GA-PCA-FSAM [334] 2015 95.9 * * 
GA-Wavelets-FSAM [334] 2015 97.4 * * 
IT2FLS-KMIP [335] 2015 95.8 * * 
PCA-IT2FLS-KMIP [335] 2015 96.3 * * 
Wavelets-IT2FLS-KMIP [335] 2015 97.8 * * 
IT2FLS-GCCD [335] 2015 96.9 * * 
PCA-IT2FLS-GCCD [335]  2015 96.9 * * 
Wavelets-IT2FLS-GCCD [335] 2015 97.9 * * 
FL [338] 2017 97.6 * * 
FSRAIRS [339] 2015 100 * * 
AIRS (average) [339] 2015 96.9 * * 
FARTMAP [340] 2019 96.0 * * 
FARTMAP-BSO (best) [340] 2019 96.7 * * 
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Fig. 2.11: Histogram of the accuracies obtained from the developed rule/fuzzy-based models in the 
literature 
 
Table 2.5 presents the overall performance of the developed WBCD classifiers based on the decision 
trees. The histogram graph for the accuracies of the tree-based models is shown in Fig. 2.12. 
According to the error analysis presented in Table 2.5 and Fig. 2.12, more than half of the available 
tree-based classifiers can be used for the WBCD problem with accuracies more than 95%. Except 
for a model called DT-AdaBoost [315], other models predict the breast cancer class with accuracies 
higher than 90%.  
Table 2.6 presents the error analysis for KNN-based models. Histogram of the accuracies of the 
reviewed KNN-based models is shown in Fig. 2.13. As can be seen, most developed KNN models 
provided results with accuracies higher than 95%. Furthermore, it can be observed that hybrid 
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models like RST-KNN [356] and KNN-Chi2 [370] reproduced the targets with satisfactory 
accuracy, sensitivity and specificity.  
 
Table 2.5: Performance of the available tree-based WBCD classification models in the literature 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
C4.5 [249]  1996 95.8 *. * 
CART [259] 1996 94.2 *. * 
C4.5 [21] 2015 94.3 96.2 91.1 
C4.5 [286] 1998 93.4 * * 
RF (10 trees) [299] 2014 90.1 92.0 89.0 
RF (100 trees) [299] 2014 95.6 97.0 94.0 
IG-DT [300] 2014 95.6 93.7 93.7 
Gini-DT [300] 2014 94.0 90.0 92.7 
C4.5  [301] 2017 94.0 * * 
GA-C4.5 [301] 2017 93.2 * * 
DT-AdaBoost [315] 2005 61.0 * * 
GA-RF [301] 2017 95.3 * * 
C4.5 [309] 1999 95.1 * * 
C4.5 [342] 1996 94.7 * * 
Modified-C4.5 [342] 1996 94.7 * * 
C4.5 [305] 1996 96.0 * * 
FRSE-PSO-RF (average) [333] 2014 97.3 * * 
SMOTE-RF (average) [333] 2014 97.4 * * 
C4.5 [344] 2003 94.4 * * 
CART [352] 2009 98.7 * * 
TreeNet [352] 2009 98.4 * * 
DT [354]  2013 92.4 93.0 93.4 
C4.5 [359] 2015 94.6 94.6 95.6 
SMO-C4.5-NB-Decorate [359] 2015 97.0 96.3 97.4 
SMO-C4.5-NB-IBK [359] 2015 97.3 97.5 97.2 
SMO-C4.5-Bagging-NB [359] 2015 96.9 97.1 96.7 
RF [301] 2017 95.4 * * 
C4.5 [361] 2016 94.6 * * 
C4.5-KNN-BN  [361] 2016 95.3 * * 
C4.5-BN [361] 2016 94.9 * * 
C4.5-NB [361]  2016 97.0 * * 
C4.5-RF [361] 2016 95.7 * * 
RF [361] 2016 96.9 * * 
C4.5 [363]  2017 94.2 * * 
RF [363]  2017 95.4 * * 
*indicates that the value of the parameter in not reported in the original work 
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Fig. 2.12: Histogram of the accuracies obtained from the developed tree-based models in the 
literature 
 
Table 2.6: Performance of the available KNN-based WBCD classification models in the literature 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
KNN [259] 1996 96.6 * * 
KNN [281] 2016 90.6 * * 
KNN [319] 2012 96.4 * * 
KNN (average) [345] 2003 96.4 * * 
OWA-KNN [351] 2016 99.7 * * 
KNN [356] 2015 98.8 98.8 98.9 
RST-KNN [356] 2015 99.4 100 99.2 
KNNE [319] 2012 96.4 * * 
KNN [360] 2016 85.6 * * 
KNN [363] 2017 93.5 * * 
KNN [374] 2020 98.0 99.0 95.0 
KNN (best model) [370] 2019 96.6 98.2 96.3 
KNN-LSVC (best model) [370] 2019 97.7 99.0 98.4 
KNN-Chi2 (best model) [370] 2019 99.4 99.1 100 
*indicates that the value of the parameter in not reported in the original work 
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Fig. 2.13: Histogram of the accuracies obtained from the developed KNN-based models in the 
literature 
 
Similar to the ANN-based, SVM-based, rule/fuzzy-based, tree-based and KNN-based models, the 
error analysis for other available WBCD classification models, reviewed in this study, is collected 
and given in Table 2.7.  
The accuracy histogram for these classifiers is depicted in Fig. 2.14. With accuracies less than 75%, 
nine models including QDA [259], MBL [300], AdaBoost [315], GA-AdaBoost [315], CC-
AdaBoost [315], NB , Zero R [363], TGC [24], CGCRM [24] are amongst the weakest developed 
models in the literature. On the other hand, GNRBA [365], RST-KNN [356], RotationF [301], GA-
RotationF [301], OWA-KNN [351] provide accuracies more than 99% for classifying the WBCD. 
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Table 2.7: Performance of the other available WBCD classification models in the literature 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
LFC [259] 1996 94.4 * * 
LDA [259] 1996 96.0 * * 
QDA [259] 1996 34.5 * * 
ASR [259] 1996 94.7 * * 
ASI [259] 1996 95.6 * * 
SNB [259] 1996 96.6 * * 
NB [259] 1996 96.4 * * 
AIRS [261] 2002 97.2 * * 
LR [21] 2015 94.3 97.2 94.8 
GA [21] 2015 98.8 100 98.0 
CGCRMM [24] 2013 72.0 * * 
TGC [24] 2013 70.0 * * 
k-means [274] 2011 89.9 94.2 85.5 
NB [281] 2016 88.7 * * 
OC1 [286] 1998 95.9 * * 
OTG [286] 1998 95.7 * * 
NB [299] 2014 65.3 57.0 72.0 
NB [300] 2014 96.7 99.6 92.0 
MBL [300] 2014 63.1 45.7 36.6 
Ensemble [300]  2014 97.4 97.9 95.1 
LR  [301] 2017 98.5 * * 
BN  [301] 2017 95.3 * * 
RotationF [301] 2017 99.5 * * 
GA-LR [301] 2017 98.4 * * 
GA-BN [301] 2017 95.3 * * 
GA-RotationF [301] 2017 99.5 * * 
GG [312] 2003 93.1 * * 
AdaBoost [315]  2005 61.9 * * 
GA-AdaBoost [315] 2005 62.2 * * 
CC-AdaBoost [315] 2005 63.1 * * 
QC [319] 2012 94.5 * * 
QCE [319] 2012 96.6 * * 
PCA [322] 2009 97.7 * * 
SC [324] 2011 97.5 * * 
PA-LSA [343] 2002 98.3 * * 
GAP [344] 2003 95.6 * * 
KRNN (average) [345] 2003 96.2 * * 
BFS [346] 2004 96.5 * * 
FS-AIRS [349] 2005 98.5 * * 
OWA [350]  2009 98.4 * * 
OWA-LLR [351] 2016 95.5 * * 
DPCCM [352] 2009 97.1 * * 
VPMCD [352] 2009 97.1 * * 
LDA [352] 2009 95.7 * * 
PCAE [353]  2011 97.0 * * 
*indicates that the value of the parameter in not reported in the original work 
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Table 2.7: Continued. 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
CFSSE [353]  2011 94.8 * * 
CSAE [353]  2011 94.6 * * 
CSE [353] 2011 95.1 * * 
COSE [353] 2011 95.1 * * 
FAE [353] 2011 94.6 * * 
FSE [353]  2011 94.8 * * 
GRAE [353] 2011 94.4 * * 
IGAE [353]  2011 94.6 * * 
RAE [353] 2011 94.6 * * 
SUAE [353] 2011 94.6 * * 
SUASE [353] 2011 94.0 * * 
IS [354] 2013 97.5 95.4 96.1 
EIS [354] 2013 98.6 98.3 97.5 
NB [358] 2015 96.2 * * 
W-NB [358] 2015 98.5 99.1 98.3 
Decorate [359] 2015 96.4 94.6 96.7 
Dagging [359] 2015 96.6 96.2 97.5 
IBK [359] 2015 95.1 95.1 96.7 
NB [359] 2015 96.0 95.9 95.2 
SMO [359] 2015 97.0 96.2 97.3 
SMO-Bagging-NB-IBK [359] 2015 97.0 97.1 96.9 
BN [361] 2016 97.1 * * 
NB [361] 2016 96.0 * * 
PSO-KDE (average) [362] 2016 97.7 94.0 99.7 
GA-KDE (average) [362] 2016 96.9 91.6 99.7 
IDRSA [363] 2017 96.5 * * 
RST [363] 2017 95.3 * * 
Zero R [363] 2017 65.5 * * 
NB [363] 2017 95.6 * * 
PSO [363] 2017 95.4 * * 
IBK [363] 2017 93.7 * * 
KSTAR [363] 2017 94.7 * * 
LWL [363] 2017 92.2 * * 
M-Classifier [363] 2017 95.7 * * 
Decision table [363]  2017 93.3 * * 
RT [363] 2017 93.3 * * 
WOA [364] 2017 98.7 * * 
SFFS [364]  2017 92.9 * * 
SFS[364]   2017 89.1 * * 
RSFS [364] 2017 94.4 * * 
MI [364]  2017 93.1 * * 
PCA [364]  2017 92.3 * * 
SD [364]  2017 93.9 * * 
GA [364] 2017 95.9 * * 
KM (average) [365] 2017 92.5 * * 
GNRBA (average) [365] 2017 99.3 * * 
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Table 2.7: Continued. 
Model  Year  
Performance (%) 
Accuracy Sensitivity Specificity  
D score-GP (average) [371] 2020 98.9 98.9 98.4 
F2 score-GP (average) [371] 2020 99.4 98.7 99.1 
SFS [373] 2020 90.1 * * 
SBS  [373]  2020 89.9 * * 
FAEMODE [373] 2020 95.3 * * 
GAOGB [366] 2019 94.3 93.1 93.2 
OSELM [366] 2019 93.3 89.6 95.6 
OLRAB [366] 2019 90.6 91.0 90.6 
OLRGB [366] 2019 87.8 86.7 88.6 
OLR [366] 2019 66.6 63.3 68.5 
PPA (average) [368] 2019 99.4 * * 
CS (average) [368] 2019 99.2 * * 
CSA (average) [368] 2019 99.0 * * 
CSO (average) [368] 2019 99.3 * * 
WOA (average) [368] 2019 99.2 * * 
GDis-ML [369] 2020 88.3 * * 
GGDis-ML [369]  2020 92.3 * * 
BGDis-ML[369] 2020 89.2 * * 
BGGDis-ML[369] 2020 93.2 * * 
GDis-B [369] 2020 89.8 * * 
GGDis-B [369] 2020 93.1 * * 
BGDis-B [369] 2020 90.8 * * 
BGGDis-B [369] 2020 94.6 * * 
LDA [374] 2020 97.0 100 92.0 
MOPSO [375] 2019 91.9 95.8 86.3 
NSGA-II [375] 2019 90.4 93.1 85.2 
MOEA/D [375] 2019 90.2 94.5 84.2 
 
 
Average accuracies obtained from each category of the studied literature models, i.e. ANN-based, 
SVM-based, rule/fuzzy-based, tree-based, KNN-based and other ones, for WBCD classification are 
shown in Fig 2.15. As can be observed from this figure, the average accuracy of the investigated 
rule/fuzzy-based tools is higher than that of other categories.   
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Fig. 2.14: Histogram of the accuracies obtained from other available models in the literature 
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Fig. 2.15: Average accuracies obtained from the studied literature models for WBCD classification 
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2.6 SUMMARY AND CONCLUSION  
A reliable diagnosis of BC is of great importance amongst the researchers, as it has a considerable 
impact on patients’ lives. In addition to the laboratory tests and examinations for BC investigations, 
a group of researchers have focused on the application of artificial intelligence and MLDM 
approaches in the development of CAD systems for fast, reliable and inexpensive BC detection. As 
smart models are able to extract hidden knowledge from BC databases, these systems can pave the 
way for more advanced studies in this medical field.  
Among all the available databases for BC, the WBCD is the most employed database for BC 
classification studies. This work identified papers on the application of MLDM approaches for 
WBCD classification, published between 1995 and 2020. The time scale of studies on the WBCD 
utilizing MLDM techniques indicates that the number of works has been increased over the years. 
The presented classification models in the reviewed papers were analysed according to some 
statistical parameters, including accuracy, sensitivity and specificity. As some papers just reported 
the accuracy of the proposed models, this parameter selected as the main variable for comparisons. 
This was the major limitation of our study.  
Based on the obtained results, hybrid MLDM classifiers are generally effective in classifying the 
WBCD into malignant or benign cases. This shows the potential of the MLDM approaches for BC 
detection, especially at the early stages. Further implementation and improvements of the predictive 
modeling techniques for BC classification can pave the way for better medical diagnostic decision 
support systems. 
Indeed, the majority of the reviewed hybrid MLDM algorithms like CWV-BANN-SVM model 
[304], RST-KNN [356], and GA-RotationF [301] have flexible capability of nonlinear modeling. 
Hence, it can be concluded that a combination of machine learning algorithms and optimization 
techniques can lead to higher accuracy and precision. However, as some approaches are known to 
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be black boxes, the resulting model might not be clear and could not be easily understood by non-
experts like physicians.  
 
2.7 RECOMMENDATIONS  
The main recommendations for future studies are summarized as follows: 
• This work just investigated the MLDM models for the WBCD. It is recommended to review 
the studies on the application of MLDM techniques in modeling other databases like MIAS, 
IRMA and DDSM. 
• According to some studies, employing feature extraction techniques may boost the overall 
performance of the employed classifier. Hence, evaluating different feature extraction 
techniques should be considered.  
• Hybrid models like provided excellent outcomes for the WBCD classification. It is 
recommended to assess the sustainability of different hybrid models on different datasets.  
• In the case of small datasets like the WBCD, the speed of the employed MLDM technique 
might not be significant. However, slow performance caused by massive computations is a 
problem to be solved when big databases are employed. Therefore, researchers are 
encouraged to evaluate the models in terms of computation speed as well.  
• Last but not least, having a thorough database with a sufficient number of features for BC 
can help to build more reliable and novel CAD systems. Hence, in addition to employing the 
available databases for BC, the development of an extensive database for BC investigations 
is also recommended.  
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Abbreviations 
ACO ant colony optimization  
ACR American College of Radiology 
AIRS artificial immune recognition system  
AM artificial metaplasticity  
AM artificial meta-plasticity 
ANFCLH adaptive neuro-fuzzy classifier with the linguistic hedges  
ANFIS adaptive neuro-fuzzy inference system  
ANN artificial neural network 
ART adaptive resonance theory  
ART association rule 
ASCO American Society of Clinical Oncology 
ASI assistant-I  
ASR age-standardized rates 
ASR assistant-R  
B Bayesian inference  
BC Breast cancer 
BFS Bayesian feature selection  
BGD batch gradient descent  
BGDis Bounded Gaussian distribution 
BGDM batch gradient descent with momentum  
BGGDis Bounded generalized Gaussian distribution  
BI-RADS Breast Imaging Reporting and Data System  
BN Bayes net  
BP back-propagation  
BSO brain storm optimization  
CADe computer aided detection 
CADx computer aided diagnosis 
CART Classification and regression tree  
CBR case-based reasoning  
CC cooperative coevolution  
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CFSSE CFS subset evaluation  
CG conjugate gradient  
CGCRMM classification rules mining model with GA in cloud computing 
CGNFC conjugate gradient neuro-fuzzy classifier  
CL competitive learning  
COSE consistency subset evaluation  
CS Cuckoo search  
CSA crow search algorithm 
CSAE Chi squared attribute evaluation 
CSE classifier subset evaluation  
CSO cat swarm optimization  
DBN deep belief network  
DDSM Digital Database for Screening Mammography 
DFNN deep feed-forward neural network  
DPCCM discriminating partial correlation coefficient metric  
DT Decision tree 
EA evolutionary algorithm 
EIS evolutionary IS  
EKF extended Kalman filter 
EVEN evolutionary ensemble classifiers  
FAE filtered attribute evaluation  
FAEMODE  Multi objective Differential Evolution for feature selection  
FAIS fuzzy-artificial immune system  
FARTMAP fuzzy ARTMAP 
FCM fuzzy C-means  
FE fuzzy entropy  
FEBFC fuzzy entropy-based fuzzy classifier  
FEM fuzzy entropy measure 
FF feed forward  
FFDM full-field digital mammography 
FGPNN fuzzy Gaussian potential neural network  
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FL Fuzzy logic 
FMM fuzzy min-max  
FRNN fuzzy-rough nearest neighbor  
FRPCA Fuzzy robust principal component analysis  
FSAM  fuzzy SAM  
FSE filtered subset evaluation  
FSM feature space mapping  
FSRAIRS fuzzy SVM-RWTS AIRS  
GA Genetic Algorithm  
GA-MOO-ANN GA-based Pareto-optima and ANN  
GAOGB genetic algorithm-based online gradient boosting  
GCCD Greenfield–Chiclana Collapsing Defuzzifier  
GD gradient descent  
GDis Gaussian distribution  
GDX gradient descent with adaptive momentum and step sizes 
GGDis Generalized Gaussian distribution  
GNRBA Gauss-Newton representation-based algorithm  
GO generally optimized  
GP genetic programming  
GR general regression  
GRAE gain ratio attribute evaluation  
GTO global tree optimization  
HFNN hierarchical fuzzy neural network  
HMM hybrid hidden Markov model  
HRCNN hyper-rectangular composite neural network  
HSS half selection strategy  
IDRSA improved dominance-based rough set 
IG information gain  
IGAE information gain attribute evaluation  
IRMA Image Retrieval in Medical Applications 
IRSS influential rule search scheme  
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IS isotonic separation  
KDE kernel density estimation 
KLR kernel logistic regression  
KM Koza’s model  
KMIP Karnik–Mendel iterative procedure 
KNN K-nearest neighbour 
KNNE KNN ensemble  
KPCA kernel principal component analysis  
KRNN k-rank nearest neighbour  
LDA linear discriminant analysis  
LFC look ahead feature construction  
LHNFCSF linguistic hedges neuro-fuzzy classifier with selected features  
LLR Laplace and logistic regression  
LLW-ANN local linear wavelet ANN  
LM Levenberg-Marquardt  
LN logical network  
LR logistic regression  
LS-SVM least squares version of SVM  
LSA logarithmic simulated annealing  
LVQ learning vector quantization  
MBL memory based learner  
MF membership function  
MI mutual information  
MIAS Mammographic Image Analysis Society 
ML Maximum likelihood 
MLDM machine learning and data mining 
MLP multi-layer perceptron  
MOE mixture of experts  
MOEA/D multi objective evolutionary algorithm based on decomposition 
MOPSO multi-objective particle swarm optimization 
MP memetic pareto   
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MRI magnetic resonance imaging 
MSS mean selection strategy  
MTO mother tree optimization  
MTOCL MTO algorithm with climate change  
NB Naïve Bayesian 
NFE NF ensemble  
NNTS neural network for threshold selection  
NSGA-II non-dominated sorting genetic algorithm 
OWA ordered weighted averaging  
P-ANN probabilistic ANN 
PCA principal component analysis  
PET Positron Emission Tomography 
PNCF parallel neural-based clusters fusion  
PNSCF parallel neural-based strong clusters fusion  
PPA Parasitism-Predation algorithm  
PSO Particle Swarm Optimization 
QC quadratic classifier  
QCE QC ensemble  
QDA quadratic discriminant analysis  
QN Quasi-Newton  
R-ANN recurrent ANN  
RAE relief attribute evaluation  
RBF radial basis function  
RF rotation forest  
RIAC rule induction algorithm based on the approximate classification 
RIW randomly initialized weight  
RLS recursive least square 
RST rough set theory  
RT random tree  
SBS sequential backward selection  
SCANN combining classifiers by using correspondence analysis  
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SCG scaled conjugated gradient  
SFFS sequential floating forward selection  
SFS sequential forward selection  
SMOTE synthetic minority over-sampling technique  
SNB semi-Naïve Bayesian  
SOM self-organizing map  
SSCGNFC scaled conjugate gradient neuro-fuzzy classifier 
SSV separability split value  
SUASE symmetric uncertainty attribute set evaluation 
SVM support vector machine 
SVMAE SVM attribute evaluation  
T2FLS type-2 fuzzy logic system 
TGC traditional genetic classification  
TrEnL transformed ensemble learning  
VPMCD variable predictive model-based class discrimination  
W-ANN wavelet ANN  
W-NB weighted NB  
WBCD Wisconsin Breast Cancer Database 
WDBC Wisconsin Diagnostic Breast Cancer Database 
WMV weighted majority vote  
WOA whale optimization algorithm  
 
Acronyms 
fn false negative 
fp   false positive 
tn true negative 
tp true positive 
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ABSTRACT  
As a common screening and diagnostic tool, Fine Needle Aspiration Biopsy (FNAB) of the 
suspicious breast lumps can be used to distinguish between malignant and benign breast cytology. 
In this study, we first review published works on the classification of breast cancer where the 
machine learning and data mining algorithms have been applied by using the Wisconsin Breast 
Cancer Database (WBCD). This work then introduces effective new tools, based on Random Forest 
(RF) and Extremely Randomized Trees or Extra Trees (ET) algorithms, for classification of the 
breast cancer. The RF and ET strategies use the decision trees as proper classifiers to attain the 
ultimate classification. The RF and ET approaches include four main stages; namely input 
identification, determination of optimal number of trees, voting analysis, and final decision. The 
models implemented in this research consider important factors such as uniformity of cell size, bland 
chromatin, mitoses, and clump thickness as the input parameters. According to the statistical 
analysis, the proposed methods are able to accurately classify the type of breast cancer. The error 
analysis results reveal that the designed RF and ET models offer the most reliable outcomes and the 
highest diagnostic performance, compared to previous tools/models in the literature for the WBCD 
classification. The highest and lowest relative importance are attributed to uniformity of cell size 
and mitoses among the factors. It is expected that RF and ET algorithms play an important role in 
medicine and health systems for the purposes of screening and diagnosis in the near future.    
 
KEYWORDS: Breast Cancer; Wisconsin Breast Cancer Database; Classification; Ensemble 
Learning; Random Forest/Extra Trees 
 
3.1 INTRODUCTION 
3.1.1 Breast cancer overview  
It is believed that the most common recognized type of cancer among women is breast cancer. 
Although breast cancer can occur in men, it is very rare. According to the research work [1], one out 
of every eight U.S. women might be affected by breast cancer during her lifetime. Another report 
claims that the breast cancer comprises 25% of all predicted cancer cases in Canadian women in 
2017 [2].  
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Different sections of the breast such as ducts and glands might be the start point of breast cancers. 
If the cancer cells are able to enter the lymph system or bloodstream, the breast cancer will spread 
to other parts of the body [3]. Adenomas, fibromas (fibroids), a soft fibroma of the eyelid, 
hemangiomas, and lipomas are examples of the benign tumors [4].  It is worth noting that benign 
breast lumps (or non-cancerous breast tumors) are not in the category of cancers. Indeed, 
development of malignant tumors including carcinoma, sarcoma, and blastoma in the breast tissues 
is responsible for breast cancer occurrence. In addition to the benign and malignant tumors, some 
tumors such as actinic keratosis, dysplasia of the cervix, and leukoplakia can be classified as 
premalignant tumors [4].  
Although considerable improvements on breast cancer investigations have been made in recent 
years, the main causes of breast cancer still remain obscured in the majority of cases [5].  Factors 
such as increasing age, obesity, a family history, estrogen exposure, alcohol consumption, and 
inheritance of susceptibility genes are normally associated with the development of breast cancer 
[5-11]. The above factors represent the indicators of risk that can be helpful when differentiating 
between women with different levels of risk. Therefore, the parameters are called “risk factors” [12].  
Early diagnosis of breast cancer using appropriate approaches may lead to a decrease in mortality 
rates of women [13, 14]. Although malignancy or benignity of the breast mass can be detected 
through surgical biopsy, this method is a costly and time-consuming operation. Moreover, the 
surgical biopsy has a negative influence on the psychology of the patient [15, 16].  For proper 
treatment of patients suffering from breast cancer, resident experts need to work as a team on the 
important corresponding aspects such as oncology, radiology, and surgery. Surgical treatment, 
systemic therapy, radiation therapy, and minimally invasive therapies might be applied, depending 
on the patient health conditions and type of cancer. More information can be found elsewhere [5].  
At-risk women (starting at age 40) can be screened for breast cancer using mammography, which is 
the most employed approach in clinics and hospitals [5]. However, this method is not always 
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accessible in poor, and underdeveloped/developing countries [17].  To screen the high-risk patients, 
in addition to mammography, the magnetic resonance imaging (MRI) method can be implemented 
[18]. A common technique, which is also used as a diagnostic and screening approach for 
investigation and diagnosis of the breast cancer, is Fine Needle Aspiration Biopsy (FNAB) [17, 19, 
20].  FNAB is a quick and simple procedure that is relatively less traumatic, compared to the surgical 
biopsy. Specimens of FNA are commonly obtained through utilizing 20- to 25-gauge needles [21].  
The Wisconsin Breast Cancer Database (WBCD) reports breast cancer-related measurements, 
according to the FNAB data. A FNAB is prepared through aspiration of a small drop of a viscous 
fluid from the breast mass using a needle [22].  Each dataset contains nine cytological characteristics 
of malignant or benign breast fine needle aspirates. Indeed, this database provides comprehensive 
data that can be employed for the distinction between the benign and malignant breast masses.  
 
3.1.2 Study objectives    
In the past few years, researchers developed several predictive models capable of classifying breast 
cancer types. For example, in 2018, Fondón et al. [23] employed Support Vector Machine (SVM) 
for breast cancer classification. In another study, Naive Bayes classification was used to classify the 
breast cancer data as malignant or benign [24]. Recently, Zhu et al. [25] investigated the performance 
of deep learning for distinguishing between molecular subtypes of breast cancer. The main goal of 
this study is to evaluate the performance of two ensemble methods, namely Random Forest (RF) 
and Extra Trees (ET), in the classification of WBCD. To the best of the authors’ knowledge, this is 
the first work that presents simple visualized models based on the ET methodology in conjunction 
with the Classification and Regression Tree (CART) method to classify the WBCD.  
To achieve the study goal, the remainder of the current work is organized into four sections. The 
related works on the WBCD classification using the machine learning and data mining approaches 
are reviewed in Section 3.2. Next, the RF and ET classification theory as well as the model 
 97 
 
development procedure are briefly explained in Section 3.3. Using the WBCD and applying RF/ET 
methods, the research results and systematic discussion are then presented in Sections 3.4 and 3.5. 
The last section, Section 3.6, concludes the research investigation.   
 
3.2 PREVIOUS WORKS  
There are several studies in the open source literature that focus on classification of breast cancer 
which rely on the WBCD database through employing various mathematical methods, statistical 
models/algorithms, machine learning, and data mining approaches. In the context of development 
of intelligent/smart classification models for breast cancer classification, the main implemented 
approaches are Artificial Neural Networks (ANNs) [26-33], Fuzzy Logic (FL) [34-38], and SVMs 
[39-44]. Other methods, including linear programming [45], Learning Vector Quantization (LVQ) 
[46], decision trees [47] and K-nearest neighbor [48], are also investigated in the literature.  
Application of feed-forward ANN with Back-Propagation (BP) in breast cancer classification was 
evaluated by Paulin, Santhakumaran [49]. They used different variations of the BP including batch 
training, Batch Gradient Descent (BGD), batch gradient descent with momentum, conjugate 
gradient, Quasi-Newton (QN), Levenberg-Marquardt (LM), and resilient BP to adjust the weights. 
The only criterion used in the work to evaluate the classification performance of the models was 
accuracy. Other parameters such as relative precision and recall were not calculated for the BP-
based models. Among the studied training algorithms, the LM provided the best results [38]. 
In 2016, Abdel-Zaher, Eldeib [50] suggested a breast cancer classifier through employing a two-
phase framework. The first phase includes an ANN in conjunction with the conjugate gradient back-
propagation algorithm or LM. This pre-training phase is then followed by an unsupervised phase. 
This method is known as a Deep Belief Network Neural Network (DBN-NN). In addition to the 
DBN-NN, the researchers provided two other models based on the Randomly Initialized Weight BP 
Neural Network (RIW-BPNN). Their results revealed that the DBN-NN approach presents a greater 
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accuracy than the RIW-BPNN method. Although the DBN-NN method is capable of classifying the 
WBCD with satisfactory accuracy, it requires considerable effort to build a classification model 
using commercial technology [39]. This is considered as the main limitation for this technique.  
Recently, Pota, Esposito, De Pietro [51] developed several rule-based fuzzy systems. Their work 
presented a procedure based on applying the naïve Bayes hypothesis to fuzzy systems. The 
employed optimization algorithms to find the fuzzy sets position, rule weights, and rule consequents 
are likelihood fuzzy analysis and neural networks. Although FL systems generally provide accurate 
results, the designing process is thorny and needs several implementation stages [40].  
Ibrikci, Ustun, Kaya [52] investigated the WBCD by utilizing two classification models. These 
approaches are presented based on the conventional SVM and the combined kernel SVM (k-SVM) 
algorithms. Comparing the two developed models revealed that the k-SVM algorithm outperforms 
the standard version of SVM in terms of accuracy and reliability. In another study [53], the least 
squares version of SVM (LS-SVM) was used for classifying the WBCD. The main advantage of the 
SVM-based classification model over most of the FLs and neural networks is its simplicity and 
process speed [42].  
Although the classification strategies employed in the literature offer reliable outcomes in the realm 
of breast cancer studies, this important health matter needs more precise and user-friendly tools. In 
a published study [54], the RF method is used as the weak learner. Then, ensembles of bagging, 
AdaBoost, dagging, multi boost, random subspace, and decorate were employed to develop a breast 
cancer classification model. However, in this study, RF is utilized as an ensemble model and the 
weak learner is the classification and regression tree (CART) model. In another study [55], the 
researchers developed two RF-based models employing 10 and 100 decision trees as weak learners. 
However, there is no information available regarding the structure of the created RF models. 
Furthermore, the accuracy of their predictive model is not satisfactory. Tripoliti et al. [56] proposed 
a model for the classification of WBCD which is based on RF with multiple estimators. 42 decision 
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trees were used in the best obtained forest. Ahmad and Yusoff [57] also implemented RF classifier 
for WBCD classification. A recent published study by Murugan et al. discusses about the application 
of RF in classification of WBCD [58]. In 2019, Hosni et al. [59] reviewed the published works on 
the application of different ensemble methods in the breast cancer research area. According to their 
study, the WBCD is the most frequently used database by researchers to perform experiments and 
modeling related to the breast cancer.  
 
3.3 CLASSIFICATION PROCEDURE 
3.3.1 WBCD  
The WBCD was used to develop RF and ET classification models capable of classifying breast 
cancer into the benign or malignant case. The WBCD was originally presented by Dr. William H. 
Wolberg at the University of Wisconsin Hospitals in Madison [45]. Table 3.1 gives further 
information regarding the dataset employed for the RF and ET modeling.   
 
Table 3.1: Information about the refined WBCD. 
Feature  Range Average 
Uniformity of Cell Size 1-10 4.442 
Uniformity of Cell Shape 1-10 3.151 
Bare Nuclei 1-10 3.215 
Single Epithelial Cell Size 1-10 2.830 
Bland Chromatin 1-10 3.234 
Normal Nucleoli 1-10 3.545 
Clump Thickness 1-10 3.445 
Marginal Adhesion 1-10 2.870 
Mitoses 1-10 1.603 
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This database contains 699 records where 241 (34.5%) are categorized as “malignant” and 458 
(65.5%) are classified as “benign”.  Excluding the ID number, the WBCD has nine independent 
attributes. Each characteristic is graded with a value ranging from 1 to 10; 1 denotes a typical benign 
and 10 represents a typical malignant. There are some patters in the databank of WBC with missing 
values (16 data series). These incomplete datasets are removed from the databank before the 
modeling process in this research work. The remaining data points contain 239 malignant and 444 
benign cases.  
 
3.3.2 Methodology 
Ensembles are the methods that utilize several weak learners and aggregate the outcomes of them to 
develop a robust model. In this section, two ensemble methodologies, namely RF and ET, are briefly 
described. 
RF method. Originally, the RF model was developed by Breiman and Cutler [60]. As an ensemble 
methodology, RF employs a number of decision trees as weak classifiers or regressors. During the 
learning phase, randomness can be introduced to attain certain relationships between the trees grown 
on the same training set. Each node of the tree has access to only one randomly chosen subset of 
features, while training a decision tree in the RF approach.  
Commonly, the RF employs the CART algorithm, introduced by Breiman, Friedman, Stone, Olshen 
[61], as a weak classifier to develop a strategy for classification tasks. In the CART method, the 
input space is separated into several rectangular or cuboid regions that are non-overlapping [62-64]. 
To train each CART, different sub-datasets of the training points are chosen with replacement. After 
construction of CARTs through using bootstrap samples, the remaining data, i.e. the data which are 
not utilized in the CART construction, are used to determine the model’s error and feature 
importance. For each CART, about 35% of the data series are left out of the bootstrap samples. 
These data are called Out-Of-Bag (OOB) cases.   
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Using RF, a random instance of p  features is drawn at each CART split. The original work suggests 
that pp = , where p is the total number of features. Considering a training set including D with n 
samples, the RF algorithm is as follows: 
 
RF General Algorithm 
1: generate m bootstrap samples D1, D2, …, Dm 
2: for each i in [1, m] do 
3: grow a tree predictor 
*ˆ
if  using the CART method, that: 
4: at each split pp   random variables are selected. 
    each CART is fully grown and not pruned. 
5: end for 
6: classification of a parameter like x using ensemble of the CARTs:  
                the most voted class 
  
With the aim of computing the importance of each feature of the investigated database, Gini 
measurements or permutations can be used in the RF method. This study applies the Gini 
importance. Consider that there is a total number of n samples at node  . Through defining 
nnp kk /=  as the kn  samples’ fraction from  1,0=k  category out of all the samples at node 
, the following expression calculates the Gini impurity [65]:  
2
0
2
11)( ppi −−=                                   (3.1) 
where )(i  stands for the Gini impurity. Consequently, Equation (2) defines the decrease of )(i  
that follows from splitting and sending the instances to sub-nodes 
1  and 2  by a threshold t  on 
feature   as follows [65]:  
)()()()( 21  ipipii rl −−=              (3.2) 
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where nnp ll /=  and nnp kk /=  introduce the sample fractions. 
Over all features existing at the node, a thorough search is performed. Conducting this stage, the 
pair   t,  responsible for a maximal i  is obtained. Then, a decrease in )(i  as a result of the 
optimal split ),( Ti   is recorded and accumulated for all nodes in all CARTs, individually for 
all features; T refers to the tree.  Finally, the Gini importance, )(GI , is determined by the 
following expression: 
( )=
T
G TiI

  ,)(                         (3.3) 
ET method. As an ensemble of randomized trees, the ET technique increases the randomization of 
the RF algorithm [66].  Similar to RF, the ET technique is computationally effective and is capable 
of dealing with high dimensional input vectors. However, considering the training time, ET 
overcomes the RF method. This is owing to a simpler procedure of ET to choose the thresholds. 
Furthermore, as compared to the RF, increased randomization of the ET reduces the variance [66]. 
Unlike RF, each tree in the ET is trained using the total training data points (in an autonomous way). 
Within the phase of ET learning, CARTs are created (in a supervised manner) from the introduced 
databank of p-dimensional samples and the corresponding targets.  
The following expression represents the score measure in ET classification [66]: 
( )
( )
( ) ( )SHSH
SI
SsScore
CS
S
C
C
+
=
2
,                                              (3.4) 
in which, S and s are the sample and split, respectively; the split entropy and classification entropy 
are indicated by ( )SH S  and ( )SHC , respectively; and ( )SI
S
C  indicates the mutual information of 
the classification and the split outcome. In regression, the relative variance reduction can be 
employed [66]. 
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As mentioned earlier, unlike RF, the randomness of ET comes from the random splits of all data 
points. Indeed, in the ET method, nodes are split using random subsets of features. The following 
pseudo-code shows the procedure to pick a random split in the ET [66]. 
 
Pseudo-code to pick a random split (S,a) 
1: Input: an attribute a and a training set S 
2: Output: a split 
3:  Categorical attribute a (denoted by A) 
4:  Compute the subset of A of values of a that available in S (AS);  
5:  Randomly draw an appropriate non-empty subset A1 of AS and a subset A2 of A/AS; and 
6:  Return the split [ 21 AAa  ]. 
  
2.3.3 Model Development   
Prior to utilizing the refined WBCD to implement the RF and ET methodologies, the collected data 
points are randomly divided into two sub-groups including training and testing sub-datasets. 
Commonly, 75-90% of the entire database are used in the training phase while employing 
connectionist predictive tools. In this study, 85% of the entire dataset are allocated for the training 
state. The remaining data points, 15%, are utilized to evaluate the capability of the developed RF 
and ET models in classifying the unseen data. Simple schematic of the procedure for RF/ET model 
development to classify the WBCD is presented in Fig. 3.1. 
It should be mentioned that instead of allocating a part of total data points for a validation phase, 
10-fold cross validation procedure is employed for training the models. Using the cross-validation 
method results in having more samples, as training data points, to develop a more reliable model. 
This study leads to development of the RF/ET classification models with the best obtainable results 
for categorization of the WBCD. As the next stage, after data pre-processing, the number of CARTs 
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in the RF and ET methodologies is altered from two to ten. The input parameters to develop the 
models are explained below.   
 
 
Fig. 3.1: A simple procedure for RF/ET model development to classify the WBCD  
 
The cells grouping in the breast are described with the clump thickness. While malignant cells are 
generally categorized in multiple layers, benign cells are often grouped in monolayers. Despite the 
benign cells, the malignant cells are equally distributed. In the WBCD, the variations in shape and 
size of the cells are described by the uniformity of shape/size. The parameter namely “single 
epithelial cell size” is strongly connected to the previous parameters. Epithelial cells with 
considerable enlargement might be an indication of malignancy. Unlike the malignant cells, there is 
a tendency for benign cells to stick together. To illustrate this property, the marginal adhesion is 
used. Nuclei lacking cytoplasm is demonstrated by bare nuclei. Cells that exhibit this phenomenon 
are most likely malignant. The nucleus texture is taken into account using the bland chromatin. 
Indeed, coarse texture is a sign of malignancy. On the other hand, the texture uniformity is a sign of 
benign. WBCD uses the normal nucleoli to describe the small structures existing in the nucleus. The 
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nucleoli, which is normally very small, starts to be prominent in the malignant cells. The cell division 
is defined as mitosis. The number of mitotic divisions can help cancer specialists to determine the 
malignancy [40-43, 50].    
It should be noted that the test trials for effective construction of a RF/ET model for classification 
of the breast cancer into two sub-classes are performed on PyCharm Community Edition 3.1.3 using 
a PC with an Intel® Core™ i7-Q740 @ 1.73-2.93 GHz CPU and 8.00 GB RAM. 
 
3.4 RESULTS  
To assess the performance of the developed RF/EF classification models for WBCD, the magnitudes 
of three important statistical parameters including Classification Accuracy (ACC), precision or 
Positive Predicted Value (PPV), and recall or True Positive Rate (TPR) are obtained. 
Based on the error analysis results, it was found that all the developed RF and ET models, except 
for the RF model with three CARTs and the ET model with two CARTs, are able to precisely (and 
reliably) classify the breast cancer type for all the data utilized in this research work. In other words, 
the obtained values of ACC, PPV, and TPR for the developed RF and ET models with three (just 
for the ET model), four, five, six, seven, eight, nine, and ten CARTs in the model structure are equal 
to 1.0000, implying a significant performance of the RF and ET methods. Figs. 3.2 and 3.3 show 
the constructed CARTs during the development of the RF model with four CARTs and the ET model 
with three CARTs, respectively.  
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(a) 
 
(b) 
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(c) 
  
 
(d) 
 
Fig. 3.2: Created trees in the structure of the proposed RF model with four trees: (a) CART#1, (b) 
CART#2, (c) CART#3, and (d) CART#4. 
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(a) 
 
(b) 
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(c) 
Fig. 3.3: Created trees in the structure of the developed ET model with three trees: (a) CART#1, 
(b) CART#2, and (c) CART#3 
 
 
The decision trees created for other RF and ET models are provided in Appendix A.  Fig. 3.4 
schematically demonstrates the RF model proposed with four CARTs for the classification of breast 
cancer types, according to the WBCD independent parameters. Similarly, a simple graphical 
representation of the created ET model with three CARTs is illustrated in Fig. 3.5. 
 
 
Fig. 3.4: Schematic of the proposed RF model for breast cancer classification. 
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Fig. 3.5: A simple graphical representation of the proposed ET model for breast cancer 
classification 
 
 
3.5 DISCUSSIONS  
This study applies the RF and ET algorithms, as proper learning machines, to categorize the type of 
breast cancer. The developed RF/ET models provide a simple and efficient graphical methodology 
for the classification purpose.  The WBCD presents the real data that includes the most vital factors 
(as input data) for the model development and then final decision on the correct type of the breast 
cancer.   
Since the RF models constructed with four to ten CARTs and ET models having three to nine CARTs 
are able to attain the highest achievable accuracy (i.e. 100% ), it is clear that no classification tool 
in the literature can offer such a robustness and precision. Supporting this statement, the accuracy 
of some available classification models in the open source literature and the accuracy of the RF and 
ET models proposed with three and four CARTs are listed in Table 3.2. As can be seen from Table 
3.2, the classifier developed on the basis of the Naïve Bayes method [55] offers the lowest accuracy 
(65.27%) amongst all the studied literature models.  
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Table 3.2: Classification performance of the presented RF and ET models in comparison with the 
accuracies of the literature models. 
Model  Performance 
Accuracy Sensitivity Specificity  
BGD-NN [49] 83.27 * * 
QN-NN [49] 98.42 * * 
LM-NN [49] 99.28 * * 
DBN-NN (conjugate gradient BP) [50] 99.59 100 99.39 
DBN-NN (LM) [50] 99.68 100 99.47 
RIW-BPNN (conjugate gradient BP) [50] 98.86 100 98.22 
RIW-BPNN (LM) [50] 99.03 99.13 98.97 
FL [51] 97.80 99.00 97.00 
SVM [31]  96.49 100 86.70 
k-SVM [31]   98.25 99.40 94.40 
LS-SVM [53] 97.08 97.87 97.77 
Dagging-RF [54] 96.49 * * 
AdaBoost-RF [54] 96.78 * * 
Multi Boosting-RF [54] 96.49 * * 
Decorate-RF [54] 96.49 * * 
Random Space-RF [54] 96.93 * * 
SVM [55] 78.45 72.00 81.00 
RF (100 trees) [55] 95.64 97.00 94.00 
RF (10 trees) [55] 90.13 92.00 89.00 
Naïve Bayes [55]  65.27 57.00 72.00 
PSO-KDE [68] 97.88 94.84 99.49 
GA-KDE [68] 96.67 91.16 99.61 
PCA-KNN [69] 82.30 * * 
PCA-SVM [69] 86.70 * * 
EM-PCA-CART-FL [69] 93.20 * * 
RF (this study, 4 CARTs) 100 100 100 
ET (this study, 3 CARTs) 100 100 100 
 
 
In addition to the robustness of the implemented RF/ET classification model, it is user-friendly and 
simple to understand in terms of utilization and mathematical formulation. Indeed, a 
physician/medical doctor can easily utilize the illustrative RF/ET model to investigate the type of 
breast cancer in patients without tools such as computers and access to the Internet Explorer. 
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The importance of the parameters included in the WBCD, namely clump thickness, uniformity of 
cell size, uniformity of cell shape, marginal adhesion, single epithelial cell size, bare nuclei, bland 
chromatin, normal nucleoli, and mitoses, in the development of the RF classification models is 
graphically depicted in Fig. 3.6.  
As discussed earlier, the Gini measurements were used to calculate the feature/parameter relative 
importance. As can be seen from Fig. 3.7, each factor exhibits different importance levels while 
applying the RF models. However, for all the developed RF models with the number of CARTs 
varying from four to ten, the mitoses factor shows the lowest importance. In addition, the uniformity 
of cell size is the most important/influential variable in the construction of the RF models with five, 
six, nine, and ten CARTs. In the case of the RF models with four and eight CARTs, the most 
important parameter is the uniformity of cell shape. On the other hand, the bare nuclei is considered 
as the most influencing factor in the RF model with seven CARTs. Fig. 3.7 depicts the same graph 
for the ET models. Similar to the development of the RF models, the mitoses has the lowest impact 
in the creation of the ET models. On the other hand, the uniformity of the cell shape is found to be 
the most influential parameter for the ET methodology.   
Table 3.3 tabulates the average values (in percentage) of the relative importance of each independent 
parameter which is incorporated in the development of the RF models with four to ten CARTs.  
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Fig. 3.6: Feature importance plot for the developed RF models. 
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Fig. 3.7: Relative importance of the features involved in the developed ET models. 
 
  
The results presented in Table 3.3 are in a very good agreement with the feature importance obtained 
by the information gain technique performed on the WBCD in another study [67]. In the context of 
relative performance, the main difference between the results achieved from the current study and 
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the outcomes in the literature [67] is that it is concluded in our study that the single epithelial cell 
size has a higher impact on the RF model development, compared to the bland chromatin, which is 
different from the results of a study conducted by Hsieh et al. [65]. Similar information for the 
developed ET models is given in Table 3.4. 
 
Table 3.3: Feature importance in average for the developed RF models with four to ten CARTs. 
Feature  Rank Importance 
Uniformity of Cell Size 1 0.307901 
Uniformity of Cell Shape 2 0.226715 
Bare Nuclei 3 0.175527 
Single Epithelial Cell Size 4 0.086836 
Bland Chromatin 5 0.066213 
Normal Nucleoli 6 0.049252 
Clump Thickness 7 0.048068 
Marginal Adhesion 8 0.030445 
Mitoses 9 0.009043 
 
Table 3.4: Feature importance in average for the proposed ET approaches with three to nine 
CARTs. 
Feature  Rank Importance 
Uniformity of Cell Shape 1 0.246 
Normal Nucleoli 2 0.235 
Bare Nuclei 3 0.177 
Marginal Adhesion  4 0.159 
Bland Chromatin 5 0.074 
Uniformity of Cell Size 6 0.051 
Single Epithelial Cell Size 7 0.028 
Clump Thickness 8 0.021 
Mitoses 9 0.008 
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The developed RF and ET models are not capable of describing the relationships in the WBCD. This 
is due to the fact that the RF and ET methodologies are predictive modeling tools. Hence, utilization 
of descriptive modeling tools is recommended for future studies to detect the relationships in the 
breast cancer data. Another limitation of the ET and RF algorithms is that there is no universal rule 
to find the optimum number of trees for a classification or regression task. As a result, defining the 
number of weak learners is commonly conducted through trial and error procedure.  It appears that 
development of a proper optimization strategy in this classification case is interesting to be studied 
by researchers. 
This research offers physician/doctors effective and simple visualization tools for classification of 
breast cancer so that high accuracy and reliability are attained without utilization of mathematical 
formulas and complicated strategies. Since the developed models based on the RF/ET algorithms 
are data-driven models, the models can be updated, depending on the availability of more data 
points. Furthermore, the RF and ET methodologies can pave the way for investigation of more new 
features that might help in classification of cancer and other diseases/health issues. Indeed, the 
relative importance of each new feature, which can be obtained using these algorithms, brings new 
insight into understanding of the corresponding influence in the breast cancer case.  
 
3.6 CONCLUSIONS  
Development of classification models for medical diagnosis is of great interest amongst the 
researchers, particularly in the medicine area. This is mainly owing to the fact that classifying the 
medical datasets paves the way to design a more efficient medical diagnostic decision support 
system. It was revealed that the deterministic models existing in the literature such as ANNs, SVMs, 
K-NNs, fuzzy-based, and hybrid approaches offer acceptable outcomes; however, greater precision 
in the medicine might considerably affect the diagnosis time, cure/therapy duration, and diagnosis 
and therapy costs. In addition, a majority of the available tools suffer from higher complexity, lack 
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of optimal structure, and overfitting. Hence, the objective of the current study was to employ RF 
and ET to classify the breast cancer type based on the WBCD with the highest achievable precision. 
To attain the objective, several RF/ET classification models in conjunction with CARTs in the model 
structure were examined. It was found that the developed RF models with four to ten CARTs and 
ET models with three to nine CARTs have high potential to forecast the WBCD type with 100% 
accuracy in all cases. The RF/ET models with the proposed CART structures are simple to 
understand and appreciably efficient to categorize the WBCD so that no model can rival this 
classification strategy in terms of robustness, reliability, implementation speed, and precision. 
Hence, it is recommended to evaluate the performance of these approaches for studying the future 
databases on the breast cancer. 
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ABSTRACT  
The human papillomaviruses (HPVs) can be responsible for various types of benign tumors called 
warts. Although warts can grow on all parts of the human body, common warts and plantar warts 
(as the most prevalent warts) grow principally on the hands and feet soles, respectively. Different 
treatment approaches such as cryotherapy and immunotherapy can be used to conquer the disease. 
However, the best healing method should be selected based on the patient circumstances. This study 
employs the classification and regression tree (CART) algorithm to develop accurate predictive 
models capable of analyzing the response of patients having common and/or plantar warts to the 
cryotherapy and/or immunotherapy methods. To develop a CART classifier for the cryotherapy 
method, independent parameters including the age and gender of patient, number of warts, type of 
wart, surface area of warts and the time elapsed before treatment are used. In the case of 
immunotherapy, in addition to the above-mentioned variables, the induration diameter of the initial 
test is also considered. The error analysis reveals that the implemented CART models provide the 
highest achievable accuracy for the application of interest. Moreover, the proposed decision tree-
based models are simple to use and more reliable, in contrast to the literature models that are mainly 
originated from the fuzzy rule-based method. Hence, the models introduced in this study can assist 
both patients and physicians in saving cost/time and improving the quality of healing operation.   
 
KEYWORDS: Warts; Cryotherapy; Immunotherapy; Classification; Decision tree; Error analysis 
 
4.1 INTRODUCTION 
As a broad category of deoxyribonucleic acid (DNA) viruses, human papillomaviruses (HPVs) can 
induce diseases such as cervical, anal, vulvar, and vaginal cancers. Until now, at least 150 various 
HPVs have been discovered in human DNA [1]. Although the HPV vaccine was introduced in 2006 
as the primary prevention of HPV-related diseases, the rates of HPV vaccination are still low [2]. In 
addition, HPVs are responsible for benign proliferations, called warts, on the body skin [3]. It is 
believed that the cutaneous warts are mainly caused by some alpha-PV types (HPV2, HPV3, 
HPV10, HPV27, and HPV57), gamma-PV types (HPV4, HPV60, and HPV65), and mu-PV types 
(HPV1 and  HPV63) [4-12]. A number of research studies found that the racial factor has a 
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significant impact on the rate of warts, since its rate is lower in African-Americans than in 
Caucasians [13-15]. In an annual family practice, 6% of school children and 2% of general people 
were known to have warts [16]. 
There are different types of warts including flat wart, plantar wart, common wart, filiform wart, 
mosaic wart, subungual wart, butcher’s wart, endophytic wart, and myrmecia wart. The plantar and 
common warts are predominant among them [17]. Generally, the plantar warts are initiated on the 
foot/toes bottom and the common warts are found on the feet and hands. 70% of the cutaneous warts 
are known to be common warts. About 65% of untreated common warts will disappear within two 
years [18]. The spontaneous disappearance rate of plantar warts without treatment is between 65% 
and 78% [19]. Depending on the sensitivity of the patient and the anatomic location of plantar warts, 
they can be either painful or non-painful [20]. The medical reports show that patients, who have 
never had a wart, have a lower risk to be affected by warts, compared to those who have had plantar 
or common warts previously [21-24]. 
To overcome warts, there are several treatment approaches: destructive methods, immunotherapy, 
antimitotic drugs, and other available methodologies (e.g., duct tape, garlic extract, sinecatechins, 
and local hyperthermia). Surgical excision, cryotherapy, laser therapy, electro-surgery, and curettage 
are categorized as destructive methods. It should be mentioned that the topical chemotherapy 
including bichloroacetic or trichloroacetic, salicylic acid, podophyline, cantharidin, and 5-
flurouracil is also considered as a conventional destructive treatment method [18]. Based on a study 
conducted by Kassis et al. [25], it was concluded that  continuous ultrasound has no healing effect 
while struggling with wart disease. In the immunotherapy, the humoral and/or cellular immune 
responses are elicited by using drugs such as imiquimod, zinc sulfate, diphenylcyclopropenone, and 
cimetidine [26]. However, none of them are well-tolerated and high efficient [27]. Indeed, the 
therapeutic approaches can eliminate the symptoms and signs of warts. This is due to the fact that 
HPVs have no cure [20]. It was found that plantar warts and common warts are different in 
responding to the treatment [28]. Hence, it was believed that the cure for warts needs to be 
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individualized [18]. According to the previous studies, the success rate of the known methods 
applied for common wart treatment varies from 32% to 93% [29, 30].  
Cryotherapy is one of the most utilized treatment methods for warts. Although cryotherapy is 
painful, and it has side effect, however, it is inexpensive and easy to employ. In this method, the 
liquid nitrogen is directly applied to warts for 10 to 20 seconds [26]. The mechanism of the 
cryotherapy technique is still unknown. However, it seems that the freezing operation results in local 
irritation and consequently, an immune response is stimulated [26]. To achieve satisfactory results, 
the procedure should be repeated every 2 to 3 weeks. According to a study by  Bourke et al. [31], 
the healing rate of the cryotherapy, repeated every three weeks, for warts on hands was between 
30% and 70% after three months. Other studies showed that warts treated with cryotherapy and/or 
salicylic acid have a 60% to 80% success rate [32-34]. This destructive approach causes blistering 
as it causes damage to the skin and it is painful. Moreover, there are risks of hyperpigmentation, 
hypopigmentation, and scarring with the cryotherapy [26].  
As another wart treatment method, immunotherapy does not suffer from most disadvantages 
associated with the cryotherapy [17]. In this approach, a skin test antigen is injected into a lesion 
with the aim of inducing a T-cell-mediated, immunological response.  In contrast to other available 
strategies for wart treatment, immunotherapy has the potential to result in a generalized immune 
response to the virus [35]. The key mechanism of this method is linked to a delayed-type (or type 
IV) hypersensitivity reaction [21]. For the first time, Lewis [36] reported the use of immunotherapy 
with dinitrochlorobenzene (DNCB) for common warts in 1973. Due to the mutagenic nature of 
DNCB, it is not utilized in the clinical setting anymore [36]. The non-mutagenic substance, known 
as diphencyprone (DCP), can be used for immunotherapy. Buckley et al. [37] investigated the warts 
treated with solutions of DCP over eight years.  
For the purpose of improving the diagnosis in the medical science, implementation of machine 
learning and data mining approaches can be beneficial in terms of prediction accuracy and time (and 
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cost) aspect. Several studies reported in the literature introduce the application of predictive 
methods/algorithms for diagnosis and treatment selection of skin-related diseases. For example, 
Parikh and Shah [38] employed the support vector machine method combined with the polynomial, 
radial basis function, linear, t-student, and inverse multi-quadratic kernels for classification of skin 
diseases including fungal infection, bacterial infection, scabies, and eczema. The datasets employed 
in their study have been obtained from an Indian hospital. An accuracy of about 95% was attained 
in their study.  In another research investigation, El Bachir Menai and Altayash [39] used decision 
tree-based method for diagnosis of erythemato-squamous disease in dermatology. Their proposed 
approach led to a 95% precision. In addition, there are a number of research works in the open 
sources that have implemented connectionist tools to investigate treatment of the melanoma (a 
category of skin cancers) in terms of classification and diagnosis ways [40-45]. 
Khozeimeh et al. [17] proposed a fuzzy rule-based methodology to study the effectiveness of 
cryotherapy and immunotherapy methods for treatment of common and/or plantar warts. Using the 
databases provided by Khozeimeh et al. [17], Akben [46] applied the ID3 algorithm to develop 
classification models for wart treatment selection. The developed ID3 models were then employed 
to create the fuzzy informative images. In another study, Khatri et al. [47] utilized the J48 algorithm 
in combination with the genetic programming for the same application of interest where they used 
the same databases as well.  Guo et al. [48] employed a deep convolution neural network 
discriminator for differentiating between the seborrheic keratosis and flat warts.  Guimarães et al. 
[49] utilized the fuzzy neural network method to improve the prediction capability of the expert 
system for the immunotherapy approach. For two commonly employed cryogens; namely nitrous 
oxide probes and liquid nitrogen spray, Mercer and Tyson [50] performed a mathematical modeling 
approach to find a relationship between the tissue freezing zone and freezing time. 
Decision trees (DTs), as a type of supervised machine learning and data mining approaches, are 
capable of conducting the regression and/or classification problems. There are several forms of DTs 
including classification and regression tree (CART), ID3, C5, and C4.5 to develop a DT-based 
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model. In 2017, CART methodology was employed to forecast the carbon dioxide solubility in ionic 
liquids [51]. In another study [52], a CART-based model was presented to model the equilibrium 
carbon dioxide loading capacity of sodium Glycinate. In the context of classification problem, DT 
classification was implemented for predicting the soil drainage classes in Denmark [53]. 
To the best of our knowledge, there no research studies in the literature that use CART-based 
methods for selection of the best approach for wart removal.  The primary objective of the present 
work is to introduce simple-to-employ and accurate decision tree (DT)-based models that can be 
used by physicians to select the best treatment method for common and/or plantar warts. To attain 
this goal, the CART algorithm is utilized for the development of efficient classifiers.  Dividing the 
desired database iteratively, CART leads to a homogenous classification of the target/dependent 
parameter. One of the main advantages of the strategy proposed in this study over other algorithms 
is that the designed CART-based models can be visualized through an understandable manner. 
Indeed, there is no need for medical experts to obtain mathematical and computational information 
regarding the classification methodology. Hence, the visualized tree-based models can be effectively 
used by medical experts/doctors for the prediction purposes.   
The remainder of the current research study consists of four main sections: Section 4.2 briefly 
describes the CART algorithm and the theory behind it. In Section 4.3, the classifier development 
procedure is explained. Then, the results achieved in this work are presented and discussed in 
Section 4.4.  Finally, the conclusions are drawn in Section 4.5.   
 
4.2 DECISION TREE LEARNING 
Similar to other machine learning and intelligence approaches such as artificial neural networks, 
support vector machines, and adaptive neuro-fuzzy inference system, the decision trees (DTs) 
technique is able to solve regression and classification problems. Highlighting one important 
characteristic of DTs, the DT learning is known to be computationally inexpensive. Furthermore, no 
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assumptions are needed concerning the predictors’ parameters distribution. The DTs approach is 
also robust in handling the missing data points [54-56].  
As a decision support method, the DTs method employs a tree-like model that can be visualized. 
Fig. 4.1 demonstrates a simple decision tree. The depicted tree is designed for a hypothetical analysis 
that has ( )2,1 XXX =  as a vector of two independent variables. As can be observed from Fig. 4.1, 
the target (dependent parameter) can be estimated through four internal nodes and five leaves. In 
this approach, Ti and Li are the threshold values of the leaf. According to the decision tree presented 
in Fig. 4.1, the tree development is performed from the top to the down. At the beginning, the 
magnitude of X1 is compared to a threshold value. If the value of X1 is higher than the value of T1, 
the right branch, i.e. NO, is selected for the remaining steps to obtain the final result. Otherwise, the 
left branch should be chosen.  
 
 
Fig. 4.1: A typical decision tree (adapted from Ref. [62]). 
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There are a number of algorithms suggested in the literature to develop decision tree-based 
regressors or classifiers. A few of the well-known algorithms include iterative Dichotomiser 3 (ID3) 
[55], C4.5 (developed as a successor of the ID3 learning algorithm) [57], fuzzy ID3 [58], and CART 
[59]. In the regression and classification applications, DTs technique offers distinct advantages. For 
example, the DTs model is easy to interpret and also to visualize. Indeed, compared to black-box 
models such as artificial neural networks, DTs models can be demonstrated in a graphical form. 
However, there are some disadvantages associated with DTs. One of the main drawbacks of DTs is 
their limitation for estimating continuous values in the context of regression analysis. Furthermore, 
for both classification and regression tasks, the structure of the created tree might be complicated 
due to the presence of many branches. The structure of DTs is highly dependent on the data 
introduced for modeling. In other words, variations in the dataset will change the structure of the 
tree. Hence, DTs methods might be variable and unstable.   
Over the years, the classical CART algorithm has remained as a commonly utilized decision tree. 
This is mainly due to the nature of this effective methodology [51, 60]. Indeed, the CART model is 
fast to create, and it applies to both the quantitative and qualitative data.  In this study, the CART 
method is used to develop tree-based classifiers for the application of interest. To develop a CART 
model, the recursive binary splitting is used. For regression problems, the squared residentials 
minimization algorithm is preferred to be employed for the splitting. In the case of classification 
analysis, splitting rules such as Twoing and Gini may be applied.  In this research, the Gini splitting 
rule is utilized. To determine the importance of each feature in the collected databases, the strategy 
of Gini permutations/measurements is also applied. Consider that the kn  samples’ fraction from 
 1,0=k  category out of all the samples at the node   is expressed as follows: 
nnp kk /=                                                  (4.1) 
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In Equation (1), p refers to the probability of having a specific data class in a branch of the DT (node 
 ). The following equation presents the mathematical expression for the Gini impurity, )(i :  
2
1)( −=
k
kpi                                             (4.2) 
If the node has only one single class, the equation output becomes zero that is the best value for the 
impurity. For a two-class problem (class 0 and class 1), )(i  is calculated as follows [61]: 
2
0
2
11)( ppi −−=                                   (4.3) 
As the samples are separated and sent to sub-nodes 
1  and 2 , the Gini impurity changes. To define 
the reduction amount of )(i , as a result of separating and sending the samples to sub-nodes 1  
and 
2  by a threshold t  on feature  , the following expression can be used [61]:  
)()()()( 21  ipipii rl −−=              (4.4) 
Depending on the applied setting (when creating a tree), the ideal strategy is to make enough 
branches until each branch has a Gini impurity of zero.  
Conducting a proper/systematic search over all the available features at the node, the pair   t,  that 
leads to a maximal i  is obtained. After this stage, the algorithm records and accumulates a 
decrease in )(i  for all the nodes (individually for all features). If we have a random forest of 
CARTs instead of a single CART, the Gini importance is calculated using the following expression 
[61]: 
( )=
T
G TiI

  ,)(                         (4.5) 
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in which, )(GI  resembles the Gini importance and T denotes the number of trees in the model. The 
Gini importance indicates how often a specific feature   is employed for a split, and how important 
its general discriminative value is for the classification analysis of the objective function. 
 
4.3 MODEL DEVELOPMENT  
4.3.1 Databases  
To develop classifiers to study the applicability of the immunotherapy and cryotherapy (as wart 
treatment approaches), two different databases reported in the literature [17] are employed. The 
databanks have been gathered in Ghaem Hospital’s dermatology clinic (Mashhad, Iran), in the time 
period of January 2013 to February 2015, from the patients affected by common and/or plantar 
warts. It is believed that these two categories of warts are the most widespread warts. The detailed 
procedure to obtain the information on the types and treatment ways of warts for the model 
development can be found elsewhere [17].  
Using one of the databases, six vital parameters including the age and gender of the patient, number 
of warts, type of warts, surface area of warts, and the time elapsed before treatment are recorded to 
demonstrate the patient response to the cryotherapy method. The second database has seven 
variables to investigate the responses of the patients to the immunotherapy treatment.  Both 
databases have six variables in common. However, the induration diameter of initial test is also 
considered as a key parameter for the immunotherapy approach. Eqs. (4.6) and (4.7) mathematically 
represent the independent variables to study the responses of patients to the cryotherapy and 
immunotherapy methods, respectively. 
( )areatypewartsnumberwartstimeSexAgefRESPONSE ycryotherap ,,,,, −−=                          (4.6) 
( )diameterindurationareatypewartsnumberwartstimeSexAgefRESPONSE apyimmunother −−−= ,,,,,,  (4.7) 
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More information/data such as ranges of the independent parameters existing in the databases are 
given in Tables 4.1 and 4.2.    
 
Table 4.1: Information of patients treated with the immunotherapy strategy. 
Independent parameter Value/type 
Gender 49 woman and 41 man 
Age (year) 15-56 
Time elapsed before treatment (month) 0-12 
Number of warts 1-19 
Types of warts 47 common, 22 plantar, and 21 both the common 
and plantar 
Surface area of the warts in mm2 6-900 
Induration diameter of initial test (mm) 5-70 
 
Table 4.2: Information/data of patients treated with the cryotherapy method. 
Independent parameter Value/type 
Gender 43 woman and 47 man 
Age (year) 15-67 
Time elapsed before treatment (month) 0-12 
Number of warts 1-12 
Types of warts 54 common, 9 plantar, and 27 both the common and 
plantar 
Surface area of the warts in mm2 4-750 
 
4.3.2 General step 
To construct the robust classifiers based on the CART algorithm for selecting the appropriate wart 
treatment method, each collected database is randomly divided into two distinct categories; namely 
training dataset and testing dataset. Since there is no universal rule for allocations of data points to 
training and testing phases, the trial and error procedure can be utilized for this task. Normally, 80-
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90% of the data points are used for the model training. Using 90% of the wart dataset, it is found 
that the CART model can provide satisfactory results.   
In our study, the training dataset consists of 90% of the used databank. The remaining 10% of the 
data points are labelled as the test samples. This is due to the fact that the random separation of data 
results in a more reliable (and generalized) model. Indeed, the classifier model can be created by 
employing the data points allocated for the training phase of the CART model proposed in this study. 
Once the model was built, it can be assessed in terms of accuracy using the unseen data points, i.e. 
the testing dataset.  
 
4.3.3 Classifier development  
This study utilizes the CART algorithm to introduce rigorous classifiers for the proper selection of 
the wart treatment approach. The model development procedure is graphically represented in Fig. 
4.2. To build a tree-based model on the foundation of the CART method, two influencing parameters 
including the number of features and the maximum depth of the tree need to be defined. The 
maximum depth of the CART refers to the maximum length among the existing paths that joins a 
root of the tree to a leaf.  
The number of independent variables determines the number of features. The databank for the 
cryotherapy method consists of six independent parameters.  In the case of immunotherapy method, 
there are seven independent parameters in the corresponding database. Since there is no universal 
rule to obtain the optimal CART maximum depth, a trial and error procedure is used. To start the 
procedure, the initial CART depth is supposed to be three. Eventually, it is found that the optimum 
values of the CART maximum depth are 10 and 8 for the immunotherapy and cryotherapy cases, 
respectively. Fig. 4.3 demonstrates the developed CART classifier to investigate the effectiveness 
of the immunotherapy technique for wart treatment. The CART model proposed for the cryotherapy 
method is depicted in Fig. 4.4.  
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Fig. 4.2: Schematic of the procedure for model development to select the appropriate wart 
treatment method. 
 
 
Fig. 4.3:  The developed CART approach to study the effectiveness of the immunotherapy 
technique for wart treatment. 
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Fig. 4.4:  The introduced CART model to examine the effectiveness of the cryotherapy method for 
wart treatment. 
 
The digraphs of the CART models created for wart treatment through employing the cryotherapy 
and immunotherapy methods are provided in Appendix B.   
 
4.4 RESULTS AND DISCUSSION   
4.4.1 Accuracy assessment  
In the case of classification problems, the accuracy only indicates the correct classification. This 
parameter considers equal costs for misclassification. Considering the unequal costs of decisions, 
the confusion matrix can be utilized to determine the specificity, sensitivity, and accuracy. 
Furthermore, statistical parameters such as mean squared error (MSE) and absolute average 
deviation (AAD) are normally used when the values of continuous variables are predicted. Most 
classification problems are binary variable (correct/false and yes/no.). As shown in Figs. 4.3 and 
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4.4, the proposed CART classifiers provide easy-to-use and rigorous graphical models to evaluate 
the success of cryotherapy and immunotherapy in treating the common and/or plantar warts.  
Assessing the capability of the proposed classifiers, some appropriate statistical parameters such as 
classification accuracy (ACC), sensitivity or true positive rate (TPR), and specificity or true negative 
rate (TNR) are utilized. The corresponding formulas for ACC, TPR, and TNV (in percentage) are 
listed below through Eqs. (4.8) to (4.10), respectively.   
100
+++
+
=
tnfnfptp
tptn
ACC                    (4.8) 
100
+
=
fntp
tp
TPR                                          (4.9) 
100
+
=
fptn
tn
TNR                                        (4.10)                                
where fp, fn, tn, and tp stand for the false positive, false negative, true negative, and true positive, 
respectively. 
The statistical analysis reveals that the outcomes obtained from the presented CART models are in 
excellent agreement with the existing real data. Indeed, both the CART models developed for the 
cryotherapy and immunotherapy methods are able to forecast the patient response to the treatment 
without any error. In other words, the values of ACC, TPR, and TNV for the proposed CART models 
are equal to 100% for both the training and testing phases. 
 
4.4.2 Comparison with other available techniques 
In 2017, Khozeimeh et al. [17] employed a fuzzy rule-based framework to select the proper method 
for wart treatment. Recently, Akben [46] and Khatri et al. [47] utilized DT-based algorithms for the 
development of classification models with a capability for selecting the best approach for wart 
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treatment. Furthermore, Khatri et al. [47] evaluated the classification capability of several methods 
including support vector machine (SVM), k-nearest neighbors (KNN), random forest (RF), naïve 
Bayes (NB), logistic regression (LR), linear discriminant (LD), bagged trees (BaT), and boosted 
trees (BoT). It should be mentioned that all the previous studies discussed in the current research 
work have used the same databanks to introduce the classification strategies. To evaluate the 
robustness of the model proposed in this study for selecting the most effective wart treatment 
technique, the previous research investigations that employed the same databases, but different 
predictive approaches, are chosen for the comparison purposes.  
For the immunotherapy technique, Table 4.3 summarizes a comparison between the proposed 
CART model and the available models (in the literature) in terms of sensitivity (TPR) and specificity 
(TNV) as well as the accuracy. As it is evident from Table 4.3, the decision tree-based models 
outperform the previous models introduced for the immunotherapy case. In addition, the BoT and 
LD models exhibit the weakest results with an accuracy rate of 78.9% for the immunotherapy 
scenario.  
Fig. 4.5 illustrates a graphical method to compare the accuracies of our new CART models and the 
models available in the open sources.  
Correspondingly, Table 4.4 compares the classification performance of the introduced CART model 
for the cryotherapy case to that of the above-mentioned literature models. Similar to the 
immunotherapy case, the results tabulated in Table 4.4 exhibit the superiority of the suggested 
CART model over the previous models for the cryotherapy treatment methodology.  
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Table 4.3: Comparison between the performance of the proposed CART model and the literature 
models for immunotherapy case based on statistical analysis. 
Model Assessment parameter 
ACC TPR TNR 
CART (this work) 100 100 100 
Fuzzy rule-based [17]  83.3 87.0 71.0 
J48 [47] 82.2 82.2 56.7 
GA-J48 [47] 96.7 96.7 91.4 
ID3 [46] 90.0 97.2 63.2 
SVM [46] 87.8 * * 
KNN [46] 87.8 * * 
LR [46] 83.3 * * 
LD [46] 78.9 * * 
NB [46] 87.8 * * 
RF [46] 80.0 * * 
BaT [46] 80.0 * * 
BoT [46] 78.9 * * 
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Fig. 4.5: Graphical comparison of the proposed CART model with the literature models for the 
immunotherapy method.  
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Table 4.4:  Values of statistical parameters for the proposed CART model and the literature 
models for cryotherapy case based on comparison between predictions and real data.  
Model Assessment parameter 
ACC TPR TNR 
CART (this work) 100 100 100 
Fuzzy rule-based [17]  80.0 82.0 77.0 
J48 [47] 93.3 93.3 93.9 
GA-J48 [47] 98.9 98.9 87.0 
ID3 [46] 94.4 89.6 100 
SVM [46] 90.0 * * 
KNN [46] 88.9 * * 
LR [46] 86.7 * * 
LD [46] 87.8 * * 
NB [46] 85.6 * * 
RF [46] 92.2 * * 
BaT [46] 92.2 * * 
BoT [46] 82.2 * * 
 
 
For the cryotherapy case, the fuzzy rule-based strategy [17] achieved 80% accuracy, which is the 
lowest amongst the available literature models. The performance of the literature models as well as 
our CART model in terms of precision is graphically presented in Fig. 4.6. 
Comparing the results of the proposed CART models with the outcomes of the models suggested by 
Khozeimeh et al. [17], Akben [46], and Khatri et al. [47] reveals the supremacy of the decision tree-
based techniques over the literature models for selection of the best approach for wart treatment.  
Beside the accuracy, the CART models provide a simple-to-use framework to select the proper 
treatment method without any calculator or computer assistance, while the fuzzy rule-based models 
appear to be appreciably sophisticated where the computational procedure might be complicated. 
As a result, the predictive models proposed in this study is more reliable and applicable than other 
literature models for medical experts. In other words, since there is no need to have knowledge and 
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theoretical background about mathematical expressions or machine learning fundamentals, the 
proposed tree-based models can be simply utilized by medical experts/doctors before implementing 
a treatment procedure. Generally, employing this type of classification techniques in the health and 
medical sectors leads to higher success rates in diagnosis and treatment of various diseases so that 
they decrease the associated expenses and time required for the corresponding medical operations.    
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Fig. 4.6: Comparison of performance of the proposed CART model with that of the previous 
models for the cryotherapy scenario.   
 
4.4.3 Feature importance  
The importance of each independent parameter involved in the development of the CART classifiers 
for the immunotherapy dataset is depicted in Fig. 4.7.  
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Fig. 4.7: Relative significance of the features involved in the CART model for immunotherapy 
approach. 
 
As seen in Fig. 4.7, the most important feature, to realize whether the immunotherapy is a proper 
treatment method or not, is the time elapsed before performing the treatment. This feature has 22.7% 
importance in the construction of the CART model. The outcome of the study conducted by 
Khozeimeh et al. [17] is in agreement with this research finding as Khozeimeh et al. [17] concluded 
that the time elapsed before accomplishing the immunotherapy has the highest effectiveness. Also, 
gender of the patient, with just 2% influence on the CART structure development has the least 
significance among the contributing factors. Although the literature [17] claimed that the gender of 
patient has a low effectiveness in immunotherapy case, the lowest impact is associated with the 
number of warts based on our research study. Other features including the induration diameter of 
initial test, age of the patient, number of warts, type of warts, and the surface area of the warts have 
almost the same significance in the decision tree creation process. 
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Fig. 4.8 describes the relative importance of the features employed to develop the CART model for 
assessment of the effectiveness of the cryotherapy method. Similar to the immunotherapy case, the 
most important variable in the CART development process is the time elapsed before starting a 
treatment. It is worth noting that this parameter is more important than other features of the database 
all together such that it has a 55.77% significance in the CART model development for the 
cryotherapy method. However, the lowest importance for this database belongs to the gender of the 
patient. The results obtained by Khozeimeh et al. [17] showed that the gender has the minimum 
importance when the patient is treated by the cryotherapy, which is the same as the finding of the 
current study.  However, based on the methodology employed by Khozeimeh et al. [17], the highest 
relative rank was given to the age of patients, which is in contradiction with the outcome of the 
present study.   
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Fig. 4.8: Feature importance plot of the CART model suggested for cryotherapy method. 
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4.5 CONCLUSIONS 
In the current, CART methodology is employed to develop robust classifiers to choose the proper 
treatment approach (cryotherapy or immunotherapy) for common and/or plantar warts. The 
performance of the developed tree-based classifiers is compared to that of the methodologies 
available in the literature in terms of reliability and prediction accuracy. Outcomes of the introduced 
CART models reveal an excellent performance for both cryotherapy and immunotherapy approaches 
so that the ACC, TPR, and TNR are found to be 100%.  On the other hand, the literature models for 
the cryotherapy case lead to ACC, TPR, and TNR ranging from 80.0% to 98.9%, 82.0% to 98.9%, 
and 77.0% to 100%, respectively.  For the immunotherapy case, the magnitudes of ACC, TPR, and 
TNR are between 78.9%-96.7%, 82.2%-97.2%, and 56.7-91.4%, correspondingly. Furthermore, the 
proposed models appear in a graphical form and can be easily employed in an understandable 
manner. Hence, it can be concluded that no model can rival the proposed CART models in terms of 
both accuracy and simplicity of implementation. By obtaining further information from various 
groups of patients, it is possible to present more efficient (and generalized) decision tree-based 
models that can be more practical for different cases. It is recommended to incorporate effective 
hybrid and ensemble methodologies (e.g., genetic algorithm and particle swarm optimization) into 
the CART algorithm for future studies. Implementation of hybrid/ensemble methods might further 
simplify (and improve) the structure of the tree-based models developed for wart treatment.   
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ABSTRACT  
Background and Objective: As the most common cardiovascular defect, coronary artery disease 
(CAD), also called ischemic heart disease, is one of the substantial causes of death globally. Several 
diagnosis approaches such as baseline electrocardiography, echocardiography, magnetic resonance 
imaging, and coronary angiography are suggested for screening the suspected patients that may 
suffer from CAD. However, applying such methods may have health side effects and/or expensive 
costs.  
Methods: As an alternative to the available diagnosis tools/methods, this research involves a 
decision tree learning algorithm called classification and regression tree (CART) for a simple and 
reliable diagnosis of CAD. Several CART models are developed based on the recently CAD dataset 
published in the literature.  
Results: Utilizing all the features of the dataset (55 independent parameters), it was found that only 
40 independent parameters influence the CAD diagnosis and consequently development of the 
predictive model. Based on the feature importance obtained from the first CART model, three new 
CART models are then developed using 18, 10, and 5 selected features. Except for the five-feature 
CART model, the outcomes of developed CART models demonstrate the maximum achievable 
accuracy, sensitivity, and specificity for CAD diagnosis (100%), while comparing the predictions 
with the reported targets. The error analysis reveals that the literature models including sequential 
minimal optimization (SMO), bagging SMO, Naïve Bayes (NB), artificial neural network (ANN), 
C4.5, J48, Bagging, and ANN in conjunction with the genetic algorithm (GA) do not outperform the 
CART methodology in classifying patients as normal or CAD.  
Conclusions: Hence, the robustness of the tree-based algorithm in accurate and fast predictions is 
confirmed, implying the proposed classification technique can be successfully utilized to develop a 
coherent decision-making system for the CAD diagnosis. 
 
KEYWORDS: coronary artery disease; classification; decision tree; error analysis; Classification 
and Regression Tree 
 
5.1 INTRODUCTION 
Coronary artery disease (CAD) appears to be the most common cardiovascular defect; heart disease 
is a leading cause of global deaths. A study showed that CAD is responsible for the death of one-
third of women, regardless of the ethnicity or race [1]. According to the World Health Organization 
(WHO) [2], CAD is the world’s biggest killer amongst the top ten death causes including CAD, 
stroke, chronic obstructive pulmonary disease, lower respiratory infections, Alzheimer disease and 
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other dementias, diabetes mellitus, road injury, diarrhoeal diseases, tuberculosis and trachea, 
bronchus, and lung cancers. Although the heart disease management has drastically changed in 
recent decades [3, 4], individuals with stable CAD are still prone to a significant adverse 
cardiovascular incident [5-7]. According to a study [8], more than 6% of the adult population in the 
United States are suffering from CAD. Furthermore, it has been estimated that the clinical CAD will 
be the issue of approximately one-third of middle-aged women and half of the middle-aged men 
across the United States [8].   
Atherosclerosis, a condition in which plaque builds up inside the arteries supply oxygen-rich blood 
to the heart, characterizes CAD. The plaque formed over the years is responsible for narrowing the 
coronary artery lumen and, consequently, limiting the blood flow through the artery. The chest pains 
in the form of pressure sensation or squeezing can be a symptom of CAD. However, several patients 
with CAD show no symptoms of the disease [9]. To screen the patients, guideline recommendations 
are employed; the proposed tips are currently documented by the American Association of Clinical 
Endocrinologists (AACE), American College of Cardiology/American Heart Association 
(ACC/AHA), and US Preventive Services Task Force (USPSTF) [10-12]. 
The 2004 INTERHEART study [13] defined nine modifiable risk factors that are correlated with 
CAD. These factors include smoking, hypertension, abdominal obesity, diabetes, stress and 
depression, regular alcohol consumption, daily consumption of vegetables and fruits, dyslipidemia, 
and regular physical activity. The majority of the risk factors are similar in women and men. 
However, compared to men, women are found to have a stronger risk factor profile at younger ages. 
Men, on the other hand, tend to have better health conditions at older ages [14]. Indeed, at first CAD 
manifestation, women are approximately ten years older than men [15]. However, smoking, diabetes 
or premature menopause throw this advantage away [14]. The race is known to be another risk factor 
for CAD. For example, some studies revealed that CAD rate among Asian Indians is higher than 
that of other ethnics [14, 16]. Family history is also associated with the risk of CAD. Based on a 
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research investigation [17], CAD family history in a sister has 12-fold higher risk versus 3-fold for 
a parent and 6-fold for a brother.  
For patients with known or suspected CAD, conventional invasive coronary angiography is found 
to be the gold standard for diagnosis purposes [18]. However, this approach is time consuming, 
invasive, and expensive. Its invasiveness nature may cause a degree of discomfort for some patients, 
since this method usually needs a short stay at the hospital [19]. Moreover, this modality has a small 
but considerable complication rate [20]. Electron-beam computed tomography (EBCT) has paved 
the way for morphological evaluation of cardiac structures. This is owing to the high temporal 
resolution of EBCT and the use of prospective electro-cardiographic triggering as well.  However, 
due to the inferior spatial resolution of the EBCT approach, it was not considered as a proper strategy 
for identifying the presence of coronary stenosis [19]. The introduction of computed tomography 
(CT) angiography led to substantial improvements in the detection of CAD as well as the assessment 
of the heart function in different conditions [21-23].  
There are some prevention ways to deal with CAD. These approaches can be divided into two 
categories, namely primary prevention and secondary prevention. Indeed, primary prevention can 
be defined as the treatments or modification of risk factors that are proven to avert the first or initial 
coronary event [24]. A common example of this prevention category is using lipid-lowering agents 
to avoid the occurrence of the first myocardial infraction [25]. On the other hand, the treatment 
modalities that are initiated after the first event for the prevention of subsequent outcomes are known 
as secondary prevention strategies. For example, utilization of beta-blockers after myocardial 
infarction, for new events reduction, belongs to this classification [26].     
Studies showed that physical activity reduces the CAD risk. The role of physical activity in both 
primary and secondary prevention is studied in the literature. For example, in the case of primary 
prevention, the protective function of working out was declared in the United States for a large 
cohort of longshoremen [24]. For the secondary prevention, the Clinical Practice Guidelines for 
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Cardiac Rehabilitation [27] indicated that the improvement extent is dependent on different factors, 
including duration, intensity and frequency of activity, and the training time interval. The concerns 
regarding regular aerobic exercise are addressed in some research investigations. It was revealed 
that regular moderate-intensity exercise decreases the cardiac mortality risk, and even with vigorous 
exercise, the sudden death incidence is low [28, 29]. However, the risk of myocardial infarction 
increases with a high-intensity and vigorous exercise [24].  
In addition to the traditional and routine screening approaches to detect CAD, some predictive 
models have been developed based on different machine learning (ML) and data mining 
methodologies. This study is intended to employ the decision tree learning algorithm, particularly 
the CART, for the diagnosis of CAD.  To the best of our knowledge, this is the first work on the 
application of CART to study the Z-Alizadeh Sani CAD dataset for diagnosis/classification 
purposes. Furthermore, we compare the outcomes of our new models with the results of the 
previously used models, developed based on various methodologies such as ANN and support vector 
machine (SVM). Furthermore, we develop several CART models based on different inputs; the 
inputs are not selected randomly. Indeed, we introduce a new CART model through employing all 
the inputs existing in the Z-Alizadeh Sani CAD dataset. Based on the Gini index, we then define the 
relative importance of each independent parameter for the development of the CART model. Finally, 
we obtain two more CART-based models using the independent parameters, which are detected 
(recognized) as important parameters. Further highlighting the novelty of this research, the 
contributions of the work is as follows: a) Utilization of the CART strategy for CAD diagnosis using 
Z-Alizadeh Sani CAD dataset for the first time, b) Selection of vital input parameters and 
determination of relative importance of inputs, c) Design of the optimal CART model in terms of 
structure/topology and parameters values, d) Proper data mining for training and testing phases, e)  
Systematic statistical analysis for performance evaluation of various classification tools, and f) 
Higher accuracy and simpler (and more understandable) outcomes of the CART approach, compared 
to the previous techniques applied to the dataset. 
 153 
 
In fact, the CART results would help physicians and health scientists to better understand the 
relationships between different parameters and CAD. 
According to the literature, several connectionist and predictive/deterministic methods are currently 
being used in various science, health, and engineering disciplines for different purposes, particularly 
when a large amount of data is available. In all cases, selection and application of proper techniques, 
data mining/management, choosing vital important input data, tuning the parameters of deterministic 
or classification models based on the selected methods, finding the relative importance of input 
parameters, results and statistical analysis, and making proper decisions are among the novelties of 
research works. 
After the introduction section, a review of the published works in the literature on the classification 
of CAD using various ML and data mining approaches is provided. Section 5.3 presents an overview 
of the CART methodology for the classification task. Modeling procedure for the application of 
interest is addressed in detail in Section 5.4. Section 5.5 includes the findings as well as a discussion 
about the modeling results. Finally, the main conclusions are highlighted. 
 
5.2 RELEVANT STUDIES 
In 2017,  Xu et al. [30] employed the multivariate logistic regression to detect the correlation 
between CAD and defined risk factors such as smoking status, angina, age, sex, hypertension, 
diabetes, serum creatinine, and dyslipidemia. The developed model was then used to differentiate 
non-CAD from CAD in the test sample. The data required for modeling purpose were gathered by 
studying 8297 patients, ranging between 19 to 90 years old, in the north and south of China between 
2008 and 2014. After excluding the patients with incomplete data, 4678 male patients and 2682 
female patients, both symptomatic and asymptomatic cases, were selected/utilized.  
The following expression represents the model developed by Xu et al. [30] for CAD prediction:   
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where p is the probability of CAD and ( )xf  refers to the discriminant vector. Eq. (5.2) is used to 
calculate the value of ( )xf as follows: 
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in which, i  and ix  denote the regression constants and risk factors, respectively; and 0A  is the 
intercept. 
The above-mentioned model presented a specificity of 0.709 and a sensitivity of 0.658, which is 
fairly acceptable, but not accurate enough. Although this model is simple to use based on the original 
work described by the researchers, it is a simplified model that does not consider other vital risk 
factors including family history and body mass index.  
Davari Dolatabadi et al. [31] implemented the support vector machine (SVM) algorithm to present 
an automatic CAD diagnosis model. In their study, they employed the signal extracted from 
electrocardiogram (ECG) as well as heart rate variability (HRV). The used data points were obtained 
from the recording of 86 lengthy ECG of 80 individuals, in which 46 cases were men aged between 
44 and 85, and 29 cases were women aged between 23 and 87 years. Finally, they only selected 23 
cases, who suffered from CAD, from this databank. For the normal group, they used 23 normal 
individuals that were obtained from 24-hour Holter monitor recordings of 30 healthy men and 24 
healthy women (aged from 29 to 76). With the aim of reducing the features’ dimension, the authors 
applied a method called principal component analysis (PCA). The proposed SVM classifier was able 
to offer a sensitivity, specificity, and accuracy of 98.43%, 100%, and 99.2%, respectively.  
Utilizing a simulated dataset of heart disease containing 1000 patient records, Ilayaraja and 
Meyyappan [32] applied a data mining algorithm for prediction of the heart diseases risk via 
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Frequent Itemsets. Chest pain, swelling of the ankles and feet, swelling in legs, shortness of breath, 
fatigue, fever, fluttering in the chest, swelling in the abdomen, changes in the heart rhythm, racing 
heartbeat, slow heartbeat, dry or persistent cough, lightheadedness, fainting or near fainting, skin 
rashes or unusual spots, breathlessness with exertion or at the rest, irregular heartbeats (rapid, 
pounding or fluttering), pain in the neck, jaw, throat, upper abdomen or back pain, numbness and 
weakness or coldness in the legs or arms (if the blood vessels are narrowed) are the attributes of the 
used dataset.  
Tan et al. [33] implemented the convolutional neural network (CNN) with long short-term memory 
(LSTM) model for the CAD diagnosis through employing ECG signals. The presented stacked 
CNN-LSTM model is fully automatic. The CNN method was also utilized by Acharya et al. [34] for 
automated detection of CAD by applying different durations of ECG segments. In another research 
investigation, Giri et al. [35] used heart rate signals to develop a methodology for the automatic 
detection of CAD and normal conditions. They employed several approaches such as PCA, SVM, 
independent component analysis (ICA), linear discriminant analysis (LDA), Gaussian mixture 
model (GMM), k-nearest neighbor (KNN), and probabilistic neural network (PNN). Acharya et al. 
[36] employed CWT-based contourlet and shearlet transforms of ECG signals for the detection of 
CAD, congestive heart failure (CHA), and myocardial infarction. Higher-order statistics and spectra 
(HOS) and flexible analytic wavelet transform (FAWT) methods were also investigated in other 
studies [37, 38]. 
In a research study conducted by Sood et al. [39], the heart rate signals were processed using the 
empirical mode decomposition (EMD) technique. To classify CAD and normal subjects, the 
researchers extracted several features. In addition to EMD, Acharya et al. [40] employed various 
methods including Poincare plots, recurrence quantification analysis (RQA) parameters, Shannon 
entropy, approximate entropy, sample Entropy, higher-order spectra methods, detrended fluctuation 
analysis (DFA), cumulants, and correlation dimension for the application of interest.  
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For the prediction of CAD, Forssen et al. [41] employed metabolomic data along with several 
approaches namely PCA regression, L1 regression, and random forest. The required data for 
modeling were collected from the Clinical Cohorts based on the Coronary Disease Collaboration 
study in some UK hospitals. Using a nuclear magnetic resonance (NMR) technique, they quantified 
256 metabolites for each individual. The dataset was randomly divided into two subsets: training 
(75%) and testing (25%). The presented models provided sensitivities between 88.2% and 98.4%. 
However, the obtained values for specificity were between 2.6% and 33.9%.  
There are some publications in the literature on the application of various machine learning and data 
mining strategies in the development of predictive models with the aid of a publicly available 
database known as UCI Cleveland dataset [42] for CAD diagnosis. The Cleveland dataset contains 
303 cases of patient data points, in which 6 of them are incomplete. Hence, these data were omitted 
from the dataset before the modeling process. Each set of data points has 13 independent attributes 
including age, gender, chest pain type, serum cholesterol, resting blood pressure, fasting blood sugar, 
resting electrocardiographic results, exercise-induced angina, maximum achieved heart rate, ST 
depression induced by exercise relative to rest, the heart status, number of major vessels, and the 
slope of the peak exercise ST segment. The dependent parameter is the diagnosis of heart disease 
that is either normal or sick (three different types). For example,  Purushottam et al. [43] compared 
the performance of several methods such as SVM, C4.5, multi-layer perceptron (MLP) ANN, and 
radial basis function (RBF) ANN in classifying the Cleveland dataset.  
Nguyen et al. [44] proposed the interval type-2 fuzzy logic system (IT2FLS) and wavelet 
transformation (WT) for Cleveland dataset classification. They compared the results of the proposed 
model with the outputs of other models including SVM, probabilistic neural network (PNN), 
adaptive neuro-fuzzy inference system (ANFIS), and fuzzy ARTMAP. Based on the performance 
metrics, the IT2FLS in conjunction with wavelets provided the best predictions with accuracy, 
sensitivity, and specificity of around 80%, 84%, and 77%, respectively.    
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In another work, Uyar et al. [45] employed the Cleveland dataset for developing a diagnosis model. 
The approach introduced by Uyar et al. [45] is based on recurrent fuzzy neural networks (RFNNs). 
The authors employed GA for training the RFNN. 85% of the data points were used for the training 
phase and the remaining 15% was allocated for the testing phase. The presented GA-RFNN model 
led to a sensitivity, specificity, and accuracy of 97.74%, 95.73%, and 96.63%, respectively. Other 
works in this research area can be found elsewhere [46-50]. 
In 2013, a new dataset for heart disease, known as called Z-Alizadeh Sani dataset, was published 
[51]. Alizadehsani et al. [51] utilized several methods namely ANN, SMO, NB, and bagging 
algorithms to analyze the Z-Alizadeh Sani dataset. In addition to the above-mentioned algorithms, 
they also used feature creation and feature selection methods to assess the results. It was found that 
the performances of the classification algorithms are better when both the feature creation and 
feature selection techniques are used.  
In another study by Alizadehsani et al. [52], Z-Alizadeh Sani dataset was divided into the train (90%) 
and test (10%) datasets. Then, the information gain and SVM were used for feature analysis and 
feature selection. For the classification purpose, the researchers employed the SVM methodology in 
combination with several kernel functions including RBF, sigmoid, linear, and polynomial.  
Utilizing the ANN and GA modeling techniques, Arabasadi et al. [53] classified the Z-Alizadeh Sani 
dataset in 2017. The attained magnitudes of sensitivity, specificity, and accuracy for the GA-ANN 
were 97%, 92% and 93.85%, respectively. On the other hand, the ANN model classified the dataset 
with 84.62% accuracy, 86% sensitivity, and 83% specificity. Hence, the classification capability of 
the presented hybrid model of GA-ANN is considerably higher than the developed ANN model. 
Performance of cost-sensitive techniques along with the Naïve Bayes, SVM, SMO, C4.5, and KNN 
strategies in CAD classification was also evaluated in a research study by Alizadehsani et al. [54]. 
To achieve more accurate outputs in the context of CAD classification, Alizadehsani et al. [55] 
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proposed a machine learning-based model to detect left circumflex, left anterior descending, and 
right coronary artery.  
Acharya et al. [56] compared the performance of discrete wavelet transform (DWT), empirical mode 
decomposition (EMD), and discrete cosine transform (DCT) in the detection of CAD and  
myocardial infarction. Alkeshoush et al. [57] evaluated the potential of the PSO algorithm in the 
diagnosis of heart disease. The diagnostic performance of cardiac phase-space tomography analysis 
was examined by Stuckey et al. [58]. In another study, Steele et al. [59] found that ML methods in 
electronic health records are better than conventional survival methods for forecasting patient 
mortality in CAD. Recently, Johnson et al. [60] employed ML approaches for the scoring of CAD 
characteristics on coronary CT angiograms. In 2019, Alizadehsani et al. [61] conducted a review of 
ML-based studies for CAD prediction. 
 
5.3 CART METHODOLOGY  
Among the available learning algorithms for decision trees such as Iterative Dichotomiser 3 (ID3) 
[62], C4.5 [63], successor of the ID3 learning algorithm, fuzzy ID3 [64] and CART [65], the CART 
strategy is known to be one of the most successful techniques [65, 66] that can be utilized for both 
classification tasks and regression analysis [67, 68]. CART is a nonparametric ML method. This 
feature enables the CART method to freely learn any form of the mapping function from the 
employed training data samples [69]. To detect complicated interdependencies between a series of 
parameters, CART is capable of using the same parameters more than once in several parts of the 
model [70]. As a result, this algorithm is flexible and powerful. As the CART method is 
nonparametric, it does not depend on (or belong to) a specific type of distribution. However, it needs 
more training datasets, compared to the parametric methods including Naïve Bayes and linear 
discriminant analysis. It is worth mentioning that outliers in the input parameters do not considerably 
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affect the CART performance. On the other hand, imbalanced classes may result in under-fitted 
trees.   
This method develops binary trees. Indeed, splitting in CART is performed based on single features. 
Thus, the CART method is a univariate decision tree. Fig. 5.1 shows a simple binary tree. It is 
supposed that ( )2,1 XXX =  is the vector of the independent variables. In the respective order, the 
values of the threshold and leaf are indicated by Ti and Li. As can be seen from Fig. 5.1, the CART 
algorithm is a top-down decision tree. The top-down development continues until the stopping 
criterion (or criteria) is met. For both the regression and classification problems, one of the 
advantages of the tree-based models is that they can be employed in graphical forms, which do not 
require calculations. However, it may be not accurate enough for variables that are continuous [71]. 
There are different splitting criteria for decision trees; namely: impurity-based criteria, information 
gain, Gini index, likelihood ratio chi-squared statistics, DKM criterion, normalized impurity-based 
criteria, gain ratio, distance measure, binary criteria, Twoing criterion, orthogonal criterion, 
Kolmogorov-Smirnov criterion, and AUC splitting criteria. In this work, the Gini index [72] was 
employed.  
 
Fig. 5.1: A typical decision tree (adapted from Ref. [78]). 
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5.4 MODELING PROCEDURE  
5.4.1 CAD dataset 
To develop a tree-based classifier for CAD diagnosis, the dataset reported by Alizadeh et al. [51], 
known as the Z-Alizadeh Sani dataset, is employed. The collected databank comprises of the 
information of 303 patients. This databank has 55 independent parameters and classifies a person 
into a normal or CAD class. The criterion for classifying a person as a patient who has CAD is 
her/his diameter narrowing status. If the diameter narrowing is lower than 50%, the patient is 
classified as normal, and otherwise, as CAD affected [73]. 
The independent parameters include age, weight, length, gender, body mass index (BMI), diabetes 
mellitus (DM), hyper tension (HTN), current smoker, ex-smoker, family history (FH), obesity, 
chronic renal failure (CRF), cerebrovascular accident (CVA), airway disease, thyroid disease, 
congestive heart failure (CHF), dyslipidemia (DLP), blood pressure (BP), pulse rate (PR), edema, 
weak peripheral pulse (WPP), lung rates, systolic murmur, diastolic murmur, typical chain pain, 
dyspnea, function class, atypical, nonanginal CP, low thyroid angina, bundle branch block (BBB), 
Q wave, ST elevation, ST depression, T inversion, left ventricular hypertrophy (LVH), poor R wave 
progression, fasting blood sugar (FBS), creatine (Cr), triglyceride (TG), low density lipoprotein 
(LDL), high density lipoprotein (HDL), blood urea nitrogen (BUN), erythrocyte sedimentation rate 
(ESR), hemoglobin (HB), potassium (K), exertional CP, sodium (Na), white blood cell (WBC), 
lymphocyte, neutrophil, platelet (PLT), ejection function (EF), regional wall motion abnormality 
(region with RWMA), and valvular heart disease (VHD). 
Table 5.1 gives the ranges of the independent parameters that have quantifying values. DM, HTN, 
ex-smoker, smoker, obesity, FH, CVA, CRF, thyroid disease, airway disease, DLP, CHF, edema, 
weak peripheral pulse, systolic murmur, lung rales, diastolic murmur, typical chest pain, dyspnea, 
atypical, low threshold angina, exertional CP, nonanginal CP, Q wave, poor R progression, ST 
depression, ST elevation, T inversion, and LVH are “yes” or “no” parameters. Before introducing 
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the dataset to the CART algorithm, “yes” and “no” are substituted with one and zero, respectively. 
Function class is defined by 1, 2, 3 or 4, and region with RWMA is defined by 0, 1, 2, 3 or 4. VHD 
status is normal (0), mild (1), moderate (2), or severe (3). Finally, female and male are indicated by 
0 and 1, respectively.   
 
Table 5.1: Ranges of features of Z-Alizadeh Sani dataset [51]. 
Parameter  Range  
FBS, mg/dl 62-400 
TG, mg/dl 37-1050 
Cr, mg/dl 0.5-2.2 
HDL, mg/dl 15-111 
LDL, mg/dl 18-232 
BUN, mg/dl 6-52 
HB, g/dl 8.9-17.6 
ESR, mm/h 1-90 
K, mEq/lit 3.0-6.6 
Na, mEq/lit 128-156 
Lymph, % 7-60 
WBC, cells/ml 3700-18000 
Neutrophil, % 32-89 
EF, % 15-60 
PLT, 1000/ml 25-742 
BMI, kg/m2 18-41 
PR, ppm 50-110 
BP, mmHg 90-190 
Weight, kg 48-120 
Age, yr  30-86 
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5.4.3 CART development   
In order to develop a CART model for the classification of the Z-Alizadeh Sani dataset into two sub-
classes, including CAD and normal, the PyCharm Community Edition 3.1.3 is used. The modeling 
is performed on a PC with an Intel® Core™ i7-Q740 @ 1.73-2.93 GHz CPU and 8.00 GB RAM. 
To construct a CART model capable of classifying the patients into normal and CAD, two 
parameters should be determined/adjusted: the number of features and the maximum depth of the 
CART.  
The number of features is equal to the number of independent parameters in the collected CAD 
dataset. Hence, there are 55 features. To adjust the maximum depth of the CART (e.g., defined as 
the maximum length among the existing paths that joins a root of the tree to a leaf), there are no 
universal rules. In this study, the trial and error procedure is employed to find the optimum maximum 
depth of the tree. As the starting point, the maximum depth is assumed to be three. Based on the 
error analysis results, it is found that the CART model offers the best results with an optimum 
maximum depth of 19. The CART classifier proposed for the diagnosis of CAD is depicted in Fig. 
5.2.  
 
Fig. 5.2: Graphical representation of the CART model (using all features) introduced for CAD 
diagnosis. 
 163 
 
5.4.4 Assessment criteria  
This section aims to provide proper criteria for evaluating the performance of the proposed graphical 
classifier, based on the CART algorithm, in the diagnosis of CAD. The accuracy is one of the main 
model assessment parameters that defines the proportion of correct classifications. The following 
expression presents the accuracy in percent (ACC%) [74]: 
100% 
+++
+
=
tnfnfptp
tptn
ACC                   (5.3) 
In Equation (3), fp, fn, tn, and tp introduce the false positive, false negative, true negative, and true 
positive, respectively.  
True negative value (TNV) can be defined as the percentage of healthy people that the classification 
model correctly identifies them as not having CAD. TNV% is defined by Eq. (5.4) as follows [74]: 
100% 
+
=
fptn
tn
TNV                                       (5.4)                                
True positive rate (TPR) measures the proportion of correct CAD predictions to all cases that have 
CAD. The definition of the TPR (in percent) is given below [74]:  
100% 
+
=
fntp
tp
TPR                                          (5.5) 
 
5.5 RESULTS AND DISCUSSIONS  
This section includes the main findings/results of this study and corresponding discussions on the 
relative performance of the input parameters and model performance (compared to the previous 
approaches). Table 5.2 shows the contingency table, also known as the confusion matrix, for the Z-
Alizadeh Sani databank. According to Table 5.2, the accuracy considers the same costs for 
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misclassified samples. Hence, in addition to the accuracy, TNV and TPR can be employed to 
perform a comprehensive assessment of the classification models.  
 
Table 5.2: Contingency table of the developed CART models based on the Z-Alizadeh Sani 
databank. 
  CART outcomes 
  Normal CAD  
Targets 
Normal 
tn  
(correct rejections) 
fp  
(Normal is predicted as CAD) 
CAD  
fn  
(CAD is predicted as Normal)  
tp  
(correct considerations) 
 
 
It follows that the importance of TPR is higher than TNV, while evaluating the effectiveness of the 
models developed for the CAD diagnosis. It reveals that correct identification of patients having 
CAD is more important than identifying healthy people. 
The values of the parameters selected as assessment criteria (e.g., ACC%, TNV%, and TPR%) are 
found to be 100%, concluding that the presented CART model is capable of predicting people having 
CAD as well as identifying healthy people without any error.  
 
5.5.1 Feature importance  
The importance of each feature in the creation of the decision tree-based model (using all the features 
existing in the Z-Alizah Sani dataset) for CAD diagnosis is graphically demonstrated in Fig. 5.3. 
Based on Fig. 5.3, atypical alone has more than 16.5% importance in the development of the CART 
model when using all the features of the Z-Alizadeh Sani dataset.  In addition, some features 
including neutrophil, poor R wave progression, Q wave, low thyroid angina, dyspnea, systolic 
murmur, WPP, edema, CHF, thyroid disease, airway disease, CVA, CRF, and EX-smoker have no 
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impact on the development of the CART model. In other words, the aforesaid features have 0% 
importance in the tree creation.     
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Fig. 5.3: The relative importance of all features involved in the CART model developed for CAD 
diagnosis/classification. 
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The independent parameters of the Z-Alizadeh Sani dataset can be categorized into four classes 
namely symptom and examination, demographic, electrocardiogram (ECG), and laboratory and 
echo features [51]. Table 5.3 summarizes the importance of each feature of the aforementioned 
categories of the dataset for the CART-based CAD diagnosis. According to Table 5.3, ECG features, 
with a 5.18% effect on the creation of the tree, have the lowest importance, compared to other 
groups. On the other hand, the most important class that influences the structure of the CART 
classifier is the symptom and examination. The remaining feature classes have approximately equal 
importance in the predictive model.  
 
Table 5.3: Importance of each feature in the development of the CART model (using all the 
features) for CAD diagnosis. 
Feature Category Feature Name Importance (%) 
Demographic 
Age 9.63 
DM 3.40 
BMI 3.02 
Length 2.52 
Weight 2.46 
DLP 2.08 
Obesity 2.02 
FH 1.43 
Sex 1.16 
HTN 0.15 
Current Smoker 0.13 
EX-Smoker 0.00 
CRF 0.00 
CVA 0.00 
Airway disease 0.00 
Thyroid Disease 0.00 
CHF 0.00 
Total 28.00 
ECG 
LVH 1.81 
BBB 1.09 
T inversion 1.08 
St Elevation 0.71 
St Depression 0.49 
Q Wave 0.00 
Poor R Progression 0.00 
Total 5.18 
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Table 5.3: Continued. 
Feature Category Feature Name Importance (%) 
Laboratory and echo   
VHD 4.25 
ESR 3.66 
K 2.98 
Region RWMA 2.96 
PLT 2.52 
EF-TTE 2.30 
BUN 1.94 
FBS 1.19 
LDL 0.99 
WBC 0.99 
HB 0.92 
TG 0.90 
Lymph 0.71 
HDL 0.59 
CR 0.55 
Na 0.30 
Neutrophil 0.00 
Total  27.75 
Symptom and 
examination  
Atypical 16.60 
Typical Chest Pain 8.96 
Diastolic Murmur 4.44 
Lung rales 2.39 
BP 2.30 
Nonanginal 1.98 
PR 1.60 
Function Class 0.80 
Exertional CP 0.00 
Edema 0.00 
Weak Peripheral Pulse 0.00 
Systolic Murmur 0.00 
Dyspnea 0.00 
Low thyroid angina  0.00 
Total  39.07 
 
 
5.5.2 Reclassification  
Based on the importance of the features of the Z-Alizadeh Sani dataset in the development of the 
CART model (see Table 5.3), this section describes the simple and clear approaches to develop 
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CART models for CAD diagnosis using selected features. To do so, all features with obtained 
importance of less than 2% are removed from the dataset, which is logical (and common) in the 
CART strategy. The remaining features (18 features) are then employed for the creation of a tree-
based predictive model. The resulted CART model using 18 selected features classifies the targets 
with the highest achievable accuracy, TNV, and TPR (100%). The visualized version of the 
proposed CART model with 18 features is presented in Fig. 5.4.  
 
 
Fig. 5.4: Schematic of a created tree to represent the proposed CART model with 18 features for 
CAD diagnosis. 
 
To introduce another CART model, the first 10 features that have the highest importance in the 
developed CART model (referring to Fig 5.2) are selected. Similar to the approach used for 
developing the CART models with all features (see Fig. 5.2) and 18 features (see Fig. 5.4), the 
CART classifier with 10 features shows an accuracy, TNV, and TPR of 100%. The created tree-
based model with10 selected features is illustrated in Fig. 5.5.  
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Fig. 5.5: Graphical representation of the developed CART model for diagnosis of CAD while 
using 10 features.  
 
The importance degree of each selected feature in the development of the CART models using 18 
and 10 selected features is listed in Tables 5.4 and 5.5, respectively.  
Examining the performance of CART methodology in classifying the targets with a limited number 
of inputs, the next model is developed through including only 5 features namely age, diastolic 
murmur, typical chest pain, atypical, and VHD. These features are found to be the most influential 
parameters in the development of the CART model with all the Z-Alizadeh Sani dataset’s features. 
Fig. 5.6 shows the CART model introduced by 5 selected features.  It should be noted that the same 
dataset splitting procedure is utilized for the development of CART models with 18, 10, and 5 
selected features; 90% of the new dataset is dedicated to the training phase, and the remainder of the 
dataset (10%) is used for model testing.   
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Table 5.4: Significance of each feature in the development of the CART model (using 18 features) 
for CAD diagnosis.  
Feature Category Feature Name Importance (%) 
Demographic 
Age 8.95 
DM 4.72 
BMI 7.82 
Length 5.49 
Weight 9.25 
DLP 0.78 
Obesity 0.52 
Total 37.53 
Laboratory and echo   
VHD 3.66 
ESR 5.62 
K 3.19 
Region RWMA 5.81 
PLT 4.72 
EF-TTE 3.95 
Total  26.95 
Symptom and examination  
Atypical 1.62 
Typical Chest Pain 27.31 
Diastolic Murmur 0.91 
Lung Rales 0.29 
BP 5.39 
Total  35.52 
 
 
 
Table 5.5: Importance of each feature in the development of the CART approach with10 features 
for CAD diagnosis.  
Feature Category Feature Name Importance (%) 
Demographic 
Age 11.25 
DM 6.13 
BMI 21.96 
Total 39.34 
Laboratory and echo   
VHD 5.01 
ESR 10.97 
K 8.15 
Region RWMA 9.39 
Total  33.52 
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Table 5.5: Continued. 
Feature Category Feature Name Importance (%) 
Symptom and examination  
Atypical 4.64 
Typical Chest Pain 21.57 
Diastolic Murmur 0.93 
Total  27.14 
 
 
 
Fig. 5.6: Graphical representation of the CART model with 5 features for CAD diagnosis. 
 
As can be observed from Fig. 5.2 and 5.4-5.6, the optimum maximum depths of the trees for the 
created CARTs with all the features, 18 features, 10 features, and 5 features are 19, 17, 17 and 16, 
respectively. Hence, it is crucial to employ a comprehensive database for the development of a 
CART classifier for CAD diagnosis.  
Feature importance values for the five-feature CART model are tabulated in Table 5.6. According 
to the results, the age and typical chest pain have the highest significance among all features of the 
Z-Alizadeh Sani dataset. Indeed, these two CAD risk factors exhibit the most contributions to the 
development of the tree-based model structure.   
Table 5.7 presents the contingency table of the developed CART model with 5 selected features. 
The contingency table reveals that the highest accuracy cannot be obtained using age, diastolic 
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murmur, typical chest pain, atypical, and VHD as the independent parameters for the CART 
methodology, while classifying the Z-Alizadeh Sani dataset.  
 
Table 5.6: Importance of each feature in the development of the CART structure (using 5 features) 
for CAD diagnosis.  
Feature Category Feature Name Importance (%) 
Demographic Age 51.72 
Laboratory and echo   VHD 3.92 
Symptom and examination  
Atypical 16.85 
Typical Chest Pain 22.59 
Diastolic Murmur 4.92 
Total  44.36 
 
 
Table 5.7: Contingency table of the developed CART model with 5 features on the basis of the Z-
Alizadeh Sani databank. 
  CART outcomes 
  Normal CAD  
Targets 
Normal 67 20 
CAD  3  213 
 
 
5.5.3 CART versus literature models  
The proposed CART models with all, 18, and 10 features lead to the highest achievable reliability 
(and accuracy) based on the Z-Alizadeh Sani dataset. The classification performance of the 
developed CART model with 5 features in the CAD diagnosis is compared to that of the previous 
models, as seen in Table 5.8.  
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Table 5.8: Error analysis results for the developed CART model (using 5 features) and the 
literature models while conducting CAD diagnosis.  
Algorithm 
Parameter 
ACC% TNV% TPR% 
Bagging SMO [51] 93.40 87.36 95.83 
Naïve Bayes [51] 75.51 95.40 67.59 
SMO [51] 94.08 88.51 96.30 
ANN [51] 88.11 80.46 91.20 
ANN [53] 84.62 83.00 86.00 
ANN-GA [53] 93.85 92.00 97.00 
N2GC-nuSVM [79] 93.08 * * 
SMO [75] 92.09 79.31 97.22 
SVM [75] 89.11 83.91 91.20 
C4.5 [75] 83.85 55.17 95.37 
Naïve Bayes [75] 80.15 94.25 74.54 
KNN (k=1) [75] 74.61 28.74 93.06 
KNN (k=2) [75] 74.94 17.24 98.15 
KNN (k=10) [75] 72.62 4.60 100 
Naïve Bayes (average) [76] 60.61 47.56 73.02 
C.45 (average) [76] 68.76 67.59 65.80 
KNN(average) [76] 60.05 56.62 57.85 
Naïve Bayes [80] 87.22 76.50 91.50 
SMO [80] 86.95 79.00 90.11 
Ensemble [80] 88.52 82.05 91.12 
C4.5 (average) [81] 68.30 60.14 71.04 
Bagging (average) [81] 69.64 61.32 71.38 
J48+MFA (average) [82] 91.09 * 91.10 
BF tree+MFA (average) [82] 87.70 * 87.70 
REP tree+MFA (average) [82] 84.28 * 84.27 
NB tree+MFA (average) [82] 93.77 * 93.77 
CART (5 features) 92.41 77.01 98.61 
 
Considering TPR, the KNN (k=10) model [75] gives better results, compared to other approaches 
(see Table 5.8). The NB/SMO model is the best model in terms of TNV extent (accuracy). Although 
the CART model created with 5 features generates acceptable results, some literature models exhibit 
greater accuracy and reliability.  However, the CART models with all, 18, and 10 features offer 
100% accuracy, TNV, and TPR; this accuracy level is not achieved in the previously reported 
models. Appendix C presents the digraphs of all the developed CART models.   
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The outcomes of the literature models developed based on algorithms such as Bagging, SMO, 
Bagging SMO, NB, C4.5, J48, SVM, ANN, and ANN linked with the GA are compared to the 
predictions of the developed CART models with all, 18 and 10 features in Fig. 5.7 where the Z-
Alizadeh Sani dataset is used.   
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(C)  
Fig. 5.7: Comparison of the performance of the developed CART systems with all, 18, and 10 
features and the literature models in terms of (A) accuracy, (B) TNV, and (C) TPR. 
 
It is concluded from Fig. 5.7(A) that the SMO and Bagging SMO models, presented by Alizadehsani 
et al. [51], as well as the ANN-GA model, suggested by Arabasadi et al. [53], lead to the highest 
accurate results, compared to other literature models. Based on Fig. 5.7(B) and 5.7(C), the values 
of the TPR% and TNV% for the ANN-GA model [53] are greater than those for the SMO and 
Bagging SMO models. Therefore, it can be concluded that the ANN-GA [53] is the best literature 
model. On the other hand, the lowest accuracy and TPR are attained while employing the KNN 
(average) model, as noticed in Table 5.8 [76]. It also reveals that the lowest TNV is associated with 
the KNN model with k=10 [75]. 
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5.5.4 Future work  
One of the main advantages of the strategy proposed in this study over other algorithms is that the 
designed CART-based models can be visualized in an understandable manner. Indeed, there is no 
need for medical experts to obtain mathematical and computational information regarding the 
classification methodology. However, comparing the developed CART models with different sets 
of Z-Alizadeh Sani dataset’s features reveals that the structure of the CART classifier is highly 
sensitive to the employed data points and independent parameters for modeling. The ML approaches 
are commonly sensitive to the introduced datasets. To obtain satisfactory outcomes, the employed 
dataset typically needs to be extensive, inclusive, and unbiased. For future studies, it is thus 
suggested to collect more data from diverse resources for CAD diagnosis/classification. 
Furthermore, the quality of the datasets for CAD diagnosis can be improved by considering more 
independent parameters.   
According to No Free Lunch Theorem for ML [77], there is no universal model that provides the 
best results for every problem. Hence, for every analysis, regression or classification, the most 
common strategy is to implement several ML methods and evaluate their performance and reliability 
based on statistical parameters. A model developed for a particular objective may be assessed in 
terms of accuracy and/or complexity. Depending on the nature and importance of the problem, the 
best model can be selected. As the number and size of datasets for CAD are growing, it is 
recommended to implement different ML or connectionist tools and find a model that produced the 
best outcomes for new datasets.  
  
5.6 CONCLUSIONS  
Several tree-based classifiers are developed on the basis of the CART algorithm where a recently 
collected clinical data namely the Z-Alizadeh Sani dataset is utilized for CAD diagnosis. To ensure 
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that the developed models based on the CART algorithm are reliable, both testing strategies with 
10-fold cross validation and with a test sub-dataset are included in the validation process.  
Employing ACC%, TPR%, and PPV% as the model assessment criteria, the classification 
performance of the presented CART models and previous predictive models is evaluated. The 
findings of the present study reveal that the CART method is capable of classifying individuals as 
normal or CAD. The CART models developed by considering all, 18, and 10 risk factors of the 
employed CAD dataset attain the highest precision (and reliability) and no literature model can rival 
it. The classification results of the CART approach with 5 selected features shows that using only 5 
parameters in model development leads to some errors, though the error percentage is still low 
compared to a majority of the models available in the open sources.   
The outcome of this study supports the idea that the CART method is able to present a simple-to-
use, reliable, and accurate approach for CAD diagnosis. Hence, the simplicity and robustness of the 
CART technique when applying to the CAD dataset make this modeling tool as a potential 
component of a proper healing framework. Furthermore, healthcare professions and postgraduate 
students can benefit from it. Since the CART classification modeling is highly sensitive to the quality 
and quantity of the introduced data, a more extensive database for CAD with a greater number of 
independent parameters might be required for further practical implications of CART tools in 
hospitals and health centers.      
 
NOMENCLATURES  
A0 Intercept 
AACE American Association of Clinical Endocrinologists 
ACC Accuracy  
ACC/AHA American College of Cardiology/American Heart Association 
ANFIS Adaptive neuro-fuzzy inference system 
ANN Artificial Neural Network 
BBB Bundle branch block 
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i  Regression constants  
BMI Body mass index 
BP Blood pressure  
BUN Blood urea nitrogen 
CAD Coronary artery disease  
CART Classification and Regression Tree 
CHF Congestive heart failure 
Cr Creatine 
CRF Chronic renal failure 
CVA Cerebrovascular accident 
DLP Dyslipidemia 
DM Diabetes mellitus 
EBCT Electron-beam computed tomography  
ECG Electrocardiogram 
EF Ejection function 
ESR Erythrocyte sedimentation rate 
f(x) The discriminant vector 
FBS Fasting blood sugar 
FH Family history 
fn False negative 
fp False positive 
GA Genetic algorithm  
HB Hemoglobin  
HDL High density lipoprotein  
HRV Heart Rate Variability  
HTN Hyper tension 
ID3 Iterative Dichotomiser 3  
IT2FLS Interval type-2 fuzzy logic system  
K Potassium 
LDL Low density lipoprotein 
Li Value of the leaf 
LVH Left ventricular hypertrophy 
ML Machine learning 
MLP Multi-layer perceptron  
Na Sodium 
NB Naïve Bayes 
NMR Nuclear magnetic resonance  
p Probability of CAD  
PCA Principal component analysis  
PLT Platelet  
PR Pulse rate 
RBF Radial basis function  
region with RWMA Regional wall motion abnormality 
RFNN Recurrent fuzzy neural network 
SMO Sequential Minimal Optimization 
SVM Support Vector Machine  
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TG Triglyceride 
Ti  Value of the threshold 
tn True negative 
TNV True Negative Value 
tp True positive 
TPR True Positive Rate  
USPSTF US Preventive Services Task Force  
VHD Valvular heart disease 
WBC White blood cell 
WHO World Health Organization  
WPP Weak peripheral pulse 
WT Wavelet transformation 
xi Risk factors 
X vector of the independent variables 
Y Output of the decision tree 
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6 SUMMARY, CONCLUSIONS AND RECOMMENDATIONS 
6.1 CHAPTER 2 
6.1.1 Summary  
Further to the laboratory examinations for BC studies, machine learning and data mining approaches 
could be implemented for the development of computer-aided BC diagnosis systems. There are 
several datasets for BC studies. The WBCD is known to be the most employed one for classification 
modeling using different machine learning and data mining techniques. The primary objective of 
this review study was identifying published works on the application of smart algorithms for the 
WBCD classification. To this end, papers published between 1995 and 2020 were reviewed. 
Moreover, available classification models in the literature were analysed according to some 
statistical parameters. 
 
6.1.2 Conclusions  
As some papers just reported the accuracy of the proposed models, this parameter selected as the 
main variable for comparisons. This was the major limitation of our study. Based on the error 
analysis results, it was found that hybrid models are generally effective in classifying the WBCD 
into malignant or benign cases. Indeed, the majority of the reviewed hybrid methods have flexible 
capability of nonlinear modeling. Furthermore, it was found that employing feature extraction 
techniques boosted the overall performance of some classifiers.  
However, as some approaches, like ANNs, are known to be black boxes, the resulting model might 
not be clear and could not be easily understood by non-experts like physicians.  
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6.1.3 Recommendations 
In this study, we just investigated the developed models for the WBCD. As it was mentioned in 
Chapter 2, there are more datasets like MIAS, IRMA and DDSM. It is recommended that all 
published papers on the classification modeling using these datasets also be reviewed. Evaluation of 
the effect of feature extraction techniques on classification performance is also recommended. As 
mentioned earlier, hybrid models provided excellent outcomes for the WBCD classification. It is 
recommended to assess the sustainability of different hybrid models on different datasets. Another 
recommendation is to develop an extensive database with a sufficient number of features for BC 
investigations. In the case of small datasets like the WBCD, the speed of the employed techniques 
might not be significant. However, slow performance caused by massive computations is a problem 
to be solved when big databases are employed. Therefore, researchers are encouraged to evaluate 
the models in terms of computation speed as well.  
 
 
6.2 CHAPTER 3 
6.2.1 Summary  
Classifying the medical datasets using such approaches as ANNs, SVMs and KNNs paves the way 
to design a more efficient medical diagnostic decision support system. Chapter 3 aimed at employing 
the RF and ET algorithms to classify the breast cancer type based on the WBCD. To attain the 
objective, the CART technique was used as a weak learner in conjunction with several RF/ET 
classification models. It was found that the developed RF models with four to ten CARTs and ET 
models with three to nine CARTs have high potential to forecast the WBCD type with 100% 
accuracy in all cases. 
6.2.2 Conclusions  
The development of classification models for BC diagnosis is of great interest to the researchers. It 
was revealed that the deterministic models and hybrid approaches existing in the literature offer 
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acceptable outcomes; however, greater precision in the medicine might considerably affect the 
diagnosis time, cure/therapy duration, and diagnosis and therapy costs. In addition, a majority of the 
available tools suffer from higher complexity, lack of optimal structure, and overfitting. The 
presented RF/ET models are simple to understand and appreciably efficient to categorize the WBCD 
so that no model can rival this classification strategy in terms of robustness, reliability, 
implementation speed, and precision.  
 
6.2.3 Recommendations 
The presented ensemble models based on the RF and ET methodologies in conjunction with the 
CART method provided excellent outcomes for the WBCD. However, as machine learning and data 
mining approaches, like the RF and ET ensemble techniques, are highly sensitive to the employed 
datasets, it is recommended to evaluate the performance of these approaches for studying other 
available databases on breast cancer. 
Another recommendation would be incorporating optimization algorithms like genetic algorithm 
and particle swarm optimization algorithm into the investigated ensemble methodologies for future 
studies. Implementation of hybrid ensemble methods might further simplify and improve the 
structure of the weak learners of the ensembles. 
 
6.3 CHAPTER 4 
6.3.1 Summary  
This research employed the CART algorithm to present accurate predictive models capable of 
analyzing the response of patients having common and/or plantar warts to the cryotherapy and/or 
immunotherapy methods. To develop a CART classifier for the cryotherapy method, input 
parameters including the age and gender of patient, number of warts, type of wart, surface area of 
warts and the time elapsed before treatment are used. In the case of immunotherapy, in addition to 
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the above-mentioned variables, the induration diameter of the initial test is also considered. To the 
best of our knowledge, this was the first study on the application of CART-based methods for 
selection of the best approach for wart removal. 
 
6.3.2 Conclusions  
The presented models provide simple-to-employ and accurate tools that can be used by physicians 
to select the best treatment method for common and/or plantar warts. The performance of the 
developed classifiers is compared to that of the methods available in the literature in terms of 
reliability and prediction accuracy. For both cryotherapy and immunotherapy approaches, the 
outcomes of the proposed CART models offered excellent performance. ACC, TPR, and TNR of 
the presented models are found to be 100%.  
On the other hand, the literature models for the cryotherapy case lead to ACC, TPR, and TNR 
ranging from 80.0% to 98.9%, 82.0% to 98.9%, and 77.0% to 100%, respectively.  For the 
immunotherapy case, the magnitudes of ACC, TPR, and TNR are between 78.9%-96.7%, 82.2%-
97.2%, and 56.7-91.4%, correspondingly. Furthermore, the proposed models appear in a graphical 
form and can be easily employed in an understandable manner. Hence, it can be concluded that no 
model can rival the proposed CART models in terms of both accuracy and simplicity of 
implementation.  
 
6.3.3 Recommendations  
The current datasets for the application of interest can be expanded by obtaining further information 
from various groups of patients. Consequently, we are able to present more efficient (and 
generalized) decision tree-based models that can be more practical for different cases. Another 
recommendation is to incorporate capable hybrid and ensemble methodologies (e.g., genetic 
algorithm and particle swarm optimization) into the CART algorithm for future studies. 
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Implementation of hybrid/ensemble methods might further simplify (and improve) the structure of 
the tree-based models developed for wart treatment.   
 
6.4 CHAPTER 5 
6.4.1 Summary  
Based on the Z-Alizadeh Sani dataset for CAD diagnosis, several classifiers were developed using 
the CART algorithm. Employing some statistical parameters as the model assessment criteria, the 
classification performance of the proposed CART models, as well as the literature models, is 
assessed. The findings of this chapter revealed that the CART algorithm is capable of classifying 
individuals as normal or CAD. The CART models built by considering all, 18, and 10 risk factors 
of the used CAD dataset attain the highest precision (and reliability), and no literature model can 
rival it. The classification results of the CART model with five selected features indicated that using 
only five parameters in the development process leads to some errors. However, the error percentage 
is still low compared to a majority of the models available in the open sources.   
 
6.4.2 Conclusions  
The outcome of Chapter 5 supports the idea that the CART method is capable of presenting an easy-
to-use, reliable and accurate tool for CAD diagnosis. Hence, the simplicity and robustness of the 
CART technique when applying to the CAD dataset make this modeling tool as a potential 
component of a proper healing framework. Furthermore, as the CART model is easy to understand, 
healthcare professions and postgraduate students can benefit from it.  
6.4.3 Recommendations  
Most machine learning and data mining approaches, including the CART classification algorithm, 
are highly sensitive to the quality and quantity of the introduced data. Hence, a more extensive 
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database for CAD with a higher number of independent parameters might be required for further 
practical implications of CART tools in hospitals and health centers.      
 
APPENDICES  
 
APPENDIX A 
Digraphs of the created trees for the RF classification models with 5 to 10 CARTs as well as the ET 
classification models for breast cancer with 4 to 9 CARTs are provided in an additional file.   
 
APPENDIX B 
The digraphs of the CART models proposed in this study for wart treatment are provided as an 
additional file.  
 
APPENDIX C 
This appendix provides digraphs of the CART models created for coronary artery disease. 
